Zell-freie Expressionssysteme: ein “Bottom-Up”-Ansatz für die Synthetische Biologie by Schwarz-Schilling, Matthaeus
Physics Department
Cell-Free Expression Systems:
a Bottom-Up Approach to
Synthetic Biology
Dissertation by
Matthaeus Schwarz-Schilling
TECHNISCHE UNIVERSITA¨T MU¨NCHEN

TECHNISCHE UNIVERSITA¨T MU¨NCHEN
Fakulta¨t fu¨r Physik
Physik synthetischer Biosysteme
Cell-Free Expression Systems:
a Bottom-Up Approach to Synthetic
Biology
Matthaeus Schwarz-Schilling
Vollsta¨ndiger Abdruck der von der Fakulta¨t fu¨r Physik der Technischen Univer-
sita¨t Mu¨nchen zur Erlangung des akademischen Grades eines
Doktors der Naturwissenschaften
genehmigten Dissertation.
Vorsitzende(r): Prof. Dr. Martin Zacharias
Pru¨fer der Dissertation:
1. Prof. Dr. Friedrich C. Simmel
2. Prof. Dr. Ulrich Gerland
Die Dissertation wurde am 06.05.2019 bei der Technischen Universita¨t Mu¨nchen
eingereicht und durch die Fakulta¨t der Physik am 01.07.2019 angenommen.

Contents
Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Zusammenfassung . . . . . . . . . . . . . . . . . . . . . . . . . . 6
1 Introduction 8
1.1 Synthetic biology . . . . . . . . . . . . . . . . . . . . . . . . . 8
1.2 Goals of synthetic biology . . . . . . . . . . . . . . . . . . . . 9
1.3 Challenges in synthetic biology . . . . . . . . . . . . . . . . . 9
1.4 Synthetic biology in bacteria . . . . . . . . . . . . . . . . . . . 14
1.5 Cell-free synthetic biology . . . . . . . . . . . . . . . . . . . . 18
1.6 Overview of the thesis . . . . . . . . . . . . . . . . . . . . . . 21
2 Background 22
2.1 Transcription and translation . . . . . . . . . . . . . . . . . . 22
2.1.1 DNA and RNA . . . . . . . . . . . . . . . . . . . . . . 22
2.1.2 Transcription by T7 RNA polymerase . . . . . . . . . . 23
2.1.3 Transcription by E. coli RNA polymerase . . . . . . . 24
2.1.4 Translation . . . . . . . . . . . . . . . . . . . . . . . . 24
2.2 Controlling gene expression . . . . . . . . . . . . . . . . . . . 26
2.3 Noise in gene expression . . . . . . . . . . . . . . . . . . . . . 29
2.4 Using chemical reaction networks to model a cell . . . . . . . . 31
2.5 CRISPR-Cas9 . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.6 CRISPRi . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.7 RNA nanostructures . . . . . . . . . . . . . . . . . . . . . . . 41
3 Chemical communication between a cell-free expression sys-
tem and bacteria 45
3.1 Biological background and motivation . . . . . . . . . . . . . . 45
3.1.1 Artificial biomimetic systems . . . . . . . . . . . . . . 46
3.1.2 The Lux-system . . . . . . . . . . . . . . . . . . . . . . 46
3.2 The AHL sender-receiver plasmids . . . . . . . . . . . . . . . . 48
3.3 Water-in-oil droplets . . . . . . . . . . . . . . . . . . . . . . . 48
3.4 Outline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
1
3.5 TXTL: AHL receiver plasmid . . . . . . . . . . . . . . . . . . 49
3.5.1 Hill curve . . . . . . . . . . . . . . . . . . . . . . . . . 49
3.5.2 Comparison to bacteria . . . . . . . . . . . . . . . . . . 50
3.5.3 Related studies . . . . . . . . . . . . . . . . . . . . . . 51
3.5.4 LacI control of the receiver plasmid . . . . . . . . . . . 52
3.6 Encapsulated TXTL or bacteria with an AHL receiver plasmid
in a spatial AHL concentration gradient . . . . . . . . . . . . 53
3.6.1 Experimental set-up . . . . . . . . . . . . . . . . . . . 53
3.6.2 Considerations: inducer gradients . . . . . . . . . . . . 53
3.6.3 Reaction-diffusion system . . . . . . . . . . . . . . . . 57
3.6.4 TXTL droplets in a spatial AHL concentration gradient 58
3.6.5 Apparent diffusion coefficient . . . . . . . . . . . . . . 59
3.6.6 Depreciation of TXTL . . . . . . . . . . . . . . . . . . 61
3.6.7 Surfactant micelle formation . . . . . . . . . . . . . . . 62
3.6.8 Binding to LuxR . . . . . . . . . . . . . . . . . . . . . 63
3.6.9 1D geometry . . . . . . . . . . . . . . . . . . . . . . . 63
3.7 TXTL droplets vs. bacteria droplets with AHL reservoir . . . 64
3.8 IPTG concentration gradient . . . . . . . . . . . . . . . . . . . 66
3.9 Reservoir inducer droplets . . . . . . . . . . . . . . . . . . . . 67
3.10 From AHL senders to AHL receivers using TXTL and bacteria
droplets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
3.11 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
3.12 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . 71
3.12.1 Preparation of the cell-free gene expression system . . . 71
3.12.2 Bacterial strains and culture media . . . . . . . . . . . 71
3.12.3 Microfluidics . . . . . . . . . . . . . . . . . . . . . . . . 72
3.12.4 Bulk characterization . . . . . . . . . . . . . . . . . . . 73
3.12.5 Microscopy . . . . . . . . . . . . . . . . . . . . . . . . 73
3.12.6 Data analysis . . . . . . . . . . . . . . . . . . . . . . . 73
3.12.7 Filling of the capillaries . . . . . . . . . . . . . . . . . 74
3.13 Contributions . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
4 RNA-protein nanostructure in a cell-free expression system 76
4.1 Bionanotechnology . . . . . . . . . . . . . . . . . . . . . . . . 76
4.2 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
4.3 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
4.4 RNA nanostructure design . . . . . . . . . . . . . . . . . . . . 80
4.5 Protein scaffold optimization using FRET . . . . . . . . . . . 82
4.5.1 Determining the complex concentration with
FRET . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
4.5.2 The fraction fcomplex . . . . . . . . . . . . . . . . . . . 86
4.5.3 Cooperative equilibria . . . . . . . . . . . . . . . . . . 88
4.6 RNA stability in a cell-free expression system . . . . . . . . . 90
4.7 One-pot expression and assembly of the RNA-protein nanos-
tructure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
4.8 Co-expression and localization of RNA-protein complexes on
streptavidin beads . . . . . . . . . . . . . . . . . . . . . . . . 96
4.9 Expression of the RNA-protein structure inside bacteria . . . . 96
4.10 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
4.11 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . 99
4.11.1 In vitro transcription . . . . . . . . . . . . . . . . . . . 99
4.11.2 RNA purification and quantification . . . . . . . . . . . 100
4.11.3 Protein purification . . . . . . . . . . . . . . . . . . . . 100
4.11.4 Electrophoretic mobility shift assay (EMSA) . . . . . . 100
4.11.5 Plasmid construction and purification . . . . . . . . . . 101
4.11.6 Cell-free expression system . . . . . . . . . . . . . . . . 101
4.11.7 Fluorescence intensity time traces . . . . . . . . . . . . 102
4.11.8 Encapsulation study using streptavidin coated beads . 103
4.11.9 TEM and AFM imaging . . . . . . . . . . . . . . . . . 103
4.11.10 Bacterial cultures . . . . . . . . . . . . . . . . . . . . . 104
4.12 Contributions . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
5 CRISPR interference: filamentation and restoration of nor-
mal growth in bacteria 106
5.1 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
5.2 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
5.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
5.3.1 Experimental design with decoy-binding sites . . . . . 110
5.3.2 Reversal of CRISPR interference using anti-sense RNA 113
5.3.3 Single-cell analysis of filamentation . . . . . . . . . . . 113
5.3.4 Efficiency of restoration of normal cell division . . . . . 113
5.3.5 Glycerol stocks . . . . . . . . . . . . . . . . . . . . . . 119
5.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
5.4.1 Switching cell division off . . . . . . . . . . . . . . . . 121
5.4.2 Restoration of E. coli to normal growth . . . . . . . . 122
5.4.3 Heterogeneity in gene expression . . . . . . . . . . . . 123
5.5 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . 124
5.5.1 Plasmids . . . . . . . . . . . . . . . . . . . . . . . . . . 124
5.5.2 Bacterial cell culture . . . . . . . . . . . . . . . . . . . 124
5.5.3 Fluorescence time-lapse microscopy . . . . . . . . . . . 124
5.5.4 Cell-free expression . . . . . . . . . . . . . . . . . . . . 125
5.5.5 Data analysis . . . . . . . . . . . . . . . . . . . . . . . 125
5.6 Contributions . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
6 Conclusion and outlook 127
List of publications . . . . . . . . . . . . . . . . . . . . . . . . . 129
Appendix . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 153
Acknowledgement . . . . . . . . . . . . . . . . . . . . . . . . . . 170
Abstract
Synthetic biology focuses on the design and implementation of new tools and
functions in biological systems. As an alternative to cells, cell-free expression
systems provide an open and controllable platform to develop and study
functional aspects of synthetic gene constructs. In this thesis, we employed
cell-free expression systems to characterize synthetic gene constructs and
then transferred them in living organisms.
First, we characterized a sender-receiver plasmid system which is based
on a quorum sensing molecule in bacteria and in a cell-free gene expression
system. To study the response of the receiver plasmid in spatial gradients
of the gene inducer, we encapsulated the bacteria/cell-free gene expression
system in emulsion droplets. We quantified the reaction-diffusion system
based on the expression of a fluorescent protein within the receiver droplets
and were able to demonstrate spatial control of gene expression. We further
showed that the chemical signal can be produced enzymatically in vitro and
in vivo. Finally, these findings allowed us to implement chemical communi-
cation between a cell-free expression system and bacteria.
In a second project, we investigated the expression of a RNA-protein
nanostructure in a cell-free expression system. The RNA-component of
the structure combined functional aspects such as scaffolding of a protein
FRET-pair, binding of a fluorescent ligand and binding of the nanostruc-
ture to streptavidin coated beads. We characterized the structure in regard
to complex formation efficiency and chemical stability. We then optimized
the simultaneous expression of the components and monitored their assem-
bly on streptavidin coated beads in a cell-free expression system in emulsion
droplets. Finally, we transformed the plasmids into bacteria and compared
the expression and assembly of the components in bacteria and in a cell-free
gene expression system.
In a third project, we studied the reversibility of filamentation of E. coli
bacteria with an inducible version of CRISPR interference (CRISPRi). In
this context we tested CRISPRi and an anti-sgRNA strategy in a cell-free
expression system. We then targeted the expression of the ftsZ gene with
CRISPRi in bacteria. Targeting the gene stops cell division while still al-
lowing for cell growth, thus resulting in filamentous cells. We showed that
both static (decoy binding sites) and inducible thresholds (anti-sgRNA) can
affect the characteristics of the switching process. Combining bulk data with
single cell measurements, we eventually characterized the efficiency of the
switching process.
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Zusammenfassung
Synthetische Biologie bescha¨ftigt sich mit dem Entwerfen und Implemen-
tieren von neuen Werkzeugen und Funktionen in biologischen Systemen. Hi-
erbei stellen zellfreie Expressionssysteme eine Option zur Erprobung und Un-
tersuchung synthetischer Werkzeuge in Zellen dar. Zellfreie Expressionssys-
teme bieten eine offene und kontrollierbare Umgebung fu¨r die Entwicklung
und Beschreibung von funktionellen Aspekten synthetischer Genkonstrukte.
In einem ersten Projekt wurde ein System, welches auf Sender- und
Empfa¨nger-Plasmiden und Quorum sensing Moleku¨len, welche als chemische
Signale fungieren, basiert, in Baktieren und in einem zellfreien Expressionsys-
tem charakterisiert. Um die Wirkung von ra¨umlichen Konzentrationsgradi-
enten des chemischen Signals auf das Empfa¨nger-Plasmid zu untersuchen,
wurden die Baktierien bzw. das zellfreie Expressionssytem in Emulsion-
stro¨pfchen kompartimentiert. Anhand der Expression eines fluoreszenten
Proteins vom Empfa¨nger-Plasmid wurde die Diffusion des chemischen Signal-
moleku¨ls quantifiziert. In der Folge war es mo¨glich, Genexpression ra¨umlich
zu strukturieren. Zudem wurde gezeigt, dass es mo¨glich ist, das chemis-
che Signalmoleku¨l in vitro und in vivo zu produzieren. Dies ermo¨glichte die
Etablierung einer chemischen Kommunikation zwischen Bakterien und dem
zellfreien Expressionssystem.
In einem zweiten Projekt wurde die Expression einer hybriden Nanostruk-
tur aus RNA und Protein in einem zellfreien Expressionsystem untersucht.
Der RNA-Anteil der Struktur erfu¨llt mehrere Funktionen wie das Bereit-
stellen eines Geru¨sts fu¨r ein Protein-basiertes FRET-Paar, das Anbinden
der Nanostruktur an Streptavidin-bedeckte Mikrokugeln oder das Binden
eines fluoreszenten Liganden. Zudem wurde die Struktur in Bezug auf ihre
chemische Stabilita¨t und auf die Effizienz der Komplexbildung charakter-
isiert. Daraufhin wurde die simultane Expression der Komponenten der
RNA-Protein-Nanostruktur optimiert und die Anordnung der Komponen-
ten auf Streptavidin-bedeckten Mikro-kugeln in Emulsionstro¨pfchen gezeigt.
Schließlich wurden die Plasmide in Bakterien transfomiert und die Expres-
sion der Komponenten in Bakterien wurde mit der Expression im zellfreien
Expressionssystem verglichen.
In einem dritten Projekt wurde die Reversibilita¨t der Bildung von Fila-
menten von E. coli -Bakterien mittels einer induzierbaren Version eines Sys-
tems auf Basis der CRISPR-Interferenz (CRISPRi) untersucht. In diesem
Kontext wurde CRISPRi mit einer Antisense-RNA-Strategie kombiniert und
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in einem zellfreien Expressionssystem betrachtet. Anschließend wurde durch
CRISPRi die Expression des ftsZ -Gens in E. coli unterdru¨ckt, was zu einem
Verlust der Fa¨higkeit zur Zellteilung fu¨hrte, nicht aber zum Abschalten des
Zellwachstums. Wir konnten zeigen, dass sowohl statische als auch induzier-
bare Schwellwerte den Umschaltprozess beeinflussen ko¨nnen. Schließlich kon-
nten wir durch die Kombination mehrerer Messmethoden die Effizienz des
Umschaltprozesses von sich teilenden Bakterien hin zu filamentierenden Bak-
terien charakterisieren.
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Chapter 1
Introduction
This section serves as an introduction into the field of synthetic biology. We
briefly introduce different approaches and then take a look at the proclaimed
goals and challenges of the field. Then the focus changes and we look at
the development of synthetic biology in bacteria, mainly E. coli, and cell-free
synthetic biology. Finally, we will give a brief overview of the content of the
thesis.
1.1 Synthetic biology
”Synthetic biology is the science of designing biological systems” [1] and
brings an engineering mindset to biology. It is an interdisciplinary field
enabled mainly by advancements in molecular biology and biotechnology.
Traditionally, research was limited to understanding and optimizing natural
systems, whereas today one can create and study artificial biological systems.
The research can range from engineering of biomolecules such as proteins to
changing the genome of living organisms. One can identify two main ap-
proaches, which are called top-down and bottom-up. The top-down approach
starts with existing biological organisms and reduces them until one can
understand aspects of it. A classical example for a ’top-down’ approach
to synthetic biology is the minimized genome of the Mycoplasma mycoides
JCVI-sny1.0, where the genome was reduced from about 1079 kilo base pairs
(kbp) to 531 kbp which was the minimum for the organism to still grow and
replicate [2]. Bottom-up synthetic biology, starts from non-living molecules
and combines them to create molecular systems or even an artificial cell. An
example for the ’bottom-up’ approach is a microfluidic assembly line that
carefully constructs lipid vesicles with trans-membrane proteins inside that
can use protein gradients to catalyze the creation of ATP [3]. In order to gain
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more clarity about the definition and direction of the research field, the next
two subsections will focus on more general goals and challenges of synthetic
biology.
1.2 Goals of synthetic biology
The MIT Synthetic Biology Center defines that the goal of ”synthetic biology
is to make the construction of novel biological systems into a practical and
useful engineering discipline” [4]. However, as there are different sub-areas
under the term synthetic biology, the immediate goals in these sub-areas will
differ. The spectrum ranges from finding new ways to manufacture molecules
within engineered organisms to the construction of molecular computers to
solve computational problems within or even outside of cells [5] [6] [7].
One unifying aspect of all the existing sub-areas in synthetic biology is the
creation of novel functional parts from bio-molecules. This means that the
field is not only carried by fundamental insights into the molecular world of
biology but also driven by the hypotheses of the designer of a novel functional
parts. The formulation of an hypothesis allows for falsification which can re-
sult in the generation of relevant research questions and advance fundamental
research in the biological sciences. Hence, from an academic standpoint the
boundaries of the field are particularly interesting. When a construct does
not work as planned a new research question is formulated. In this spirit,
Richard Feynman said: ”what I cannot create I do not understand”. How-
ever, sometimes the creation of functional parts such as the genetic construct
for the bio-production of a malaria drug precursor via engineered yeast [5] is
more of a story of trial-and error than the establishment of engineering rules
[8]. Hence one of the challenges of synthetic biology can be articulated in a
similar fashion as the quote from Richard Feynmann: what I can create, I
do not necessarily understand [9]. The next section will go into more detail
about the challenges in synthetic biology and how this can serve the field to
reach its goals.
1.3 Challenges in synthetic biology
As outlined by Rollie´ et al., electrical or chemical engineering have established
themselves as traditional engineering disciplines by successfully implement-
ing four general methods to reduce the complexity of the physical world:
abstraction, modularization, standardization and optimization [10]. The in-
troduction of engineering concepts to biological systems [11] is discussed in
9
this section. How well synthetic biology was able to apply and implement
these four conceptual steps of engineering in its research is more controversial
[8].
Standardization
In an effort to standardize genetic parts and inspired by standards from me-
chanical engineering the idea of BioBricks was introduced by Thomas Knight
in 2003 [12]. BioBricks parts are nucleic acid sequences that form a functional
unit such as a transcription promoter and are combined to create BioBrick
devices such as genes with all the components necessary for expression. Fur-
thermore there is a BioBrick assembly standard to assemble parts and devices
into systems that can perform a task [13] (Fig. 1.1A). The list of parts are
accessible in an online repository called ”The Registry of Standard Biologi-
cal Parts” which is mainly maintained by undergraduate students that take
part in the international Genetically Engineered Machines (iGEM) competi-
tion [14]. However, one of the problems with the registry is that there is no
warranty for the performance and quality of the parts, making it difficult to
reliably combine parts into functional modules [15]. However, the efforts for
the development of tools and parts in order to precisely control gene expres-
sion in bacteria, yeast and mammalian cells are ongoing [16] [17] [18]. The
creation of a reliable toolbox for genetic parts is an important requirement
for their abstraction, so that one can create genetic circuits from well char-
acterized parts without having to consider the molecular details of the parts
themselves. The next section is about the concept of abstraction in synthetic
biology.
Abstraction
The process of abstraction is a projection or reduction towards a simpler
system. A systems can be abstracted if it is known which details one can
neglect and which details one has to consider. Biological systems are chal-
lenging to abstract due to a large number of molecules and molecular species
present. Collisions between nearly all molecules within a cell create a large
amount of interactions. Many parameters such as reaction rate constants or
concentrations are difficult to access. Furthermore there are hidden interac-
tions between molecules due to shared interaction partners or biochemical
noise due to the stochastic nature of some reactions. These facts can hinder
the formulation of predictive models about the behavior of synthetic systems
within cells. For example in 2000, Leibler and Elowitz constructed a genetic
oscillator termed ”repressilator” due to its topology, which consists of three
10
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Figure 1.1: A Design of the BioBrick base vector. The pictographs on the vec-
tor each represent a different part. The vector is designed in such a manner that
the construct which is framed in the gray box can be easily exchanged with the
BioBrick assembly standard. The image is adapted from Ref. [13]. B Schematic
representation of the microfluidic trap for bacteria to monitor single cell lines over
several generations. Right upper image: kymograph from microscopy images of
the fluorescence signal of bacteria growing in the microfluidic trap. The bacte-
ria contain the original repressilator plasmid system from Ref [19]. Right lower
image: kymograph from microscopy images of the fluorescence singal of bacteria
with the revised ’repressilator’ plasmid system from Ref [20]. The subfigure is
adapted from Ref. [20]. Adapted by permission from Springer Nature, 2016. C
Schematic representation of modularization by compartmentalization. Network
graphs where each node represents a part and their interaction is represented by
an edge, are separated by an compartment (dotted line). The subfigure is adapted
from Ref. [10]. Copyright (2012), with permission from Elsevier. D An example
of how directed evolution improved an enzyme (cytochrome c from Rhodothermus
marinus) that catalyzes chiral Si-C bond formation. The bar graph shows the the
total turnovers (ttn) of the enzymes in the wild type form, and with one, two and
three mutations. The subfigure is adapted from Ref. [21].
transcription factors, repressing each other in a ”rock-paper-scissors” fash-
ion [22]. The oscillations of the transcription factors are observed via the
co-expression of a fluorescent protein. Experiments then showed that out
of approximately 100 analyzed bacteria about 60 % did not oscillate as was
expected by the design of the genetic circuit. In 2016, Potvin-Trottier et
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al. then published a revised version of the 16 year old genetic circuit, which
decreased the coefficient of variation in period length of the oscillator from
0.35% to 0.14% [20]. Having the possibility of tracking single bacteria over
generations, Potvin-Trottier et al. were able to identify and eliminate sources
of noise in the oscillations. It could be experimentally shown that by consid-
ering new parameters it was possible to improve the performance of an genetic
circuit (Fig. 1.1B). Some parameters they considered for the new design were
the fluctuation of the plasmid copy number and the coupling through shared
degradation pathways and the stochastic nature of gene expression. This ge-
netic circuit can now be regarded as a synthetic clock module within E. coli.
This example illustrates how synthetic biology struggles with the process of
abstraction due to the complexity of biological systems and how it can over-
come this problem by identifying the important and relevant mechanisms at
play. It is possible to design a system in such a way that it can be reduced
to its function, such as being a genetic clock.
Modularization
Modularization, meaning the interchangeability between different functional
parts without affecting the functionality of the other parts or breaking the
whole system, is a concept that is closely tied to all engineering disciplines.
Due to the fact that most biological functions probably evolved together with
the rest of the organism, modular architecture is not a necessity. Functional
units can co-depend in intricate ways on other functional units or have visible
or hidden redundancies within a cell or organism. This does not imply that
functional systems in a cell are not modular, it can signify that the modules
are hidden and intertwined. For example about 80% of the protein-coding
genes are non-essential for the survival in most prokaryotes and eukaryotes,
which means that their role can be compensated by other genes [23]. As
more of the gene regulation networks in bacteria is uncovered, the more
modules and functional units are identified [24]. Hence modular architec-
ture is present, however it may be hidden or hard to detect. There are two
main approaches to create modular systems. One is to create interaction be-
tween molecules which are orthogonal to the rest of the system. For example,
Meyer et al. were able to create six variants of the RNA polymerase from
phage T7 where each specifically recognizes a different promoter [25]. The
other solution is to separate a set of components from the rest of the system
by compartmentalization [11] (Fig. 1.1C). Compartments allow the separa-
tion of reactions via a membrane. A membrane can be designed to control
the input and output signals of the compartment so that compartments are
still able to communicate with each other however only via these designated
12
communication channels.
Compartments have evolved in most organisms such as protein-based
micro-compart-ments in bacteria or organelles with a lipid membrane in
eukaryotic cells [26]. Recent efforts have shown that prokaryotic micro-
compartments can be expressed and assembled in different species of bacteria
and even in yeast. The compartments can be used to encapsulate a proteins
of interest or active enzyme and protect them against degradation [27] [28].
In a different study, Avalos et al. were able to compartmentalize the Ehrlich
pathways into the mitochondria of yeast and thus greatly increase the isobu-
tanol production [29]. In conclusion, although modules have evolved in living
organisms, it can be challenging to detect them. Compartmentalization is
one of the most promising strategies for achieving modularization as it es-
tablishes clear boundaries. Thereby synthetic biologist are able to build on
solution that have already been created by nature.
Optimization
Optimization is the improvement of a functional system so it becomes more
efficient. Often optimization means an increase in product yield when concer-
ing durgs or a or an increase in the robustness of a sensor system. However,
optimization of metabolic pathways for the expression of certain molecules
can be extremely challenging due to the fact that the trial-and-error was the
most common approach to optimize synthetic genetic constructs [8].
Evolution optimized functional parts/elements in biological systems. The
algorithm of mutation and selection over up to billions of years evolved all
solutions that exist in biological systems today. Synthetic genetic constructs
will also be subjected to spontaneous mutations once inserted into a cell.
This can create a obstacle as the biological system will not be optimizing the
function encoded in the synthetic construct. It will rather follow a fitness
function that is tied to growth and survival of the organism. Often the
two functions correlate negatively with each other. The production of any
biomolecule will be costly in energy and resources. It forces engineers to opt
for one of the two solutions.
First one can try to create artificial systems that do not have to sur-
vive/sustain on their own such as in cell-free synthetic biology. Here func-
tional modules can be kept running due to engineered solutions like a me-
chanical pumping syste [30]. In addition, the creation and optimization of
synthetic systems can be greatly facilitated by having an environment that is
simpler than the cell. This can simplify prototyping and debugging of genetic
constructs. Here cell-free expression systems provide a solution [31].
The other approach for engineers to work with is that of directed evo-
13
lution. Here both functions that of the synthetic construct and the fitness
function of the organism are designed in such a way that they are tied to-
gether. This approach has proven useful in finding novel biochemistry and
optimizing enzymatic pathways [21] (Fig. 1.1D). However, it does not solve
the problem of genetic mutations inside of cells once a specific function has
been evolved. Certain constraints, like spontaneous mutations of synthetic
genetic constructs within cells have to be taken into account. The effect of
mutation rates has to be approximated and mechanisms like DNA proof-
reading, which reduce them, have to be implemented. Alternatively there
are work-around solutions outside of the cell.
This section provided an general overview of challenges within the field
of synthetic biology. Furthermore it illuminated synthetic biology in regard
to four different concepts of an engineering discipline: standardization, ab-
straction, modularization and optimization [10]. Despite the vast amount of
challenges that accompany working with living organisms, synthetic biologist
have demonstrated solutions within the constraints of knowledge and tech-
nologies. The idea of engineering biological systems is driven by the need for
sustainable and economic solutions to protect the ecosystem and inspired by
natural systems and human made machines. The next section provides an
overview of important advancements of synthetic biology in bacteria within
the last two decades.
1.4 Synthetic biology in bacteria
This section will first outline the development of tools that enabled synthetic
biology in the twentieth century. This will be followed by a brief review of
the first steps in creating artificial genetic systems in bacteria at the begin-
ning of the twenty-first century. Finally, we mention some experiments that
show current and potential developments in the area of synthetic biology in
bacteria.
The foundation for the creation of most synthetic genetic constructs is
in the understanding of the simplest biological organism such as prokary-
otes. Especially the gram-negative bacteria species, Escherichia coli, serves
as a model organism in molecular biology and now in synthetic biology. In
addition, most tools for genetic modification and molecular cloning were dis-
covered by studying bacteria in combination with bacteriophages [32]. In
1952, it was found that some bacteria can defend themselves against the in-
fection of bacteriophages and in 1968, restriction enzymes were identified as
the cause of this ability [33] [34]. In 1965 the observation was made that
linear DNA of bacteriophages is circularized after the infection of the host,
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and two years afterwards DNA ligase enzymes were successfully isolated in-
dependently by five different groups [35] [36] [37] [38] [39] [40]. Finally, in
1973 for the first time a recombinant DNA molecule was digested, ligated and
transformed into E. coli [41]. Since then the techniques for molecular cloning
have constantly improved, alongside with two very important technological
innovations, the polymerase chain reaction (PCR) which allows amplifica-
tion of recombinant DNA [42] and DNA sequencing, allowing verification of
cloning[43].
In parallel, the unraveling of molecular mechanisms of the regulation
mechanism of genes provided tools for the creation of gene switches. For
example in the early 1960s, Jacob and Monod discovered the mechanism of
regulator proteins within the lac operon [44]. Today, the so-called transcrip-
tion factors are a widely used tool in synthetic biology [45].
This paragraph will present three early examples of synthetic biology in
bacteria that have shown to be the basis for further developments in the field.
In a review paper from 2009, Purnick and Weiss declare that the first wave
of Synthetic Biology started around 2000 and entailed combining specific
functional parts like transcription promoters or transcription factors to sys-
tems within cells [48]. Three following experiments have provided researchers
with conceptual and technical ideas of how to pursue the construction of more
complicated synthetic circuits. The first example is a bistable switch, called
the ’toggle switch’. One can switch between the expression of two genes by
the transient addition of a chemical inducer for either of the genes. As each
of the genes represses the expression of the other gene it is ensured that
only one of the two proteins is expressed at a time and that it remains in
that state [49]1. The genetic device consisted of about 10 different functional
parts such as transcription promoters, ribosome binding sites (RBS), open
reading frames for three proteins and transcription terminators (Fig. 1.2A).
Another early example of a synthetic circuit that is created from functional
parts is the aforementioned protein oscillator - termed repressilator in E. coli
[19] (Fig. 1.2B). It consists of two plasmids, of three promoters two of those
are derived from phages and of three corresponding transcription repressors.
It was the first example of an autonomous synthetic circuits in bacteria as it
creates protein oscillations in a regular manner in bacteria without further
intervention by the researcher. The third and final example of a milestone
experiment was a publication by Weiss and Knight in 2000, in which they
demonstrate the creation of a sender and receiver module in E. coli (Fig.
1.2C). This allowed them to establish a chemical cell-to-cell communication
which was naturally foreign to E. coli [51].
1The first ’toggle switch’ for yeast was published in 2004 [50].
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Figure 1.2: A Schematic representation of genetic construct that encodes the
’toggle’ switch . Two inducible promoters express each a gene that represses the
other gene. The switching behavior is visualized by the co-expression of GFP with
the protein repressor 1 (induced by IPTG), where as the protein repressor 2 is
induced by aTc. The subfigure is adapted from Ref. [46]. Adapted by permission
from Springer Nature, 2000. B Scheme of the repressilator plasmid system. Three
transcription factors that repress the expression of each other in a ’rock-papers-
scissor’ fashion that results in oscillations in the concentration of proteins in the
bacteria. Left: GFP intensity of a single cell over time. The subfigure is adapted
from Ref. [22]. Adapted by permission from Springer Nature, 2000. C Scheme of a
sender and receiver system in bacteria that uses a chemical signal (here abbreviated
VAI) to induce gene expression in the receiver cell. Left, sender cells in the circle
produce the chemical signal and induce the receiver cells in the colonies around
which is visualized by GFP. The subfigure is adapted from Ref. [47]. Adapted by
permission from Springer Nature, 2003.
A crucial next step in genetic circuit design that build on the first wave
of synthetic biology was published approximately a decade later, in 2016,
when Nielsen et al. provided a software that automates the assembly of ge-
netic circuits from previously characterized parts [52]. They demonstrated
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its utility by designing 60 different genetic circuits in E. coli out of which ap-
proximately 45 worked as intended. However, new tools are constantly being
developed. Two prominent recent examples of tool that are able to control
the expression of genes are CRISPR interference (CRISPRi) and RNA toe-
hold switches [53] [54]. CRISPRi is based on a mutated non-cleaving version
of the Cas9 protein and can be used to halt transcription of a gene. The tech-
nology is described in more detail in Section 2.6. The RNA toehold switch
is a post-transcriptional gene switch based on a hairpin structure around the
RBS that inhibits ribosome assembly on the mRNA itself. Translation can
be switched on by opening the hairpin structure via the binding of another
RNA strands. Both tools have been applied to create logic circuits within
bacteria [55] [56].
The efforts to create applications for the engineered bacteria are growing
and especially medical application within mammalian guts are being explored
[57]. In addition, strategies to fight cancer with engineered bacteria are being
developed. Din et al. have recently demonstrated that certain bacteria that
grow in and around cancer tumors, could be reprogrammed so that they
lyse after a certain population density is reached. During lysis a genetically
encoded cargo is being released which potentially can destroy cancer cells.
After lysis, few bacteria survive so that the population regrows, creating
pulses of the released cargo around cancer cells which results in repeated and
coordinated attacks on the tumors.
Advancements in the engineering of bacteria in the microbiome serve as
the last example of more recent developments in synthetic biology. Potential
applications are promised in the field of diagnosis and personal medicine.
For example, recently an interspecies communication between different en-
gineered gut bacteria was established in mice. The communication was
recorded in the bacteria using a genetic circuits that was used as a mem-
ory element [58].
In conclusion, functional systems within bacteria can be constructed from
well defined parts. New tools are constantly being developed and enable the
construction of new synthetic systems. In parallel, different applications of
genetically engineered bacteria are starting to be realized despite the com-
plexity of the biological systems. The next section addresses cell-free syn-
thetic biology, which provides the possibility of synthetic genetic construct
outside of cells.
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1.5 Cell-free synthetic biology
This section provides an introduction into cell-free synthetic biology by first
taking a glance at the history of cell-free biology. A brief overview of recent
developments in the research area defined as cell-free synthetic biology is
provided.
As the name cell-free biology suggests living organisms are not involved.
Cell-free biology takes place outside the cell, but employs components and
biomolecules used and synthesized by cells such as DNA, RNA and proteins.
A large part within cell-free biology is based on cell lysates, which have been
used for decades by biologists to investigate biological processes and mech-
anisms. They originate from different kinds of cells such as: rat liver cells,
bacteria, human and rabbit reticulocytes, yeast, wheat germs and tobacco
plants [59] [60]. Cell lysates provide the possibility of cell-free protein syn-
thesis (CFPS) from supplemented DNA or mRNA. Researchers have used
the fact that it is an open system to decipher molecular mechanisms. In
1961, Nierenberg and Matthaei were able to show that the triplet of UUU in
RNA codes for the amino acid phenylalanine using purified RNA in a cell-
free expression system. They thereby cracked the genetic code [61]. Since
1994, researches were able to unravel the complex process of translation ini-
tiation in eukaryotes using yeast cell extracts [62] [63]. Furthermore, Shin et
al. have demonstrated the replication of the genetic material of the bacterio-
phage T7 and its self-assembly inside a cell-free expression system, providing
a platform to further understand, engineer and produce phages [64].
At the interface of cell-free biology and synthetic biology there is a sub-
direction called cell-free synthetic biology, which combines elements from bio-
chemistry, molecular biology and nanosciences [65] [66]. Recently there has
been an increased interest in CFPS from researchers outside of biology due
to the availability of simple protocols explaining how to create cell extract
from E. coli [67] [68]. In addition there are commercial suppliers for cell-
free expression systems based on crude cell extracts to purely reconstituted
components, called the PURE2 system [69]. With these open and relatively
simple systems, researchers can create reductionist versions of a cell using
only selected components to study molecular mechanisms under better con-
trol and accessibility. In 2005, Isalan et al. used artificial chambers filled
with agarose, cell extract and patterned genes to emulate the pattern for-
mation of the Drosophila embryo [70]. Another creative approach to study
pattern formation was enabled by creating an artificial cell like compartment
on a silicon chip that entails gene brushes and is continuously supplied with
2PURE stands for ”protein synthesis using recombinant elements”
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fresh cell-extract [71] (Fig. 1.3B). These compartments were then connected
to study spatiotemporal patterns [72]. Recently, Dupin and Simmel used a
controlled arrangement of droplets separated by a lipid bilayer [73] to study
signaling and differentiation processes in artificial multicellular system [74].
Cell-free synthetic biology can be used to prototype genetic circuits. In
2003, Noireaux et al. have demonstrated the operation of synthetic gene
circuits in a cell-free gene expression system [75] (Fig. 1.3A). Since then re-
searcher have used cell-free expression system to prototype synthetic genetic
constructs more rapidly than in vivo [76] [77]. Niederholtmeyer et al. have
used a nano-liter microfluidic reactor that can maintain a cell-free expres-
sion reaction in a steady-state [78] to prototype genetic circuits that code
for oscillatory protein expression before transforming them into bacteria [31]
(Fig. 1.3C). In parallel, cell-free expression systems themselves are the focus
of research. In order to understand their limitations and explore the pos-
sible applications, researchers are further characterizing and optimizing the
constituent parts and reactions within cell-free expression systems [79] [80].
The chemical interface of cell-free expression systems with biological or-
ganisms has been used to explore applications in the field of diagnostics.
In combination with paper-based microfluidics, RNA toehold switches and
CRISPR-Cas9 technology, Pardee et al. have created a test that can detect
a virus like Zika in purified blood samples and provide an optical read-out
within hours [82]. Furthermore, cell-free systems with genetic circuits can
sense chemicals in lungs samples from a P. aeruginosa infection which is a
common danger for people with cystic fibrosis [83].
In recent years, cell-free expression systems have also been used to syn-
thesize bioactive eukaryotic proteins that can be used for therapeutics [84] or
personalized medicine [85]. In addition metabolic pathways are engineered
within the cell-free expression system. For example, recently it was demon-
strated that engineered cell-free expression system were able to transform glu-
cose to valuable metabolites such as dihydroxyacetone phosphate (DHAP)
or isobutanol, a next generation biofuel [86]. Finally, scaling-up of batch
reactors of cell-free expression systems to about 100 liters has been demon-
strated [30] making industrial application of cell-free metabolic engineering
more feasible.
Furthermore, cell-free synthetic biology is connected to the field of bottom-
up synthetic biology. The idea behind a large German research consortium
called ”MaxSynBio” is to re-create modules of living organisms from scratch
and to combine them to create an artificial cell [87]. Exciting results from
the module replication and division come from experiments where purified
proteins that are naturally involved in cell-division in bacteria are encapsu-
lated in vesicles. The proteins interact with the vesicle membrane and create
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Figure 1.3: A Demonstration of a genetic circuit in a cell-free expression system.
Luminescence of luciferase was used as a read-out. Open circles show the signal
with IPTG (at t=0), close triangles with IPTG at t=3h and open triangles without
IPTG. The subfigure is adapted from Ref. [75]. B Upper image: Sketch of an gene
expression within an artificial mirco-compartment on a chip from gene brushes.
The cell-free expression system is pumped and exchanges material with the the
compartment over diffusion. Lower image: GFP expression from the DNA brush
within the compartment. The subfigure is adapted from Ref. [71]. Reprinted with
permission from AAAS. C Outline of a microfluidic system that operate a cell-free
expression reaction in a steady-state with the use of valves. The reaction chamber
can be imaged in real-time with an inverted microscope. The subfigure is adapted
from Ref. [78]. D Oscillations and spatiotemporal patterns on vesicle walls by
encapsulated proteins. The kymographs show pulsing, pole-to-pole oscillations,
circling and trigger waves. The subfigure is adapted from Ref. [81].
oscillations and other spatiotemporal patterns [81] (Fig. 1.3D). Furthermore
the protein oscillations can change the shape of the vesicle, which resulted
in periodic budding and merging of vesicles. In the module metabolism,
Schwander et al. were able to re-create the CETCH cycle, a carbon dioxide
fixation pathway, in vitro with 17 enzymes from nine different organisms out
of which three enzymes were engineered [88]. This opens up the possibilities
for artificial photosynthesis.
Cell-free systems are furthermore at the heart of another topic of research
called bionanosciences and molecular computing, which use mainly DNA to
construct nanostructures or materials and perform calculations [89] [90] [91]
[92]. DNA enzymes and DNA strands have been used to construct molec-
ular circuits that create spatiotemporal patterns [93] [94]. The research in
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these fields is closer to nanotechnology or computer science than to synthetic
biology.
In conclusion, synthetic cell-free biology is a fairly new research field at-
tracting researches from the outside of biology since it appears closer to an
engineering discipline than synthetic biology in living organisms. Further-
more, it is closely tied to the field of bottom-up biology, that tries to create
artificial cells from scratch. The full potential of cell-free synthetic biology
lies in the fact that it is an open system. The biochemistry of living organ-
isms hence can be more easily accessed and engineered than in cells. Having
introduced bacterial and cell-free synthetic biology, the next section is about
the structure and the content the thesis.
1.6 Overview of the thesis
The objective of the thesis is to explore the advantages of cell-free gene
expression systems over living organisms and to elucidate to what extent
one can use them to develop and prototype functional aspects of genetic
constructs. Moreover, we have focused on synthetic RNA based regulators
that can control the expression of genes or serve as a structural scaffold for
proteins. Cell-free expression systems provide an open platform in which
more parameters of gene expression are accessible. In addition, artificially
structured environments like emulsion droplets or microfluidic chambers were
introduced to facilitate the control of external parameters. The content of
this thesis is nearly exclusively focused on E. coli and E. coli based cell-free
expression systems.
The second chapter provides background information about gene expres-
sion, the control of gene expression and noise in gene expression. A brief
introduction into CRISPR, CRISPR interference and RNA nanostructures
is provided.
The third chapter looks at the establishment of chemical communication
between E. coli and a cell-free expression system via autoinducer molecules.
The content of this chapter has been published in Reference [95].
The forth chapter explores the expression and assembly of a multi-compon-
ent protein-RNA nanostructure in a cell-free expression system, where the
RNA serves as a scaffold for proteins. The content of this chapter has been
published in Reference [96].
In the fifth chapter, we examine gene expression in a cell-free system
and in E. coli, where CRISPR interference serves as repressor. Additionally
we examine an anti-sense RNA approach to CRISPRi. The content of this
chapter has been published in Reference [97].
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Chapter 2
Background
2.1 Transcription and translation
In 1958, five years after the structure of DNA was resolved, Francis Crick
introduced the central dogma of molecular biology [98]. It states that infor-
mation for proteins is stored in DNA which is transcribed by enzymes into
RNA that is then translated into proteins via an adapter molecule. The pro-
cess of creating RNA from DNA is called transcription and is mediated by
RNA polymerase (RNAP). The step from RNA to protein is mediated by the
the ribosome and is called translation. In combination, the whole reaction
from DNA to protein is termed gene expression or simply expression.
2.1.1 DNA and RNA
DNA and RNA both have their information encoded in four different nu-
cleotides that differ in their bases1. The four bases for DNA are adenine (A),
thymine (T), guanine (G) and cytosine (C). RNA shares the base of G,C
and A but has an uracil (U) as the fourth base. A DNA or RNA strand is a
sequence of bases connected by a phosphate-sugar backbone. RNA and DNA
also differ in the form of the sugar present in the backbone. DNA has a de-
oxyribose whereas RNA has a ribose. The backbone has two different ends, a
5’ and a 3’ end, which are named after the number of the carbons in the sugar
to which the first/last phosphate is attached. This provides the backbone
with an orientation (direction). In living organisms DNA is normally double
stranded, where two strands of opposite direction are intertwined forming a
double helix. Within the helix the bases are paired according to rules called
1There also exit non-canonical bases, however in the scope of this section we limit the
description.
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Watson-Crick base-pairing and are as follows: C pairs with G and A with T
or U for RNA. The information is encoded in the sequence of bases, and due
to the base pairing rules symmetric and available in both strands. RNAP uses
one of the DNA strands as a template and strings together ribose nucleotides
according to base-pairing rules with the DNA template. The concatenation
of such nucleotides is then the RNA strand. The next subsection describes
this process in more detail by looking at transcription by the RNAP from
the phage T7, which is widely used in the field of synthetic biology.
2.1.2 Transcription by T7 RNA polymerase
As described above, transcription is the polymerization of ribonucleotides
(rNTPs) to form RNA oligomers. The reaction itself consists of three phases:
initiation, elongation and termination. Here the process described will be
limited to the in vitro transcription by the RNAP from the phage T7, which
is a special case in the sense that the enzyme requires very few components
for transcription - mainly, a DNA template, Mg2+ ions, and rNTPs. The
initiation is proceeded by binding of RNAP to DNA. However to start tran-
scription the RNAP has to denature the double helix. Only at a specific DNA
sequence does the RNAP bind stably enough to start transcription and this
is called the promoter region: the promoter region for the T7 RNAP is 23
base pairs (bp) long:
5'-TAATACGACTCACTATA  GGGAGA-3
3’-ATTATGCTGAGTGATAT CCCTCT-5’
non-template
template
+1 +5
binding region
-17 -5
initiation region
Figure 2.1: The T7 promoter sequence has 23 bases pairs (bp). It can be divided
into two section, one for binding of the T7 RNA polymerase and one for the
initiation of transcription. The first base that will be used in the RNA strand is
at position +1.
Mutations in the first 12 bp affect the binding probability of the enzyme,
whereas transcription initiation is sensitive to mutations in the remaining 11
bp. The first base to be transcribed and that begins the RNA sequence is
at position +1 (Fig. 2.1). Once the RNAP has transitioned into elongation,
it migrates along the DNA strand, transiently denaturing the double helix
(transcription bubble) as it proceeds and catalyzing bond formation between
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the nascent RNA strand and new ribonucleotides. The transcription bubble
is about 8 bp long [99].The effective speed of transcription of the T7 RNAP
was measured to be about 97 nucleotides per second [100]. The sequence of
the RNA strand is complementary to the template strand of the DNA.
At the end of non-circular DNA strands the RNAP just falls off. However
in plasmids and long DNA strands the transcription is terminated by tran-
scription terminator sequences. A typical transcription terminator is made
up of a hairpin structure followed by an A-U rich sequence. The hairpin struc-
ture folds on itself after transcription and pulls on the A-U rich DNA:RNA
hybrid2. Transcription is terminated when the RNA:DNA helix dissociates
due to the pull of the hairpin formation [101].
2.1.3 Transcription by E. coli RNA polymerase
The native RNA polymerase from E. coli consists of multiple components.
For initiation of transcription a subunit called σ factor binds to the core
enzyme which then mediates the binding of the complex, also called RNA
polymerase holoenzyme, to the promoter sequence [102]. Once the complex
has found and bound the promoter region, structural changes in the enzyme
and DNA unwind the double helix and rNTPs can diffuse and position them-
selves on the template DNA strand. The enzyme catalyzes the formation of a
phosphodiester bond between between adjacent nucleotides. The polymerase
remains in this state until a strand of about 15 nucleotides has been synthe-
sized. Then the core enzyme will undergo another conformational change
and start transciptional elongation. The σ factor dissociates again and the
polymerase proceeds at a speed of about 50 nucleotides per second [102]
along the DNA strand. The transcription is terminated in the same manner
as with T7 RNAP.
2.1.4 Translation
The ribosome, originally proposed by Francis Crick as an abstract adapter
molecule between RNA and protein, was structurally resolved in 2000 [103].
Interestingly the ribosome itself is a RNA-protein structure (65% RNA and
35 % protein) [104]. The E. coli ribosome is a complex of three different
ribosomal RNA strands (rRNA), two of which form the large subunit (50S)
with 31 associated proteins. While the other strand forms the small subunit
(30S) with 21 associated proteins [103]. The rRNA holds the mRNA in place
and even catalyzes the peptide bond formation. The main role of the proteins
2A:T and A:U base pairs are energetically less stable than G:C base pairs.
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seems to be stabilizing the RNA core [102]. So called transfer RNA (tRNA)
molecules are adapters, which are charged with an amino acid and have a
three base pair sequence (called the anticodon) that pairs with the three
complementary bases on the mRNA (codon). For different amino acids there
are different tRNA molecules with different anticodons. Hence the mRNA
sequence codes for a specific chain of amino acids.
Figure 2.2: Schematic representation of translation. The small and large subunit
of the ribosome assemble on the mRNA. tRNA molecules charged with amino acids
are guided to the A site of the ribosome and bind to the corresponding codon on
the mRNA. The amino acid on the tRNA at the P site is linked to the rest of the
chain of amino acids. The uncharged tRNA molecule diffuses away, so that the
process can repeat. The image is adapted from [105].
Each amino acid is encoded in three nucleotides, therefore exact initiation
of translation is crucial as a shift by one nucleotide changes all codons. The
sequence with the correct start and end is called open reading frame (ORF)
and is flanked by a start codon (AUG) that codes for methionine, meaning all
proteins start with this amino acid and stop codons (UAA, UAG or UGA),
which do not code for an amino acid, but initiate the release of the peptide
chain via the recruitment of release factors [102].
The assembly of the two ribosomal subunits occurs on the mRNA, and
is promoted by ribosome binding sites (sometimes called Shine-Dalgarno se-
quence) on the mRNA which forms base-pairs with the small subunit of the
ribosome. Once formation of the whole complex is initiated and the first
tRNA has bound to the codon the ribosome starts to read the mRNA from
the direction of the 5’ end to the 3’ end until it reaches a stop codon which
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results in dissociation of the whole complex.
2.2 Controlling gene expression
Control over gene expression levels is one of the most important strategies
for bacteria to adapt to changing environments. As bacteria are thought to
be growing and dividing for about 3 billion years, this strategy has proved
to be robust. The biochemical repertoire of an E. coli mostly comes from
the few million proteins that are encoded by about 4000 different genes on
its genome of about 4.6 billion base pairs [106]. As a response to changing
external conditions, an E. coli can regulate the expression levels of the 4000
genes, and for that reason it has about 300 different gene regulators, also
called transcription factors [106].
Regulation of protein expression can occur on the DNA, transcriptional
and translational level. For example, there are small RNAs (sRNA) which are
non-coding RNA molecules that bind to the region of the RBS on the mRNA
thus blocking the assembly of the ribosome [107]. Furthermore, there are so
called toxin-antitoxin protein systems, that selectively target the degrada-
tion of mRNA of certain genes [108]. In so called riboswitches, the mRNA
creates a binding pocket for a small molecule which then stabilizes a certain
conformation in the mRNA secondary structure that influences the amount
of protein created from that mRNA [109].
For the scope of this thesis, we focus on a mathematical description of
gene regulation by transcription factors. If one gene, gene a activates a second
gene b, then the rate of production of gene b is a function of the concentration
of gene a. By considering a simplified scheme based on mass-action kinetics,
one can formulate the general case between the activator protein A that forms
an n-mer and then binds to promoter sequence p (Fig. 2.3A and B).
nA + p
k˙+
k˙-
nA:p (2.1)
Then:
d[nA : p]
dt
= k+[A]
n[p]− k−[nA : p] (2.2)
where [p]0 = [p] + [nA : p] is the total concentration of promoters. As-
suming a steady-state between the binding partners:
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Figure 2.3: A Schematic representation of gene activation by transcription fac-
tors. In this example, the inducer molecule binds to the transcription factor and
induces dimerization. The protein-inducer complex binds to the binding site next
to the promoter and activates transcription of the target gene by RNA polymerase
(RNAP). B Schematic representation of gene repression by transcription factors.
Here the inducer binds to the transcription factor and induces dimerization of
the transcription factor. The protein-inducer complex binds to the binding site
which inhibits transcription of the target gene. C Hill curves with different Hill-
coefficients. Left: the inducer activates gene expression (Eq. 2.11). Right: the
inducer represses gene expression (Eq. 2.12. For both plots: α = 1, α0 = 0 and
Km = 100 nM.).
d[nA : p]
dt
= 0
⇒ [nA : p] = k+
k−
[A]n[p] (2.3)
=
1
Kn
[A]n[p]
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with
Kn =
k−
k+
. (2.4)
Then the fraction of occupied to total promoters [nA : p]/[p]0 can be
calculated from equation 2.3 by substituting [p]0 = [p]− [nA : p]:
[nA : p] =
1
Kn
[A]n ([p]0 − [nA : p]) (2.5)
⇒ [nA : p]
[p]0
=
[A]n
Kn + [A]n
(2.6)
The form of equation 2.6 is called a Hill equation. The concentration
of protein B should be approximately proportional to the ratio of activated
promoters [106] so that:
d[B]
dt
≈ α [nA : p]
[p]0
(2.7)
⇒ d[B]
dt
=
α[A]n
Kn + [A]n
+ α0 (2.8)
where α is the maximal expression rate that can be reached in units
concentration per time and α0 captures the expression from non-activated
promoters. n is the Hill coefficient that determines the steepness of the
sigmoid function and quantifies the non-linearity in the relationship between
concentration of gene a and b. K is the activation coefficient and marks the
concentration of A = K at which d[B]
dt
is at half-maximum.
In case the protein C from gene c represses the expression of protein D
from gene d the Hill equation can be derived in analogous manner to equation
2.8.
d[D]
dt
≈ α [nC : p]
[p]0
(2.9)
⇒ d[D]
dt
=
αKn
Kn + [C]n
+ α0 (2.10)
There are quite some simplification steps from equation 2.6 to 2.8 or 2.10
as one infers the expression rate of the protein from the fraction of activated
promoters by using a linear relationship. In addition, the Hill equation in this
form is often used to describe the response of a gene to a certain concentration
of a small inducer molecule m which activates/inhibits a transcription factor
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[m] + [A] → [A∗]. In this case the transcription factor is constitutively
expressed but remains inactive until bound by the inducer, and its exact
concentration is unknown. In contrast the concentration of the small inducer
molecule [m] is known and if one assumes that [A∗] is proportional to [m]
then for activation one can describe the change in concentration of B:
d[B]
dt
=
α[m]n
Kn + [m]n
+ α0 (2.11)
and for repression:
⇒ d[D]
dt
=
αKn
Kn + [m]n
+ α0 (2.12)
where K and n are now the induction threshold and Hill coefficient for the
small molecule. Equations 2.11 and 2.12 can be used to describe the response
in gene expression rate due to the concentration of a small genetic inducer
(Fig. 2.3C). In synthetic biology, genetic switches are often controlled by
small molecules as they can be added externally and permeate the membranes
of bacteria. These equations serve to describe the input-output behavior of
such a switch.
2.3 Noise in gene expression
In the previous section gene regulation based on mass-reaction kinetics was
discussed. However in systems where reactants are below are certain number,
the reactions that are based on two molecules colliding become stochastic.
That means the randomness of when two reactants meet becomes noticeable
as fluctuations in the speed at which chemical reaction progress. Single
cell analysis in the study of the repressilator circuit in E. coli showed the
performance of the oscillator was affected by the stochastic nature of some
reactions inside bacteria. Since then the origins and the quantification of
noise in gene expression is a research focus in synthetic biology [22].
In 2002, Swain and Elowitz started to distinguished two sources of noise
in gene expression: the first source is the ”intrinsic” noise from the stochastic
nature of chemical reactions within a cell (Fig. 2.4). This will be uncorre-
lated between cells. The second source of noise is called ”extrinsic” noise
from fluctuations and differences in the outside conditions of the cell. These
fluctuations are shared by all cells since they are exposed to the same condi-
tions [110].
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Figure 2.4: A The concept of extrinsic noise for gene expression within a bacterial
population. As all bacteria are subjected to the similar conditions , the fluctuations
in gene expression of two different genes (red and green) with the same promoter
correlate. B An illustration of the concept of intrinsic noise. The fluctuations
in gene expression of two different genes (red and green) due to intrinsic noise
does not correlate between individual cells. The figure is adapted from Ref. [111].
Reprinted with permission from AAAS.
By introducing stochasticity the transcription and translation model was
able to reproduce the cell-to-cell variations in a population of bacteria. Tran-
scription is described to occur only rarely and mRNA molecules are degraded
quickly, so that very few mRNA molecules exist at a time. However, trans-
lation comes in bursts, where about 50 proteins are created from one mRNA
molecule. This model produces a gamma-distribution for the protein con-
centration across cells. This was confirmed by in vivo experiments [112].
However for abundant proteins (above about 10/cell), stochastic bursting
can not explain the cell-to-cell variation [113]. Then usually extrinsic noise
is used as an explanation without further explanation of what that actually
entails. Recently, there are more arguments that the gamma distributions
for the protein concentration across population of cells is a special case that
occurs when the transcription rate for that protein is extremely low [114].
In the absence of extreme condition such as the very irregular transcription
rate, protein concentrations across a bacterial population are expected to be
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log-normally distributed. This might become more important for synthetic
biologists, as they are able to engineer parameters such as transcription rates
in their genetic constructs.
2.4 Using chemical reaction networks to model
a cell
This section looks at quantitative descriptions of gene expression and their
accuracy when stochasticity is taken into account. Stochasticity can become
important for the prediction and design of genetic switches and circuits in
synthetic biology. It can also offer a more accurate picture of the cell-to-cell
variations of mRNA and protein concentrations in an isogenic population of
bacteria [115]. The closer synthetic biology and engineered bacteria come
to application the more important it is to consider not only the genetic
construct as such but also the fact that bacteria mostly occur in populations
with some underlying heterogeneity between individual cells. In addition any
protein species of interest will be only one species in a thousand. In order to
simplify this pictures and to predict the effect of this heterogenity on genetic
circuits performance, one can use computational models that capture the
fundamental mechanisms.
The following paragraph provides an overview of an algorithm published
by Furusawa and Kaneko [116] [117], in which a bacterial cell is reduced
to chemical reaction networks. The goal of the model system is to derive
experimental observations such as the cell-to-cell variations in a protein con-
centration within a homogeneous population of cells from abstract models
that require a minimal amount of biological details. This way the model
may remain more general and help in the development of engineering prin-
ciples for synthetic biology.
The internal state of a cell is described by a set of m different chemical
species within a cell volume v. The number of molecules of each species
is represented by ni with i ranging from i = 1 to m, with a total amount
of molecules in the cell N =
∑m
i ni. Then a randomly chosen catalytic
network between the species is created, where some chemical k catalyzes
the reaction of chemical i to j (i + k → j + k). All reaction coefficients
have the same values and the probability of two chemicals to be connected
(eg. i and j) is given a connection rate ρ (the connection paths are chosen
randomly). Furthermore, there are some species that can diffuse between
the environment and the cells with a diffusion coefficient D, among which
are the nutrients that have no catalytic activity and are constantly supplied
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by the environment. The permeable nutrients are catalyzed to impenetrable
chemicals so that the number of chemicals in a cell N increases until a certain
threshold Nmax is reached and the cell is divided (the cell’s molecules are
randomly split between the two daughter cells). The growth and division
process is repeated. Any two molecules taking part in a chemical reaction
are chosen randomly, same for any molecule in the diffusion process outside
or inside the cell. There is a critical value for D = Dc above which all the
nutrients flow so fast into the cell that the chemical reactions cannot keep
up with the influx. Continuous growth and division of cells is only possible
for D ≤ Dc.
Power-law distribution of abundance of chemical species
The simulation allows to calculate the abundance of each chemical species.
The result of the rank-ordered distribution, which ranks each chemical species
according to their abundance3 follows a power-law that converges to the
exponent of -1 at the critical point D = Dc [116]. Interestingly, there are
several examples of rank-ordered frequency plots with a similar shape found
in experiments. For example, the mRNA species in human liver, C. elegans
and yeast cells follow a power law with an exponent close to -1 [116]. This
occurrence of rank-ordered frequency distribution with a power law exponent
of or close to -1 in various research areas is called Zipf’s law, after the linguist
George K. Zipf, who studied the frequency of words in a language [118]. The
result tells us that we can expect that relative changes in the concentration
of one component will result in proportional changes in the concentration of
another component, independent of their initial concentrations.
Log-normal distribution of a chemical species within a population
of cell
The simulation by Furusawa et al. can also be applied to the question of cell-
to-cell variations by looking at the distribution of each chemical’s abundance
over many cells for a large number of divisions [117].
Their results fall into two different cases, depending on whether the total
sum of chemicals Nmax is larger or smaller than the amount of chemical
species m. When Nmax > k, so there is more than k one molecule of each
species, the population ratio, defined as ni
Nmax
is stable over division events so
that daughter cells have a similar chemical composition to their mother cell.
Then the abundances of all chemicals that are reproduced in the cell follow
3For example, checmical species i has rank 2 if ni is the second largest value in the set
of n1, ..., nm.
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a log-normal distribution. When k > Nmax, the population ratios are not
stable and change each generation. Now, the resulting distribution for each
chemical follows a Poisson-like distribution. However, for most cases where
the chemical species do not change from generation to generation the former
case with Nmax > k is more applicable. The main reason for the log-normal
distribution of the chemicals comes from a small group of dominant reaction
pathways that self-organized in a cascade-like fashion so that fluctuations
in the concentration of one species propagate in a multiplicative way to the
concentration of the next species. Experimental data from a bacterial culture
expressing a fluorescent protein matched the result of the calculation. The
the concentration of the protein across a bacterial populations was log-normal
distributed [117].
Gene expression: chemical complexity leads to a log-normal distri-
bution
There are a number of studies dealing with the log-normal like distribution
of gene expression across bacterial populations. The following paragraph
will outline an argument by Jacob Beal, that provides more of an heuristic
explanation to why the log-normal distribution is found for many genes and
why it is an emergent property of a complex reaction network [114].
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Figure 2.5: A schematic visualization of the chemical complexity in gene expres-
sion. Some molecular species X involved in gene expression has a passive state
XP and an active state XA. Several other molecular species f enhance state XA
whereas species g enhance state XP . Molecule XA itself may be one of many en-
hancing factors that stabilizes another molecular component in gene expression to
become active YA. The image is adapted from Ref. [114].
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Let us pick one molecule X that is included in the process of gene ex-
pression and has two states: an active state (XA) and a passive state (XP ).
There are plenty of other molecules in the cell that serve as catalytic factors
f1, f2, ..., fn that change the state of X from passive to active. Then again
there is another set of chemical factors g1, g2, ..., gm that catalyze the active
molecules (XA) back to a passive state (XP ). For example, molecule X could
be a RNA polymerase, that is transcribing a gene (active state) after it was
recruited by a sigma factor such as protein σ70 (catalytic factor f). At the
same time, for example, an anti-sigma factor like Rsd (catalytic factor g)
can inhibit the association of RNA polymerase to a sigma factor so that the
RNA polymerase stays in the cytosol (passive) (Fig. 2.5).
The rate equation for the activated molecule XA can be formulated on
the grounds of standard chemical reaction laws:
dXA
dt
=
(
kx · [XP ] ·
n∏
i=1
[fi]
)
−
(
λx · [XA] ·
m∏
i=1
[gi]
)
(2.13)
where kx and λx are reaction rate constants. Assuming that the expres-
sion of the gene under consideration does not dominate cellular resources
drastically, the state of the system is quasi-static and the expected equilib-
rium concentration of XA is given by:
0 =
(
kx · [XP ] ·
n∏
i=1
[fi]
)
−
(
λx · [XA] ·
m∏
i=1
[gi]
)
(2.14)
[XA] =
kx
λx
· [XP ] ·
n∏
i=1
[fi] ·
m∏
i=1
[gi]
−1. (2.15)
The concentration of XA is given by the product of input concentra-
tion (f1, f2, ..., fn, 1/g1, 1/g2, ...1/gm). Consequently the distribution of XA is
proportional to the product of many distributions. This argument can be ex-
tended such that XA now serves as the catalytic factor for another molecule
Y , promoting its active state YA. For example Y could be nucleotides (pas-
sive) which are catalyzed via the RNA polymerase XA to mRNA (active).
Then the equilibrium concentration of YA follows from equation (2.15) and
is given by:
34
[YA] =
ky
λy
· [YP ] ·
p∏
i=1
[hi] ·
q∏
i=1
[ji]
−1 (2.16)
[YA] =
kykx
λyλx
[YP ][XP ]
n∏
i=1
[fi]
m∏
i=1
[gi]
−1
p∏
i=1
[hi]
q∏
i=1
[ji]
−1 (2.17)
where ky and λy are reaction rate constants, and hi and ji catalytic factors
for Y analog to fi and gi for X. Now the distribution of YA is a product of
the distribution of XA and so on. The line of argument can be continued at
least several times. The central limit theorem states that the sum of indepen-
dent random variables converges to being normal distributed. Additionally,
since the logarithm of a product is equal to the sum of the logarithms, the
product of the independent random variables converges to a log-normal dis-
tribution. This means that the distribution which results from a product
of many independent random variables is a log-normal distribution. Hence,
due to the large amount of factors involved in expression of a protein, the
expected distribution in a homogeneous bacterial population approaches a
log-normal distribution. In practice, already a few factors suffice to create a
distribution that is very close to a log-normal distribution.
Geometric statistics
The result from the previous section is that concentration of most proteins
within a population of bacteria will follow a log-normal distribution. Since
this is a skewed distribution, the statistics we use to evaluate and present
the data should be adjusted. As for most skewed distribution geometric in-
stead of arithmetic statistics can be more accurate as argued in the following
paragraph.
A random variable X is log-normally distributed when Y = log(X) is
normally distributed. Hence to characterize the log-normal distribution one
can use the statistical tools which are applied to normal distributions to the
log-transformed data. For example, for log-normal distributed data one can
take the logarithm of the values and work with the log-transformed data (i.e.
Y ∼ N (µ, σ2))4. The arithmetic mean µ and the standard deviation σ of the
log-transformed data serve as a measure of location and dispersion with the
interval µ± σ containing 68.3% of the data.
However, there might be advantages to working directly with the non-
transformed data. If so, one has to consider the fact that the log-normal
4In this chapter, the symbols µ and σ always describe the arithmetic mean and standard
deviation of a normal distribution.
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distribution is asymmetrical around the mean with a longer tail towards
values that lie above the mode of X. This implies that the arithmetic mean µ
generally used for the description of a normal distribution would overestimate
high-valued outliers and thus strongly deviate from the median.
The expected value E(X) (also known as the 1st moment) or mean µLN
of the log-normal distribution is given by:
µLN = e
µ+σ
2
2 . (2.18)
However, due to the fact that the log-normal distribution is positively
skewed, the median might be more interesting as a measure of location.
Since the mean µ is also the median of the log-transformed data, eµ is the
median of the non-transformed data. Then the median of the log-normal
distribution can be determined by calculating the geometric mean µg of the
original data:
µg(x1, ..., xn) = (x1 · ... · xn)1/n = e
log(x1)+...+log(xn)
n = eµ (2.19)
where x1, ..., xn is the measured data.
Furthermore the arithmetic standard deviation σ is also not an ideal rep-
resentation for the dispersion of the data since the symmetric ranges around
a value such as the mean do not have the same probability [119]. Here an
underlying difference between a normal distribution, which is realized by the
additive sum of random variables and the log-normal distribution, which is
realized by the multiplicative product of many random variables surfaces.
As for the case of gene expression, fluctuations in the concentrations of the
factors (see eq. (2.17)) involved in the process propagate multiplicatively,
so that multiplication/division of a factor should be preferred to represent
dispersion around a value rather than addition/subtraction (e.g. ±σ). The
arithmetic standard deviation σLN of the log-normal distribution
5 is given
by:
σLN = e
µ+σ
2
2
√
eσ2 − 1. (2.20)
The back-transformed standard deviation, eσ, is termed the geometric
standard deviation6 σg and can be estimated by:
σg(x1, ..., xn) = e
√
1
n−1 ·
∑n
i (log xi−log µg)2 . (2.21)
5The standard deviation (SD) is given by SD[X] =
√
V ar[X] =
√
E[X2]− (E[X])2.
6Also called multiplicative standard deviation.
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where x1, ..., xn is the measured data. Now it is possible to re-define the
interval [µ − σ, µ + σ] associated with the normal distribution for the log-
normal distribution as [µg/σg, µg · σg], which also covers 68.3% of the prob-
ability [120]. Hence, it is advised to express gene expression data using the
geometric mean (= median) with error bars representing the geometric mean
times the geometric standard deviation for the upper bound and divided by
the geometric standard deviation for the lower bound (e.g. µg
×/ σg) [114].
In case that the arithmetic mean of a sample x¯ and the sample standard
deviation s of some gene expression data is known, one can estimate the
sample geometric mean [120]:
x¯g =
µ√
1 +
(
s
x¯
)2 (2.22)
and the geometric standard deviation:
x¯g = e
√
log
[
1+( sx¯)
2
]
. (2.23)
It should be mentioned again, that gene expression only follows the log-
normal distribution if there are no other extreme conditions forcing it into
another regime.
2.5 CRISPR-Cas9
This section provides a short introduction into the origins, mechanisms and
applications of CRISPR-Cas9. Bacteria and archaea have an adaptive im-
mune memory called CRISPR (clustrered regularly inter-spaced short palin-
dromic repeats)-Cas(CRISPR-associated genes). In short, it works by in-
serting snippets (around 20 bp) of foreign genetic material from viruses or
plasmids as spacers in CRISPR-arrays (Lamarckian-type inheritance) [121].
RNA molecules encoding the spacer sequences are used as recognition ele-
ments to find matching foreign genetic material which is then destroyed by
Cas proteins [122].
Individual Cas proteins have become the subject of intensive research, one
of the most prominent examples being the Cas9 endonuclease from Strepto-
coccus pyogenes. In contrast to many other CRISPR systems, the CRISPR-
Cas9 system involves only one protein in the effector complex cleaving the
foreign DNA.
First the CRISPR locus is transcribed forming a long precursor CRISPR
RNA (pre-crRNA) containing multiple spacer sequences and direct repeats
[123]. A second RNA molecule, the trans-activating crRNA (tracrRNA)
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binds to the direct repeats on the pre-crRNA. This long RNA complex is
further dissected and processed by RNase III and some unknown nuclease so
that one complex contains one tracrRNA, one direct repeat and one spacer
sequence of about 20 nucleotides. In this configuration the RNA complex
associates with Cas9 which is then guided towards the target sequence on
the foreign DNA given that there is a required protospacer adjacent motif
(PAM) present next to the target site, which is NGG7 for Cas9 from Strep-
tococcus pyogenes. Once bound to the DNA it cleaves the bonds in the sugar
phosphate backbone of both DNA strands.
In 2012, the CRISPR-Cas9 system was engineered to improve its func-
tion as a gene editing tool [124]. Within the next year, it was found to be
applicable for genomic editing in eukaryotic cells including yeast [125], plants
[126] [127] [128], mouse [129], zebrafish [130] and even human cells [131] [132]
[133].
In brief, the genome editing process entails identifying the target sequence
in the genome with a PAM then designing and transcribing the corresponding
RNA to guide the Cas9 protein. The resulting double strand break (DSB)
activates the DNA repair mechanisms of the cell. In the presence of large
quantities of donor template DNA containing the desired insert which are
flanked by homologous regions, the homology-directed repair (HDR) pathway
integrates the insert from the template DNA into the chromosome. Alterna-
tively, in the absence of donor template DNA, the DSBs can be repaired by
non-homologous end joining (NHEJ), which results in non-precise deletions
or insertions of a few nucleotides.
One of the major developments of the CRISPR-Cas9 system was the
merging of the two processed RNA molecules, crRNA and tracrRNA, to one
single RNA molecule named single-guide (or synthetic-guide) RNA (sgRNA)
[124]. In eukaryotic cells the removal of a putative Pol-III terminator and a
stem-loop extension improved the sgRNA stability and enhanced the assem-
bly with a Cas9 mutant [134].
Furthermore, different versions of the Cas9 protein were engineered by
mutations and fusions. For example, the mutants Cas9D10A or Cas9H840A
each cut only one of the DNA strands [124], whereas the version known as
dCas9 (with both mutations D10A and H841A) does not cleave DNA at
all [53]. The method of suppressing transcription of genes with dCas9 by
either blocking the binding of the RNAP to its promoter or the elongation
during transcription is named CRISPR interefence (CRISPRi). On the other
hand, CRISPR activation (CRISPRa) enhances the transcriptional activity
of a gene. For example dCas9 fused to the RNAP omega subunit (ω) that
7N stands for any arbitrary nucleotide.
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stabilizes the binding of RNAP to its promoter increases the expression of a
gene when placed upstream of its promoter [135]. This technique to position
specific proteins on the genome via dCas9:sgRNA has been used in different
ways.
2.6 CRISPRi
This section looks at CRISPRi as a means to regulate gene expression within
bacteria. As described above, the method uses the mutated dCas9 protein
which can be guided to a specific DNA site using the appropriate sgRNA
sequence. The only requirement is the presence of a protospacer adjacent
motif (PAM) next to the target sequence on the DNA.
The sgRNA consists of a 20-nt target specific complementary region, a
Cas9-binding RNA structure and a transcription terminator derived from S.
pyogenes. The sgRNA binds to the dCas9 and then finds the target sequence
on the DNA.
It has been shown that the bound dCas9-sgRNA complex downstream
from a promoter can stop the RNAP from transcription elongation [53] (Fig.
2.6A). Elongation of the RNAP is stopped more efficiently when the non-
template DNA strand for transcription is targeted by the sgRNA than the
template strand (Fig. 2.6B). In this case the PAM sequence is CCN at the
5’ end of the non-template DNA strand. There are still differences in the
repression efficiency depending on the position within the gene of interest
that should be repressed. Results can vary but in general the shorter the
distance of the target sequence to the start codon of the gene that should
be repressed the stronger the repression [53]. Double or multi repression of
a gene is stronger as long as the repression sequences do not overlap [53]
[138]. In addition, the number of base pairs in the guide RNA that are
complementary to the DNA influence the repression strength of the gene
expression [137]. Finally the repression efficiency is strongly reduced above
temperatures of 37◦C and is lower for stronger transcription promoters. This
has allowed the formulation of a ”kick-out” out model where the RNAP
that approaches the dCas9-sgRNA complex is either stopped with a certain
probability P (stop) or kicks the dCas9-sgRNA complex off the DNA and
proceeds with 1 − P (stop) [137] (Fig. 2.6C). According to this model the
expression level of the target gene α is given by:
α = α0 (1− P (stop) · P (bound)) (2.24)
where α0 is the native transcription rate and P (bound) is the probability
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Figure 2.6: A CRISPR interference. Illustration of the sgRNA-Cas9 complex
bound to the template DNA strand (left) and the non-template DNA strand (right)
relative to the direction of transcription. The subfigure is adopted from Ref. [136]
by permission from Springer Nature, 2013. B Depending on the target position
on the DNA, CRISPRi was different operational mechanisms. Transcription ini-
tiation is blocked if the operator or promoter sequence are bound. Here both the
template and non-template strand can be targeted. In case the target sequence is
downstream of the transcription start, the sgRNA-dCas9 complex stops transcrip-
tional elongation. Here only the non-template strand should be targeted. The
subfigure is adopted from Ref. [136] by permission from Springer Nature, 2013.
C Scheme of the ”kick-out” model. P(stop) is the probability that transcription
elongation is stopped when the RNAP runs into the bound sgRNA-dCas9 complex.
The ’occupancy’ of sgRNA-dCas9 is determined by the concentration of sgRNA-
dCas9 and the binding and unbinding rates (kon and kout). However, the fact that
incoming RNAP can kick out bound sgRNA-dCas9 complex is incorporated into
the unbinding rate kout. The subfigure is adapted from Ref. [137] by permission
from Springer Nature, 2018.
that dCas9-sgRNA is bound to the target. This probability is given by:
P (bound) =
kon[dCas9]
kon[dCas9] + kout
(2.25)
where kon[dCas9] is the rate of binding and kout is the rate of dCas9-
sgRNA ejection. The ejection of the complex can be spontaneous unbinding
or displacement by RNAP or possibly occur during DNA replication [137]
[139].
Besides targeting the non-template strand in the codon region of a gene,
40
one can also target the template strand and the promoter region. It has been
shown that targeting the template strand in the codon region is less efficient
in repressing gene than the non-template strand [53]. Targeting the promoter
region has yielded different results. Apparently here the dCas9-sgRNA com-
plex blocks the RNAP from either binding to the promoter sequence or tran-
sitioning from transcription initiation to elongation. Hence it is important
that the target sequence is within the region where the σ factor binds to
the RNAP core enzyme. Here, in contrast to the blocking of transcription
elongation, the difference between the template and non-template strand is
not visible [53].
It has also been shown that the CRISPRi induced gene knock-down is
reversible by dilution in bacteria by stopping to express dCas9-sgRNA, al-
though full recovery of gene expression can take 6 - 15 hours [53] [140]. Fur-
thermore it was demonstrated that an anti-sense RNA to the sgRNA was able
to recover gene expression in bacteria even in the presence of dCas9-sgRNA
expression [141].
In summary, CRISPRi provides a method to silence genes, which is pro-
grammable by changing the target sequence on the sgRNA. This potential is
being harnessed to create multi-layered logic or change gene expression from
the chromosome of the bacteria from a plasmid [55]. However, recently it has
been also reported, that high levels of dCas9 without sgRNA in E. coli can
cause growth defects such as stopping cell division and that specific target
sequences can cause severe growth defects or even kill bacteria [142] [143].
2.7 RNA nanostructures
One of the applications of synthetic biology is the creation of biomolecular
structures of particular interest. The following section describes the origins,
developments and techniques of nucleic acid nanostructures with a focus on
RNA nanostructures. In 1982, Nadrian Seeman proposed the idea of using
biomolecules to build artificial structures by using artificial DNA strands to
construct tiles and lattices [144]. This opened up a new field called DNA
nanostructure and nanomaterials [145]. Since then DNA has been used
to construct lattices, two and three-dimensional objects of nearly arbitrary
shapes. Especially, a technique called ’DNA origami’ allowed the creation of
more complex structures [90], where a long strand of phage DNA is folded
to a desired shape by small oligo-nucleotides called staple strands. Using
this technique researchers were able to create DNA envelopes for enzymes
that can be opened by RNA or DNA strands, create DNA nanopores in lipid
membranes or create gigadalton sized assemblies of several DNA origamis
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[146] [147] [148]. Recently, Praetorius and Dietz have used this principle to
fold double stranded DNA into designed shapes with custom designed staple
proteins [149].
In parallel, researchers have started to use RNA for the construction
of nanostructures. In comparison to DNA, RNA is chemically less stable,
but can be encoded genetically and produced enzymatically. Furthermore,
living organisms have developed structural RNA motif that can be integrated
in artificial structures. In 2000, Jaeger and Leontis used so called RNA
tectonics to creates supramolecular RNA filaments by self-assembly due to
interactions between hairpin tetraloops [150] (Fig. 2.7A). This technique
was further developed to create programmable 2D and 3D structures [151]
[152]. Furthermore, the DNA origami method was extended to the use of
RNA [153]. As there is a library of structural RNA modules found in nature,
scientists can also create different shapes by combining different modules
[154]. Recently a new set of design rules for RNA tiles made from a single
RNA strand has been proposed [155]. The size of the tiles ranges from 156 nt
to 660 nt, can be produced enzymatically, fold co-transcriptional and form
different lattice assemblies on surfaces.
Interestingly RNA structural motifs are not limited to RNA-RNA inter-
actions. RNA structural motifs termed RNA aptamers can bind a ligand
such as small molecules, proteins or even lipids. New RNA aptamers can be
evolved, selected and enriched from a random sequence library in cycles in
a well defined method called SELEX (Systematic Evolution of Ligands by
EXponential enrichment) [159]. For example, aptamers have been developed
to bind molecules and enhance their fluorescence [160]. RNA aptamers were
also evolved in nature. For example, phage RNA often has a hairpin struc-
ture at the start codon of the viral replicase which can bind the coat proteins
of that phage in order to repress the replication and facilitate packaging
[161]. RNA nanostructure can be functionalized by the integration of RNA
aptamers. For example, Delebecque et al. were able to combine aptamers
that positioned two enzymes within a larger RNA nanostructure in proxim-
ity to each other [162]. As both enzymes were involved in the production of
hydrogen, it was demonstrated that the scaffolding of the enzymes via the
RNA increased the hydrogen production in bacteria.
Single stranded RNA is actively degraded in bacteria and only lives for
a few minutes [106]. However, as there are stable RNA species in cells and
phages, there must exist strategies to avoid degradation. One remarkable
example is a three-way juction motif from an RNA strand in the phage φ29
that scaffolds a protein pore which is used for the translocation of the genome
through the cell membrane [163]. This three-way junction was shown to be
extremely resistant against degradation and denaturation [164] [165]. Using
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Figure 2.7: A An illustration of the RNA tectonic mechanism. Natural RNA
structures can be decomposed into structureal motifs. These can be combined
again in new ways from artifical and larger structures. The subfigure is adopted
from Ref. [156]. Copyright (2006), with permission from Elsevier. B Schematic
representation of the co-transcriptional folding of an RNA tile which assembles into
a supramolecular lattice on a mica surface. The subfigure is adopted from Ref.
[155]. Reprinted with permission from AAAS. C Illustration of an RNA scaffold
for two enzymes. Due to their proximity a reaction pathway involving the the two
enzymes is accelerated. The RNA scaffold can be incorporated into larger RNA
nanostructures. The subfigure is adopted from Ref. [157] by permission of Oxford
University Press, 2014. D The phage φ29 uses an RNA scaffold for the complex
that trans-locates the DNA into its prohead. A three-way junction motif in these
pRNA molecules has shown to be exceptionally stable against denaturation. This
subfigure is adopted from Ref. [158]. Reprinted by permission from Springer
Nature, 2013.
structural motifs like this can enhance the stability of RNA nanostructures
[166].
In conclusion, RNA offers the possibility to genetically encode and enzy-
matically produce artificially designed nanostructures. The interactions of
RNA with small molecules, DNA and proteins and its own catalytic activ-
ity provide the possibility to combine several functional aspects within RNA
nanostructures. In short, RNA nanostructures have probably more potential
applications than DNA nanostructures within living organisms and are easier
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to design than proteins.
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Chapter 3
Chemical communication
between a cell-free expression
system and bacteria
3.1 Biological background and motivation
The contents of this chapter have been published in the article: ”Chemi-
cal communication between bacteria and cell-free gene expression systems
within linear chains of emulsion droplets” by Matthaeus Schwarz-Schilling,
Lukas Aufinger, Andrea Mu¨ckl and Friedrich C. Simmel in Integrative Biol-
ogy, 2016,8, 564-570.
Multicellular organisms often develop from one or a few cells that divide.
The progeny then differentiates into different types of cells that take part in
fulfilling different functions [167]. In this sense multicellular organisms can
achieve functions unachievable for single cellular organisms by division of
labor using functional modules such as an eye, a muscle or a brain. The de-
velopment and maintenance of such an architecture requires coordination and
communication between cells. The field of embryogenesis studies the devel-
opment of organisms and has identified the importance of chemical gradients
across one cell or several cells as a means to provide orientation and positional
information from which further development can occur [168] [169]. For exam-
ple, the anterior-posterior axis in the embryo of Drosophila melanogaster is
determined by pre-positioned mRNA molecules that create a gradient across
the early oocyte [170].
Most of the time the chemical signals, also called morphogens, encode
information in their concentration as a function of position and time. The
natural mechanism of transport of chemicals is diffusion. There are different
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ways of signal transmission between or within a cell: by simple diffusion
across membranes, through protein channels or pores, within vesicles or by
active transport via molecular motors along pre-determined pathways [102].
As artificial cellular systems are easier to control and engineer than living
organisms, but most of the medical and biotechnological applications come
from cells, chemical communication and coordination between artificial sys-
tems and living organisms provide the possibility for an interface between
engineered systems and the biological world.
3.1.1 Artificial biomimetic systems
An advantage of artificial biomimetic systems over natural environments is
that they are often more controllable. This allows for a suitable environment
to both prototype modules, similar to aeronautical wind tunnels in aviation,
and to screen specific parameters while fixing boundary conditions. Over the
past decade, the investigation of bacterial growth, gene expression or pop-
ulation dynamics in artificially structured micro-environments has become
increasingly popular [171], as they allow researchers to follow the dynamics
of individual cells within a population over time, and also to precisely control
their spatial, temporal, and chemical boundary conditions. In this context,
the combination of fluorescence microscopy methods and microfluidic tech-
niques has been shown to be particularly versatile [172]. Micro-fabricated
bacterial traps have been applied to monitor gene expression dynamics over
extended periods of time [173], and study, for example, stochastic effects in
gene expression [174] [112] or bacterial oscillators [175] [176].
Compartmentalized bacterial consortia are of particular interest for ap-
plications in synthetic biology. For instance, compartmentalization could be
used to create systems in which several bacterial species interact and coop-
erate, although they might be incompatible in co-culture (due to different
growth conditions or predation of one species on the other). Furthermore,
hybrid systems could be created in which some droplets contain cell-free
gene expression systems, while others contain bacteria, or simply nutrients
or other chemicals.
3.1.2 The Lux-system
Bacterial cells communicate with each other via the secretion of signaling
molecules, direct exchange of genetic material. Here we focus on commu-
nication via signaling molecules. When detected, the signaling molecules
activate or change the expression of specific target genes in the receiving
cells. Due to the fact that the signaling molecules often induce their own
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production, they are also referred to as autoinducers [177]. As a result of
the positive feedback mechanism, an increase in the density of cells within
a certain volume can lead to a rapid increase in the concentration of the
autoinducers. This allows bacterial communities to perform quorum sensing,
where certain genes are over-expressed once the population density surpasses
a threshold value. For example, one of the first examples of quorum sensing
was discovered in Aliivibrio fischeri [178]. The bacterium has a symbiotic
relationship with a range of marine fishes and squids. The bacteria populate
specific places in the large organism where they grow to high densities and
produce light through quorum sensing induced expression of bio-luminescent
proteins. In response, the the marine organism provides the bacteria with
nutrients. Outside of the marine organism in the seawater, nutrients are
scarce. In this ouside environment, the quorum sensing molecule concentra-
tion remains low due to dilution and low growth, which means that the cells
do not spend resources on the expression of bio-luminescent proteins [179].
Besides bioluminescence, quorum sensing can coordinate the formation of
biofilms [180], the production of antibiotics [181] or virulence factors [182],
or regulate competence [183].
Figure 3.1: Illustration of the quorum sensing system in A. fischeri with the
transcripational activator LuxR, the AHL-synthase LuxI and the quorum sensing
molecule AHL (here abbreviated with OHHL). Reprinted with permission from
Warren et al. [184]. Copyright (2011) American Chemical Society.
Generally, autoinducers are species specific. For example, the autoin-
ducers for most gram-negative bacteria are acyl-homoserine lactones (AHL).
AHL-based systems are relatively simple and consist of two main compo-
nents: an AHL-synthase and a transcriptional activator protein with the cor-
responding promoter (Fig. 3.1). In the context of synthetic biology, Weiss
and Knight, separeted the two components of the quorum sensing system
from A. fischeri and created an AHL-sending and a AHL-sensing E. coli
strain [51]. The AHL-synthase from A. fischeri is called LuxI and produces
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3-oxo-C6-AHL for communication, which naturally does not occur in E. coli
cells [184]. The AHL molecule binds to the transcriptional activator protein,
LuxR, and promotes the formation of homodimers of the protein. The tran-
scriptional activation from the corresponding promoter, also called pLux, is
induced by the LuxR dimer binding to the lux box, which is a 20 nucleotide
sequence residing about 40 nucleotides upstream of the transcriptional start-
ing point. The bound LuxR then stabilizes the RNAP complex by binding to
the σ70 factor and the α-subunit carboxy-terminal domain (αCTD) of RNAP
[185].
3.2 The AHL sender-receiver plasmids
In previous work, Weitz et al. created an ”AHL sender” and an ”AHL
receiver” plasmid based on the Lux-system and the transcriptional repressor
protein LacI [186] (Fig. 3.2).The ”AHL sender” plasmid contains lacI and a
T7 promoter with a lacO site upstream of luxI. The ”AHL receiver” plasmid
has LuxR under the control of an endogenous E. coli RNAP promoter with a
lac0 site for luxR. In addition, GFP is under the control of a pLux promoter
that is active when an AHL-LuxR complex has bound (Fig. 3.2). Hence the
LuxI-LuxR system is activated by IPTG and expresses GFP as a read-out.
pLux             gfppLlacO1            luxR
IPTG AHL
receiver
pT7/lacO            luxI
IPTG AHL
sender
Figure 3.2: Two plasmid sender-receiver system. The sender plasmid encodes the
AHL-Synthase LuxI, which is under the control of an T7 RNAP promoter that is
inducible with IPTG. The genetic AHL receiver module responds to the inducers
IPTG and AHL: IPTG induces expression of the transcriptional activator LuxR,
which is under the control of a lac promoter. Only in the presence of AHL, LuxR
activates the expression of GFP, which is controlled by a lux promoter.
3.3 Water-in-oil droplets
It was previously found that a fluorinated emulsion droplet system that is
used to encapsulate bacteria can support communication via indcuer molecules
IPTG and AHL, as both of them are able to partition in to the continuous oil
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phase and diffuse between different water-in-oil droplets [186]. The water-
in-oil droplets are stabilized against coalescence by a surface active agent
(’surfactant’), which is in this case a triblock-copolymer that assembles at
the droplets surface. It consists of a poly-ethylene glycol (PEG) head group
that faces towards the droplets inner aqueous phase. The head-group is
flanked by 10 to 60 perfluoropolyether (PFPE) groups that form the two
tail groups, which assemble on the outside towards the oil phase [187]. The
continuous oil phase is made from a fluorinated carbon oil, such as FC-40
(see Sec. 3.12). It was then shown that bacteria with the AHL receiver plas-
mid that were induced with IPTG and encapsulated in droplets were able to
express GFP in the vicinity of droplets containing either bacteria with the
AHL sending plasmid or directly purified AHL [186].
3.4 Outline
Here we studied spatially distributed gene expression in strictly linear ar-
rangements of micro-droplet compartments. A quasi one-dimensional geom-
etry allows for a better control of boundary conditions, and also facilitates
a straightforward analysis of the experiments. One of the most important
aspects for our present study is the stronger mutual coupling of neighboring
compartments in a 1D geometry.
3.5 TXTL: AHL receiver plasmid
We transferred the AHL sender-receiver plasmids in an E. coli based cell
lysate which is supplemented with an energy solution so that transcription
(TX) and translation (TL) still work [68]. The cell-free expression system is
thus abbreviated TXTL.
3.5.1 Hill curve
The chromosomal DNA of the bacteria is degraded during the preperation of
the TXTL so that the TXTL solution can be programed by the addition of
external DNA. Hence the addition of the AHL receiver-plasmid to the TXTL
creates a solution that expresses GFP as a function of the concentration
of AHL. In plate reader experiments, the maximal rate of GFP expression
increases with the concentration of AHL and follows roughly a Hill curve
r(C) = α
Cn
Kn + Cn
+ α0 (3.1)
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with a coefficient of n = 1.5 and a threshold value of K ≈ 12.8 nM
(Fig. 3.3A), where C is the concentration of the inducer (in this case AHL),
α the theoretical maximal expression rate at full induction, α0 is the basal
expression rate and r is observed expression rate of GFP as a function of
the inducer. Then, ideally the normalized maximal expression rate r−α0
α
is
proportional to the fraction of active to inactive promoters.
3.5.2 Comparison to bacteria
A similar response to AHL is registered for the receiver plasmid in E. coli
(Fig. 3.3B1) [186]. Here the fit with a Hill function results in a Hill coefficient
of n = 2.6 and a threshold value of K ≈ 1.2 nM. However, Weitz et al. also
measured the response function of a plasmid without the LacI control of
LuxR but otherwise identical and they found a Hill coefficient of n = 1.6 and
a threshold value of K = 15 nM, which are closer to the values we measured
in TXTL [186]. This is a remarkably sensitive system as a threshold value
around K ≈ 10 nM for an E. coli corresponds to about 8 molecules per
cell [188]2. Most importantly, the AHL receiver plasmids maintains that
sensitivity in the TXTL as the threshold value is in a similar range as for
bacteria. It seems from Fig. 3.3 that the response of the receiver plasmid in
TXTL does not follow the hill curve as smoothly as for bacteria (RMSETXTL
RMSEBac
≈
13)3. The reasons for this have not been systematically investigated in the
scope of this thesis.
However, there are differences in the experimental conditions between the
samples which make a direct comparison difficult. For example, the sample
for bacteria in the plate reader has a volume of V = 300 µl at T = 37◦C in-
stead of V = 15 µl at T = 29◦C for TXTL. The overall protein concentration
in the TXTL is about 30x more diluted than in bacteria [189]. Furthermore,
during sample preparation, the components for the TXTL reactions such as
DNA and the cell lysate are under the direct influence of pipetting errors
between samples whereas bacteria in the exponential growth phase have a
control system for the plasmid copy number and the concentration of the
components of the expression machinery that depend on their growth rate
[190] [191].
1The data with bacteria was measured by Ronja Berg in her Bachelor thesis under the
supervision of Maximilian Weitz and Friedrich C. Simmel.
2molecules per cell = (12.8 nM) · (1 µm3) · (NA) = 8.
3The root mean squared error (RMSE) is defined as
√∑T
t=1(yˆt−yt)2
T , with T being the
number of data points and yt and yˆt being the data point and the predicted data point at
t.
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Figure 3.3: A Normalized maximum GFP expression rate of the AHL receiver
plasmid (7.5 nM) in TXTL for varying concentration of AHL and c(IPTG) = 10
mM, measured in a plate reader. A fit with a Hill curve (continuous line) results
in a Hill exponent of n = 1.5 and an induction threshold at K = 12.8 nM. B
Normalized maximum GFP expression rate of the AHL receiver plasmid in E.
coli in the exponential growth phase (within 5 hours) at c(IPTG) = 2 mM for
different AHL concentrations. A fit with a Hill curve (continuous line) results in
a Hill exponent of n = 2.6 and an induction threshold at K = 1.2 nM. Bacteria
data in (B) replotted from [186].
3.5.3 Related studies
It has previouly been shown that quroum sensing systems from bacteria can
function in cell lysates [192] [193]. The focus in these studies is to show
that cell-free assays are rapid, robust and cost-effective for the detection of
autoinducers. Using purified LuxR and DNA on gel shift assays, Urbanowski
et al. determined that the binding of AHL to LuxR is non-cooperative with
a hill coefficient of n = 0.9. However, the AHL concentration at which 50%
of the LuxR was unbound, which corresponds to the threshold value, was
determined to be about K = 100 nM [194].
In another study, where the response of a very similar plasmid was care-
fully studied in E. coli the Hill coefficient and threshold constant found are
n = 1.6 and K = 1.5 nM, confirming the values found by Weitz et al. [195]
[186].
In 2018, Halleran and Murray compared the cross-talk of several quorum
sensing system in bacteria and TXTL that was made with the same protocol
as in our experiments [196]. They found that the cell-free reactions accurately
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predicted cross-talk of the quorum sensing system, however it underestimated
the intensity. The difference in the ratio of transcription factor proteins to
free promoters between the TXTL and bacteria was identified as one reason
for the discrepancy in the intensity of crosstalk.
3.5.4 LacI control of the receiver plasmid
LacI is present in the E. coli stain from which the TXTL is made, so that
there should be endogenous protein in the reaction. However, the additional
IPTG control of the GFP expression only worked in the TXTL after supple-
mentation of purified LacI proteins (about 200 nM) at a DNA concentration
of 7.5 nM (Fig. 3.4A). Hence the response of the maximal production rate
of GFP as a function of IPTG did not follow a Hill curve (Fig. 3.4B) for the
TXTL that was not supplemented with additional LacI. However, also the
response of the plasmid to IPTG titration in bacteria (with 15 nM AHL) did
not follow a smooth hill curve (Fig. 3.4C4)
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Figure 3.4: A GFP fluorescene intensity of TXTL reactions with the AHL receiver
plasmid (7.5 nM) at t=5h. IPTG concentration c = 5 mM, AHL concentration
c = 200 nM. Left: without the addition of purified LacI. Right: with the addition
of about 200 nM His-tagged purified LacI. B Maximum GFP expression rate of
the AHL receiver plasmid (7.5 nM) in TXTL for varying concentration of IPTG
at c(AHL) = 200 nM, measured in a plate reader, without purified LacI. C Max-
imum GFP expression rate of the AHL receiver plasmid in E. coli for varying
concentration of IPTG at c(AHL) = 15 nM within 5 hours, measured in a plate
reader. Inset: GFP expression rate at t = 2 hours. Bacteria data in (C) replotted
from [186]
For this reasons we focused on the characterization of the AHL receiver
plasmid in respect to AHL, while saturating the reactions with IPTG.
4The data was measured by Ronja Berg in her Bachelor thesis under the supervision
of Maximilian Weitz and Friedrich C. Simmel.
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3.6 Encapsulated TXTL or bacteria with an
AHL receiver plasmid in a spatial AHL
concentration gradient
3.6.1 Experimental set-up
To introduce a spatial dimension to the gene expression, either the bacte-
ria or the TXTL with the receiver plasmid were encapsulated in picoliter-
sized emulsion droplets, which corresponds to a droplet diameter of about
40 − 50 µm, using a microfluidic droplet generation system. The droplets
were then loaded into a squared glass capillary with inner lengths of 50 µm
so that the diffusion between droplets is effectively reduced to two neighbor-
ing droplets. To study the diffusion mechanism of the inducers between the
droplets in the capillary, we introduced a spatial inducer concentration gradi-
ent at the opening of the capillary. This was realized by placing the capillary
in a reservoir with IPTG and AHL. As the aqueous phase in the droplets was
not saturated with AHL, AHL would start to diffuse into the capillary at its
open ends once placed in the reservoir. The logarithm of the partitioning
constant for octanol/water for OC6-HSL is logK ≈ 1− 2 which means that
the concentration of AHL will be 10-100x higher in the continuous phase for
octanol [197] [198]. As we use fluorinated emulsion the situation might be
quite different. However, Gruner et al. showed that there is molecular trans-
port between droplets in fluorinated emulsions through surfactant assemblies
such as micelles [199].
3.6.2 Considerations: inducer gradients
The concentration of AHL along the long axis of the capillary can be approx-
imated by solving the 1D diffusion equation
∂C(x, t)
∂t
= D
∂2C(x, t)
∂x2
(3.2)
where C(x, t) is the AHL concentration, D its diffusion coefficient. The
inducer concentration at the opening of the capillary x = 0 was assumed to
remain constant (C = C0) since the volume of the reservoir is about 1000
times larger than the interior volume of the capillary. Therefore any decrease
in AHL concentration due to molecules leaving the reservoir and entering the
capillary is quickly buffered by the rest of the reservoir.
Since the length of the capillary is l ≥ 1 cm and the run time of the
encapsulated TXTL is about t ≈ 5 − 6 hours, we assumed that the inducer
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concentration is sufficiently small at the center of the capillary so that we
can neglect it [200]. These assumption allows us to solve Eq. 3.2 using the
boundary conditions of an semi-infinite medium
C = C0 for x = 0 and t > 0 and C = 0 forx→∞ (3.3)
and intial conditions
C = 0 for x > 0 and t = 0. (3.4)
The solution can be found with the help of Laplace transformations [201]:
C(x, t) = C0 erfc
(
x√
4Dt
)
. (3.5)
where erfc(x) = 1− erf(x) is the complementary error function. With time,
the point xK(t) at which the inducer concentration has reached the threshold
value for GFP expression (C(x = xK , t) = K) is given by
xK(t) =
√
4Dt erfc−1
(
K
C0
)
, (3.6)
where erfc−1 is the inverse complementary error function. We tested the
solutions of Eq. 3.5 and 3.6 for our set-up using a rough approximation for
the diffusion constant of AHL in the capillary, based on the reported value
for aqueous solutions (D ≈ 100− 1000 µm2
s
[202] [203]). In addition we took
the effect of higher viscosity of the TXTL and the fluorinated oil (≈ factor 4
compared to water) into account which is given by the Einstein-Smoluchowski
relation. Hence the solutions for D = 25 − 250 µm2
s
are plotted in Fig. 3.5
and show that the concentration at the center of the capillary (x = 5 mm)
would only stay below the threshold concentration if the diffusion coefficient
is at the lower bound.
It is important to note here that D is an apparent diffusion coefficient,
which simplifies the description of the diffusion process. The next section
takes a more detailed view on the diffusion process in a medium that has
more than one phase.
Permeability
For the transport mechanism of the inducer between emulsion droplets, one
can use descriptions that where developed for lipid membranes such as the
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Figure 3.5: A The solution of Eq. 3.5 for three different AHL reservoir concentra-
tions C0 = 200 nM (red), C0 = 1 µM (green) and C0 = 10 µM (blue) for diffusion
coefficients D = 25− 250 µm2s . Inset: Zoom-in on the concentration. B The solu-
tion of Eq. 3.6 for the three AHL resevoir concentrations for the range of diffusion
coefficients. It can be seen that xK reaches the center of the capillary (≈ 5 mm)
within the life time of the TXTL reaction (≈ 5 h) for diffusion coefficients at the
upper bound.
Meyer-Overton Rule [204]. It states that the trans-membrane flux of a per-
meating molecule can be described in terms of the partitioning coefficient:
Koil =
Coil
Caq
(3.7)
where Caq is the aqueous phase, and Coil the continous phase. The surfac-
tant mostly increases the solubility within the continuous phase, increasing
the value of partitioning coefficient for the emulsion system. Since it was
found that an interface between the continuous and dispersed phase is not a
significant energy barrier for the molecules passing [205], Fick’s first law for
the flux between two neighboring droplets (see Fig. 3.6B) can be written as:
J = −Doil∆Coil
∆x
= −Doil (Coil(1)− Coil(2))
δ
(3.8)
= −DoilKoil (Caq(1)− Caq(2))
δ
= −Poil(Caq(1)− Caq(2)) (3.9)
Poil :=
KDoil
δ
(3.10)
where P is called the permeability, Doil is the diffusivity within the con-
tinuous phase and Coil and Caq are the concentrations at the interfaces in
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the continuous phase and aqueous phase at Position 1 and 2 (see Fig. 3.6B).
Using the Derjaguin approximation, the droplets can be approximated by
cylinders with radius d and the continuous phase with a radius δ (see Fig.
3.6A) [206]. Hence δ is the width of the oil gap between the droplets. As
previously mentioned, molecular transport in the continuous phase can be
mediated by surfactant molecules and assemblies such as reverse micelles and
vesicles [199]. This means that there are several ways of the inducer to diffuse
through the continuous phase between two droplets. This is equivalent to
the description of several membranes in parallel each with permeability Pi.
The total permeabilities then is given by:
P =
∑
i
Pi. (3.11)
When considering several droplets in a linear array, the oil gaps between
the droplets can be thought of as several membranes with Pi in series. Then,
the overall permeability P is given by:
1
P
=
∑
i
1
Pi
. (3.12)
d δ
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Figure 3.6: A Sketch of the emulsion droplets in the glass capillary and an ab-
straction of the linear array of droplets using the Derjaguin approximation. The
approximation reduces the droplet geometry to a quasi 1D array of rectangles of
width d that are separated by thin oil films of thickness δ. The oil film is separated
by a dashed line to illustrate parallel diffusion paths through the oil phase. The
upper half shows transport between droplets via inducer surfactant assemblies.
C An illustration of an AHL concentration profile accors two water reservoirs
separated by an thin oil film that is stabilized by surfactant molecules with an
partition coefficient K > 1. cres, caq(1), caq(2), coil(1), coil(2) and cmiddle are the
AHL concentration at different positions.
Hence, the apparent diffusion coefficient D for inducers in the linear ar-
rangement of emulsion droplets can be approximated by [207]:
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1P
=
1
Paq
+
1
Poil
(3.13)
d+ δ
D
=
d
Daq
+
1
Poil
(3.14)
Poil =
KoilDoil
δ
(3.15)
where Paq, Poil, P are the permeabilities and Daq, Doil and D are the
diffusion constants for the aqueous phase, the oil phase and the whole system
and Koil as defined by Eq. 3.7. If we assume that d >> δ and that Daq >>
Poild we can simplify Eq. 3.14 to:
d+ δ
D
≈ d
D
=
d
Daq
+
1
Poil
(3.16)
Poild
D
=
Poild
Daq
+ 1 ≈ 1 (3.17)
D = Poild (3.18)
This results underlines the importance of the permeability on the appar-
ent diffusion coefficient. For the case that the inducer molecules can diffuse
through the continuous phase in different ways such as in surfactant assem-
blies of different sizes or as a small molecules without surfactant molecules
the permeability is given by:
Poil =
∑
i
Pi =
∑
i
KiDi
δ
(3.19)
with Pi, Di and Ki are the permeabilities, diffusion and the partition
coefficients for the different phases in the continuous phase. As different
partition coefficients can depend on each other a clear description of each
permeability can be experimentally challenging.
3.6.3 Reaction-diffusion system
As stated previously, we infer the diffusion dynamics of the inducer from
the kinetics of the protein expression. Thus, in an attempt to increase the
accuracy, we can include the protein expression, protein maturation and the
inducers life time in our model. This step adds a term to Eq. 3.2 and
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introduces two new equations:
∂C
∂t
= D
∂2C
∂x2
− φC(x, t) (3.20)
∂G
∂t
= αexp(t)
Cn
Kn + Cn
− αmatG (3.21)
∂Gmat
∂t
= αmatG (3.22)
where C, G and Gmat are the concentrations of the inducer, nascent GFP
and maturated GFP, φ is the degradation rate of the inducer and αmat is
the GFP maturation rate. Eq. 3.21 describes the protein expression with a
Hill curve activation for the inducer like in Eq. 3.1 and a degradation term.
For the TXTL, as shown by Karzbrun et al., the the GFP expression rate is
assumed to exponentially apporach the expression rate of full induction αmax
so that αexp(t) = αmax(1−exp[−(t− t1)/t2], with the delay time t1 in protein
expression at the beginning and the lifetime of mRNA t2 [189]. Finally in
Eq. 3.22 the protein maturation is taken into account, since only maturated
GFP is detected by fluorescence.
3.6.4 TXTL droplets in a spatial AHL concentration
gradient
The receiver plasmid in TXTL supplemented with IPTG was encapsulated
and the emulsion droplets loaded into a capillary. The capillary was then
placed in a reservoir with M9 medium, c(IPTG) = 10 µM and either c(AHL) =
200 nM, 1 µM or 10 µM. It is possible to track the gene expression within
droplets in a time series of epifluorescence microscopy images (Fig. 3.7). In
order to make sure that the gene expression is only affected by the AHL
inducer gradient from one end of the capillary we restricted our analysis to
the first 1 mm of the capillary from one end.
Due to the establishment of an AHL gradient inside the capillary, gene
expression is activated faster and stronger in the droplets closer to the reser-
voir. As the TXTL system has a certain life-time of about τTXTL ≈ 5 − 6
hours after which it stops expressing protein [200] and the GFP is not de-
graded, we see a stable spatial gradient in GFP concentration (Fig. 3.8A).
Droplets at a certain distance from the reservoir were not able to express any
detectable amount of GFP above background levels, because the sufficient
AHL concentration at these droplets was not reached within the time window
of τTXTL.
Similarly, by following the dynamics of the GFP expression of each droplet,
one can see that the maximal rate of GFP expression also decreases with the
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Figure 3.7: Time series of epifluorescence microscopy images of GFP expression of
TXTL droplets containing the AHL receiver plasmid. The left end of the capillary
is connected to an AHL reservoir of different concentration: 200 nM (left), 1 µM
(center), 10 µM (right). As AHL diffuses into the capillary it activates the GFP
expression within the droplets. Time=0h corresponds to the beginning of the
acquisition.
distance from the reservoir (Fig. 3.8B). Although larger distances from the
reservoir will result in slower kinetics due to lower AHL concentrations, this
is not a one-shot AHL titration experiment which can be predicted by the
AHL dependence of the gene expression rate established in Fig. 3.3. The
dynamics of GFP expression are overlaid by the depreciating performance of
the TXTL, which has not been explicitly measured as a function of time and
by the AHL concentration flux. One simple way to change the AHL concen-
tration flux is to change the concentration of the reservoir. With increasing
AHL concentration in the reservoir, the GFP expression in more droplets
was activated, for the cost of having less spatial differentiation in GFP con-
centration between neighboring activated droplets. Interestingly, there is a
discrepancy between the expectations of the number of droplets (n) with
GFP above the background from back-of-the envelope-calculations (see Sec.
3.6.2) and the results for the AHL reservoir concentrations of Cres = 200nM
(n ≈ 3) and Cres = 1 µM (n ≈ 5). In the case of the highest amount of
concentration flux (Cres = 10 µM), is there a clear relationship between the
time of occurence of the max. expression rate and the distance of the droplet
from the reservoir (Fig. 3.8C).
3.6.5 Apparent diffusion coefficient
In order to gain a more quantitative understanding of the transport mecha-
nism we fitted two hours of the expression dynamics with the set of reaction-
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Figure 3.8: A The GFP concentration of droplets for different distances from the
AHL reservoir for three different concentrations after t = 7h of acquisition. The
mean concentration with s.e.m. of 3 samples for res. conc. of 200 nM and 10 µM
and of 2 samples for 1 µM of AHL. B Average maximal expression rate of GFP
per droplet for different distances from the three different AHL reservoirs. S.e.m.
is not shown, due the large size of the error (avg. CV = 0.15 for Cres = 200nM,
avg. CV = 0.11 for Cres = 1 µM and avg. CV = 0.21 for Cres = 10 µM). C The
time of occurrence of the avg. maximal expression rate per droplet shown against
the distance from the reservoir. The legend is Cres = 200nM (green), Cres = 1 µM
(red) and Cres = 10 µM (black).
diffusion equations 3.20-3.22 (Fig. 3.9). In the experiments with an AHL
reservoir concentration of c = 1 and c = 10µM we considered the dead time
of about 30 minutes before the acquisition due to experimental setting-up.
The equations were solved numerically and fitted with MATLAB using the
pdepe solver and the fminsearch function which was used to minimize the
least squared error between the solution and the experimental data. The
only variable parameters were the apparant diffusion constant D and the
maximal expression rate αmax. The best solution for D and αmax and the
values of the remaining constants are listed in Tab. 3.1.
The best solution for both D and αmax vary between the different AHL
reservoir concentrations. The different values for αmax most probably come
from batch-to-batch variations in the overall performance of the TXTL, as
variations in αmax mostly scale the amount of GFP produced in all droplets.
However, only by changing D is it possible to account for the time delay of
the GFP expression in different droplets as a function of the distance from
the reservoir.
By considering the GFP expression of the first two hours of acquisition,
the value for the diffusion coefficients were dependent on the AHL reservoir
concentration (Table 3.1). Whereas the apparent diffusion constant had a
value of around D ≈ 0.1 µm2s−1 for reservoirs with cAHL = 200 nM and
cAHL = 1 µM (’low’ reservoir concentration), it increased by factor of about
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Figure 3.9: The GFP expression kinetics for the first two hours of acquisition
for the three AHL concentrations of the reservoir A: 200 nM, B: 1 µM and
C: 10 µM are fitted with the reaction diffusion equations in order to estimate
the apparent diffusion coefficient of AHL.
cAHL(x = 0) (µM) Da (µm
2s−1) αmax(pMs−1)
0.2 0.15 458
1 0.09 155
10 29.89 224
Table 3.1: Apparent diffusion constants
300 to D ≈ 30 µm2s−1 for the reservoir with cAHL = 10 µM (’high’ reservoir
concentration).
3.6.6 Depreciation of TXTL
There are several potential reasons for the concentration dependence of the
apparent diffusion coefficient. As previously mentioned, the performance of
the TXTL system depreciates with time. For example, the pH of the TXTL
changes from about 7.1 to about 6.2 in 12 hours (Fig. 3.10). Encapsulation
using the surfactant and oil, might even speed up the depletion of resources
since it has been shown that substantial amounts of ions that are key to
transcription and translation such as Mg2+ where > 90 % are transferred
to the continuous phase via surfactant molecules within the time frame of
about an hour [208].
Smaller diffusive flux due to lower AHL reservoir concentrations means
that droplets at the same position are induced at later times. Hence the
slower GFP expression kinetics for the second and consecutive droplets from
the capillary opening for the reservoir concentration of 200 nM and 1 µM
might also be related to the fact the TXTL has depreciated.
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Figure 3.10: pH Test with phenol red and the cell free system: A Phenol red
calibration solutions (100 µM in PBS) between pH 7.4 and pH 5.9 and cell free
reactions supplemented with 100 µM phenol red. B Absorption spectra of cal-
ibration solutions and the cell free samples (dashed lines) at t=0h and t=12h
after start of experiment. C Absorption maxima at 555 nm plotted against the
corresponding pH values. Data points were fitted with an exponential curve for
estimating pH values of the cell free samples.
3.6.7 Surfactant micelle formation
As described in Sec.3.6.2 the transport mechanism within the capillary can
be described by a series of water reservoirs separated by thin oil films with
permeability P . So the AHL partitions into the continuous phase, diffuses
to the droplet interface, partitions into the aquous phase, diffueses to the
other side of the droplet, diffuses through the surfcatant layer and partitions
into the continuous phase again. The surfactant used in this experiments
is not expected to form adhesive bilayers and it was found that the droplet
boundary is not thought to be rate limiting.
Studies on the transport mechanisms between droplets using fluorophores
that are less soluble in the continous phase showed that the rate limiting step
is the diffusion through the continuous phase [208]. Since the surfactant inter-
face is not a barrier, the key parameters for the permeability are the spacing
between the droplets and the partitioning constant. The partitioning con-
stant and thus the permeability can be increased with increasing surfactant
concentration [199]. It has been shown that the transport of molecules be-
tween the aqueous phase through the continuous phase can be mediated by
assemblies of surfactant molecules such as vesicles, micelles or reverse mi-
62
celles with a diameter of about 100 − 1000 nM [199]. It could also be the
case that AHL itself has a low solubility in fluorinated oil.
The different ways to diffuse through the continuous phase might also
explain the discrepancy in the diffusion coefficient. For AHL reservoir con-
centrations of cAHL = 200 nM and cAHL = 1 µM, the concentrations of AHL
molecules that diffuse over a faster pathway are below the AHL induction
threshold (see Fig. 3.3), so that only the slower diffusing surfactant assem-
blies push the concentration above the threshold. In the case of the higher
AHL reservoir concentration of cAHL = 10 µM, the amount of AHL molecules
diffusing without surfactant molecules could be high enough to induce the
GFP expression, so that the apparent diffusion coefficient reported by the
GFP expression is dominated by this diffusion pathway.
3.6.8 Binding to LuxR
Additionally, the depletion of AHL due to binding of LuxR in upstream
droplets could potentially explain the dependency of the apparent diffusion
coefficient on the reservoir concentration. However, simulation with LuxR
did not show a significant difference (Fig. 3.11). An AHL binding term
was added to the reaction-diffusion equation using the model by Basu et al.
[209]. In addition the LuxR expression was simulated with the parameters
determined by Karzbrun et al. [189].
∂A
∂t
= D
∂2A
∂x2
− φA− kp · L2 · A2 (3.23)
d(A : L)
dt
= kp · L2 · A2 (3.24)
with A = [AHL], L = [LuxR] and A : L = [AHL : LuxR].
3.6.9 1D geometry
Given that the apparent diffusion coefficient is relatively small for the low
reservoir concentrations, underlines the importance of restricting the diffu-
sion along one dimension in order to see an effect in more than one droplet.
In the linear arrangement, we have only two neighboring droplets, whereas
in a 2D and 3D arrangement of closely packed droplets there are 6 and and
twelve neighboring droplets, decreasing the coupling between droplets due to
dilution of inducer molecules.
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Figure 3.11: Simulation of GFP expression without (upper) and with (lower)
LuxR expression for an AHL reservoir concentration of A: 200 nM, B: 1 µM and
C: 10 µM. The GFP expression are slightly delayed in the presence of LuxR,
however this effect cannot alone explain the large difference between the apparent
diffusion coefficients between the low and high resevoir concentrations.
3.7 TXTL droplets vs. bacteria droplets with
AHL reservoir
We also encapsulated E. coli bacteria with the AHL receiver plasmid in
the emulusion droplets to see their response within an AHL concentration
gradient using the experimental set-up explained in the previous section. The
bacteria were grown in M9 minimal medium supplemented with IPTG to an
optical density of ≈ 0.1−0.2 so that there are only a few bacteria per droplet
at the beginning and loaded into an capillary which was then placed in an
AHL reservoir (Fig. 3.12A).
Constant Value Reference
φAHL 1 · 10−5 s−1 [210]
αmat 3.33 · 10−3 s−1 [211]
t1 20 min [189]
t2 12 min [189]
n 1.5
K 12.8 nM
kp 10
−1 nM−3 s−1 [209]
Table 3.2: Parameter for the reaction-diffusion equations.
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Figure 3.12: A Time series of epifluorescence images of emulsion droplets inside a
glass capillary, containing bacteria with the AHL receiver plasmid. The capillary
is placed in a reservoir with [AHL] = 1µM. As AHL diffuses into the capillary it
induces GFP expression inside the bacteria that are growing in the droplets. B
Tracked GFP fluorescence intensity of the different droplets in the capillary for
[AHL] = 1 µM. C The GFP fluorescence intensity level of droplets for different
distances from the AHL reservoir for three different concentrations after t = 9h of
acquisition. The mean concentration with s.e.m. of 3 samples for res. conc. of
200 nM and of 2 samples for 1 µM and 10 µM of AHL.
In contrast to the TXTL, the bacteria are still growing within the droplets
during the subsequent induction, so that the signal of the induced GFP fluo-
rescence is overlaid by bacterial growth. This has an effect on the fluorescence
time traces of the droplets (Fig. 3.12B) in that it is harder to quantify the
GFP concentration per droplet, as the bacteria change their position within
the droplet which can cause a change in the detected fluorescence intensity.
In addition, the GFP fluorescence level is dependent on the number of bac-
teria in the droplets and not only on how strong they are induced. For that
reason, we did not convert the fluorescence intensity into a GFP concentra-
tion as for the TXTL.
By comparing the end level (t=12h) of the bacteria for different AHL
reservoir concentrations, we were able to see that in all cases the GFP signal
dropped to a background level for x > 500 µm from the opening of the capil-
lary (Fig. 3.12C). As oxygen is required both for bacterial growth and GFP
maturation, this signal drop might not be caused by an absence of inducers
molecules but rather a lack of oxygen availability within the capillary. This
effect was not observed for the TXTL droplets. For these reasons, bacte-
rial droplets are inferior to TXTL droplets for the characterization of the
diffusion process within the droplets in the capillary.
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3.8 IPTG concentration gradient
We looked at IPTG diffusion within the capillary, by saturating all droplets
with the receiver plasmid in either TXTL or bacteria and the reservoir with
cAHL = 200 nM, but only the reservoir with cIPTG = 10 mM. As the IPTG
diffuses through the capillary the droplets start the expression of GFP as
shown in Fig. 3.13.
0 5 10
Time (h)
0
20
40
60
80
100
120
In
te
ns
ity
 (a
.u
.)
0
45
88
187
277
324
371
415
483
Po
si
tio
n 
(µ
m
)
0 2 4 6
Time (h)
0
0.5
1
1.5
2
2.5
3
[G
FP
] (
µM
)
0
63
98
219
298
339
395
439
Po
si
tio
n 
(µ
m
)
A B
Figure 3.13: Tracked GFP fluorescence intensity of droplets with the receiver
plasmid in A bacteria or B a cell-free expression system in the capillary with
different distant to the reservoir [IPTG] = 10 mM.
The signal for bacteria is again overlaid by the growth dynamics and
the variations in intensity due to the movement of the bacteria within the
droplet. The droplets within l ≤ 200 µm express GFP stronger within the
first t = 6 h then the the rest of the droplets, whereas all the droplets up
to x ≤ 400 µm reach about the same intensity after t = 12 h, the droplets
beyond this distance seem to express significantly less amount of GFP. For
the TXTL, only the first two droplets can be differentiated from the rest,
whereas for the bacteria the first four droplets have a significantly more
GFP at about t = 6 h than the rest, making the bacteria filled droplets more
sensitive to the inducer concentration gradient. However, it was surprising
to find the GFP expression to be dependent on the distance at all, as the
bulk experiments in Fig. 3.4A did not suggest that gene expression should
be dependent on IPTG unless LacI protein is supplemented (which was not
the case in the experiments here).
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3.9 Reservoir inducer droplets
Inspired by previous work we encapsulated inducer in droplets (termed ’reser-
voir droplets’) and mixed them with droplets contaning bacteria/TXTL with
the receiver plasmid, which did not contain the encapsulated inducer [186].
With this we can restrict the gene expression to droplets in the vicinity of
the reservoir droplets (Fig. 3.14). We either encapsulated cAHL = 200 nM
and/or cIPTG = 10 mM, so that we can approximate the reach using the
macroscopic reservoir experiments from the previous sections.
50 µm50 µm50 µm
Figure 3.14: Fluorescence microscopy images of gene induction from reservoir
inducer droplets. Left capillary: [IPTG]=10 mM global, [AHL]=200 nM in
reservoir droplet (blue). Bacterial receivers in close proximity to the blue AHL
reservoir droplet express GFP (green). Centre capillary: [AHL]=200 nM global,
[IPTG]=10 mM in reservoir droplet (red). GFP expression in bacterial receivers
is induced in all droplets between IPTG reservoir droplets. Right capillary:
[AHL]=200 nM in reservoir droplet (blue) and [IPTG]=10 mM in reservoir droplet
(red). GFP expression is only activated in the vicinity of both reservoir droplets.
Hence for the experiment, with IPTG distributed globally and AHL only
locally, we found, as expected from the experiment from Sec. 3.7, that GFP
expression is activated for droplets that are either direct neighbours to the
reservoir droplets or one droplet further away. However, in the case of IPTG
reservoir droplets with AHL distributed globally, GFP expression was not
restricted to only neighboring droplets. We ruled out that all the GFP ex-
pression comes from a leakiness of the receiver plasmid to IPTG, by looking
at the fluorescence level in droplets in the absence of IPTG reservoir droplets.
Since the GFP expression for bacteria with the receiver plasmid is found to
be already maximally induced at 10 µM (see Fig 3.4C) which is 0.1% of the
concentration inside the reservoir droplets, we assume that the IPTG con-
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centration is already high enough to induce GFP expression. However, the
encapsulated TXTL for these experiments was not supplemented with extra
LacI protein, so that there should not be an IPTG dependence (see Fig. 3.4A,
B). Using a combination of AHL and IPTG reservoir droplets, it was then
again possible to spatially confine gene expression only to bacteria/TXTL
close to the AHL reservoir droplets.
3.10 From AHL senders to AHL receivers us-
ing TXTL and bacteria droplets
The receiver-sender plasmid system (Sec. 3.2) in principle allows to produce
AHL in situ. Hence we tested the production of AHL in TXTL in bulk by
the addition of both the receiver and the sender plasmid. The GFP signal
was strongly reduced without the addition of AHL at the beginning, but it
was possible to increase the GFP signal slightly by supplementing the TXTL
with S-adenosyl methionine (SAM), a precursor for the enzymatic production
of AHL with LuxI (Fig. 3.15). Additionally, the supplementation of T7
RNA polymerase leads to an earlier GFP signal, suggesting that the AHL
production is sped up.
0 2 4 6 8 10
Time (h)
0
2000
4000
6000
In
te
ns
ity
 (a
.u
.)
R+S plasmid + SAM
R+S plasmid + SAM + T7 RNAP
R+S plasmid
R+S plasmid
+ 25 nM AHL
Figure 3.15: GFP expression from the receiver plasmid ([R] = 7.5 nM) in TXTL in
a plate reader. The GFP expression is strongly reduced if the AHL is not directly
added at the beginning of the reaction (e.g. 25 nM of AHL), but instead the
sender plasmid ([S] = 2 nM) is added so that AHL is enzymatically produced. The
addition of S-adenosyl methionine (SAM) which is a substrate for the production
of AHL via LuxI can increase the response of the receiver plasmid to the sender
plasmid in TXTL. Addtionally purified T7 RNA polymerase speeds up the GFP
response due to faster expression of LuxI.
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We then proceeded to encapsulate the sender and receiver plasmid in
either bacteria or TXTL in order to create, to our knowledge for the first
time, chemical communication between either bacterial senders and cell-free
receiver droplets or vice versa. As shown in Fig. 3.16A, the bacterial receivers
express GFP as a result of the AHL production in TXTL senders. In addition,
we saw that the GFP intensities of the droplets with bacterial receivers is
strongly dependent on the position within the capillary. After about one
hour the GFP signal for the droplets at the center of the capillary plateaued,
whereas the singal of the receiver droplets closer to the ends of the capillary
continued to rise. The droplets closest to the opening of the capillary had
the strongest GFP signal after about 6 hours of increase (Fig. 3.16b). We
assume that oxygen availability limits the GFP signal within the capillary,
since both bacterial growth and GFP maturation require oxygen. Given that
the oxygen has a high solubility in fluorinated oil (about ≈ 77 ml of oxygen
gas per 1 l (at 1 bar) and can be transported relatively fast through the
continous phase with a diffusion coefficient of about D ≈ 8300 µm2
s
[212],
we assume that the fresh oxygen diffusing in at the end of the capillary gets
consumed by the bacterial droplets at the opening of the capillary before it
can reach the center of the capillary, establishing an oxygen gradient that is
reflected in the GFP signal.
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Figure 3.16: A A kymograph from a fluorescent microscopy image showing com-
munication between TXTL sender droplets (with SAM) and bacterial receiver
droplets in the presence of IPTG reservoir droplets (50 mM). The AHL is pro-
duced in the TXTL sender droplets and diffuses the the bacterial senders droplets,
in which the bacteria grow and start to express GFP (green). B The average GFP
fluorecnce intensity time trace of about 20 bacterial receiver droplets without any
TXTL sender droplets, with TXTL sender droplets without SAM, and with TXTL
sender droplets with SAM for three different positions in the capillary of length
L. At the opening of the capillary x = 0, half-way to the center of the capillary
x = L/4 and at the center of the capillary x = L/2.
In order to make the TXTL receiver droplets sense the AHL produced
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by bacteria, we changed the plasmid to the sender plasmid in E. coli and
the receiver plasmid in TXTL. Then the direction of communication was
reversed so that GFP expression was induced in the TXTL droplets by the
AHL from the sender bacteria (Fig. 3.17A). The GFP signal had the same
intensity throughout the whole capillary, in contrast to the bacterial receiver
droplets. Furthermore, we were able to differentiate TXTL receiver droplets
from their GFP expression kinetics as being a direct neighbor to a bacterial
sender droplet or not (Fig 3.17B).
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Figure 3.17: A A kymograph from a fluorescent microscopy image showing com-
munication between bacterial sender droplets and TXTL receiver droplets in the
presence of IPTG reservoir droplets (50 mM). The AHL produced in the bacteria
diffuses to the TXTL droplets and induces GFP expression (green). B Time trace
of the GFP expression kinetics in the TXTL receiver droplets without and with
bacterial sender droplets. Furthermore one can differentiate if a bacterial sender
is a direct neighboring droplet to a TXTL receiver droplet.
3.11 Conclusion
We have demonstrated spatially differentiated gene expression in linear chains
of emulsion droplets containing either bacteria or cell-free gene expression
systems. Spatial effects can be either achieved by establishing concentration
gradients of genetic inducers such as AHL and IPTG via macroscopic reser-
voirs or local sender droplets. For low inducer concentrations, the apparent
diffusion coefficient of AHL is reduced by several orders of magnitude, con-
sistent with micelle-mediated transport between neighboring droplets. Con-
finement to an effective 1D geometry leads to a stronger chemical coupling of
neighboring droplets and an extended spatial range of the inducer molecules.
This also enabled us to establish communication between cell-free sender
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droplets and neighboring bacterial receiver droplets and, conversely, between
sender bacteria and cell-free receivers. Our experiments represent a step
towards artificial multicellular hybrid systems, in which the “cells” are con-
stituted either by encapsulated bacterial consortia, artificial cells containing
cell-free gene expression systems, or supplementary cells with chemical sup-
plies, nutrients, etc. The 1D geometry utilized in this work proved particu-
larly useful to achieve spatial differentiation in such systems and to generate
interesting spatiotemporal effects, thus emulating simple developmental pro-
cesses in an artificial context.
3.12 Materials and Methods
3.12.1 Preparation of the cell-free gene expression sys-
tem
Crude S30 cell extract was obtained by beat beating a BL21-Rosetta2(DE3)
mid-log phase culture with 0.1 mm glass beads in a Minilys device (Peqlab,
Germany) as described in Ref. [68]. Instead of 3-phosphoglyceric acid (3-
PGA), phospho-enolpyruvate (PEP) was utilized as an energy source [213]
in the composite buffer (50 mM Hepes pH 8, 1.5 mM ATP and GTP, 0.9
mM CTP and UTP, 0.2 mg/ml tRNA, 26 µM coenzyme A, 0.33 mM NAD,
0.75 mM cAMP, 68 µM folinic acid, 1 mM spermidine, 30 mM PEP, 1 mM
DTT, 2 % PEG-8000). All components were stored at -80◦C before thawing
on ice. The composition of a single cell-free reaction was: 33 % (v/v) S30 cell
extract mixed with 42 % (v/v) buffer and 25 % (v/v) DNA plus additives.
Each final reaction mix was supplemented with 13.3 mM maltose for ATP
regeneration [200]. 300 µM of S-(5’-Adenosyl)-L-methionine chloride dihy-
drochloride (Sigma-Aldrich, A7007) and 1 U/µl of T7 polymerase (Epicentre,
TM910K) was added to the cell free sender droplets. LacI was His-tagged
and purified by gravity-flow chromatography with Ni-NTA Agarose Beads
(Qiagen).
3.12.2 Bacterial strains and culture media
The receiver plasmid was cloned into Escherichia coli DH5αZi (ExpressSys)
and the sender plasmid into E. coli BL21(DE3)pLysS (Promega) as described
previously [186]. As culture media, Luria-Bertani (LB) medium (Carl Roth,
X968.1) and M9 minimal supplemented with 20 mM glucose and 300 µg/ml
thiamine hydrochloride (Sigma-Aldrich, T1270) were used. For IPTG reser-
voir experiments with reiceiver bacteria, M9 minimal medium was supple-
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mented with 0.4 % (w/v) glycerol instead of glucose. Cells from glycerol
stock were grown overnight in Falcon tubes with 5 ml LB medium contain-
ing 100 µg/ml carbenicillin (Carl Roth) and 30 µg/ml chloramphenicol (Carl
Roth) at 37◦C shaken at 250 rpm. The overnight cultures were diluted to an
initial optical density (OD 600nm) of 0.01 in Falcon tubes containing fresh
LB or M9 minimal medium (Sigma-Aldrich, M6030) for sender or receiver
cells, respectively (LB medium is autofluorescent in the GFP channel) with
50 % reduced antibiotic concentrations. Before encapsulation of bacteria into
microemulsion droplets, the cultures were incubated for 2 - 3 h until an OD
600nm of 0.1 – 0.2 was reached. Sender bacteria droplets were grown in LB
medium supplemented with 1 mM IPTG, two hours before encapsulation.
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Figure 3.18: Plasmid Maps of constructs used in this study: the AHL receiver
plasmid (a) is based on the BioBrick part pSB1A3 with insert T9002 completed
with lacO-1 promoter. (b) pETDuet-1 vector was used for the sender plasmid with
the BioBrick insert C0061 (luxI). Contsruction details can be extracted from Ref.
[186].
3.12.3 Microfluidics
For the generation of droplets, we utilized a microfluidic flow-focusing geom-
etry, which was defined using soft lithographic techniques and the elastomer
poldimethysiloxane (PDMS). PDMS devices were micromolded from silicon
masters containing the channel structures, which were defined using the neg-
ative photoresist Epocore 20 (micro resist technology, Germany). The cured
microfluidic device was bonded onto a glass cover slide after oxygen plasma
treatment and baked at 200◦C for 3 hours [214]. To avoid cross contamina-
tion, each droplet species was produced in a separate device. Fluid flows were
generated with a pressure controller OB-1K (Elveflow, France) and appro-
priate PTFE-tubings (inner diameter: 0.8 mm). Pressures were set between
150-300 mbar. The droplet device was loaded with the carrier oil Fluorinert
FC-40 (Sigma-Aldrich, Germany) blended with 2% (w/w) surfactant (EA,
RainDance Technologies, USA) and focused with the appropriate aqueous
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phase. The critical micelle concentration of the surfactant is ≈ 0.02-0.04 %
[215]. The reservoirs and the collection tubes for the cell free system were
placed on ice during droplet production. Different species of droplets were
collected separately and then mixed in a new test tube in defined volume
ratios with a pipette. For capillary measurements with inducer reservoirs,
the capillary ends were placed in a chamber containing the reservoir solution.
The chamber was built with two stripes of melted parafilm on a glass slide,
immediately covered with another glass slide. The chambers were sealed with
silicone vacuum grease and nail polisher.
3.12.4 Bulk characterization
Cell-free expression of GFP was characterized via plate reader measurements
(BMG FLUOstar Optima) using 15 µl reaction volumes in 384-well plates.
3.12.5 Microscopy
Video microscopy of droplets containing only bacteria was performed with
an inverted epifluorescence microscope IX81 (Olympus, Japan) using a 10x
magnification objective, an EMCCD camera (iXon3, Andor, UK), and a mer-
cury fluorescence excitation light source (X-Cite 120Q, Excelitas Technolo-
gies, USA). The microscope was equipped with an incubator box (Okolab,
Italy) to maintain a temperature of T=37◦C. All time-lapse microscopy mea-
surements containing the cell-free system, also in combination with bacteria,
were conducted on an IX71 microscope (Olympus, Japan) using a 10x objec-
tive, a CCD camera (LucaR, Andor, UK) and a 4-wavelength fluorescence
LED source (Thorlabs, USA). The samples were thermostatted at 30◦C using
a heating plate (Tokai Hit Co. Ltd., Japan).
3.12.6 Data analysis
Image analysis is performed using a customized automated droplet tracking
software programmed in MATLAB [216]. Time traces of cell-free droplets
were generated by taking the mean fluorescence intensities over the whole
droplet area (determined from bright field images). Since bacteria accumu-
late in the centre of the droplet, in this case the mean was taken only from
bright pixels (defined by automated thresholding). Intensity traces were then
normalized by subtracting the minimum of all traces of one capillary. Based
on the distance of the droplets the time traces of multiple (2-3) capillaries
were averaged. Subsequently, time traces were normalized to the maximum
intensity for bacterial receivers. For cell-free receivers, a calibration with
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droplets containing purified GFP was performed. Finally, most of time traces
were smoothed in MATLAB with the function smoothn (S=10-100) to re-
duce the noise and account for missing data points. For data spanning more
than one observation area, i.e. 1 µM and 10 µM AHL reservoirs, images A
and B were recorded with an overlap so that a reference droplet was present
in each image. Accordingly, extracted data was stitched by transforming the
positions of droplets in B to the coordinate system of A. It was ensured that
droplets present in both images were not taken twice. Positions of droplets
were calculated as the distance to the first droplet plus the radius of the first
droplet. Pixel sizes of the cameras are 8 µm and 13 µm for IX71 and IX81,
respectively. For data of hybrids, droplets were sorted manually dependent
on their number of sender neighbours/their position inside the capillary and
averaged.
3.12.7 Filling of the capillaries
Squared borosilicate glass capillaries with inner dimensions 50 µm x 50 µm x
5 cm (VitroCom, USA) were fixed by placing one end of the capillary between
a freshly activated PDMS block and a glass slide (Fig. 3.19). The end of
the capillary was positioned within a pre-punched hole in the PDMS block
(diameter 1.25 mm), into which the droplet solution was pipetted. The
capillaries were filled by manually applying pressure on the PDMS block.
Filled capillaries were sealed with vacuum grease and nail polisher. For the
experiments with several droplet species, we scanned for and then focused
on appropriate droplet configurations.
PDMS Capillary
1. Pipette
2. Pressure
Flow
Glass Slide
Figure 3.19: Filling of capillaries.
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3.13 Contributions
The experiments were conceptualized by Matthaeus Schwarz-Schilling (M.S.)
and Friedrich C. Simmel (F.S.). The cloning of the sender-receiver plasmids
was done by Andrea Mu¨ckl (A.M.). The idea of using glass capillaries came
up in a discussion with Michael Heymann. Experimental work was done
by M.S. and Lukas Aufinger (L.A.). Characterization of the TXTL in plate-
reader was done by M.S and of bacteria by Ronja Berg and Maximlian Weitz.
Preparation of cell-free expression system was done by M.S. and A.M. Track-
ing of fluorescence intensity time traces in droplets was performed by L.A.
Loading of the capillaries was done by M.S. Chemical communication exper-
iments were conducted by M.S. Data analysis and modeling were done by
M.S., L.A., and F.S.
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Chapter 4
RNA-protein nanostructure in
a cell-free expression system
4.1 Bionanotechnology
Living organisms are full of intricate structures on the nanoscale made from
different molecules. Since the twentieth century, researchers are able to re-
solve the complex structure of biomolecules within cells, from the discovery
of the double helix of DNA to the structure of the ribosome. Structural
determination is often coupled to understanding the mechanisms behind the
molecules’ functions. There are libraries of structural motifs from deter-
mined protein structures (rcsb.org) and from nucleic acid structures (ndb-
server.rutgers.edu).
With the understanding of structural and functional aspects of bio-molecules
comes the will to design and create artificial structures. First, artificial nanos-
tructures from biomolecules were proposed in 1982 by Nadrian Seeman [144].
The field of DNA nanotechnology has progressed since then and has also in-
spired the use of RNA to design artificial nanostructures. Some examples of
RNA nanostructures have been introduced in section 2.7.
4.2 Summary
The contents of this chapter have been published in the artice: ”Optimized
assembly of a multi-functional RNA-protein nanostructure in a cell-free gene
expression system” by Matthaeus Schwarz-Schilling, Aurore Dupin, Fabio
Chizzolini, Swati Krishnan, Sheref S. Mansy and Friedrich C. Simmel in
Nano Letters, 2018, 18 (4), 2650-2657.
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The expression and assembly of an RNA-protein nanostructure is demon-
strated and optimized within a cell-free expression system. The RNA struc-
ture is composed of different structural motifs. In total four different ap-
tamers and one three-way junction derived from the phage φ29 RNA (pRNA)
have been used. We used a variety of assays to verify that each aptamer works
as intended.
The fluorescence enhancing effect of the malachite green (MG) binding
aptamer was tested using a fluorescence spectrometer. The function of the
aptamer is to report the concentration of the RNA in an expression experi-
ment. Although there are other fluorescence enhancing RNA aptamers, like
Spinach [217] with higher brightness , the advantage of MG is that its fluo-
rescence emission is in the red spectrum with a peak at about 650 nm. In
this way the signal does not interfere with other fluorescent probes that are
also used in this study, and absorb and emit in the green and yellow parts of
the light spectrum.
The main function of the RNA structure is to serve as a scaffold for two
proteins. For this purpose we used a previously optimized RNA scaffold unit
for two proteins from Sachdeva et al. [157]. The scaffold consists of two
aptamers. The first is from the phage PP7 that binds a domain of the PP7
coat-protein (PCP) [161]. The second aptamer is from a trans-activating re-
sponse RNA element in the bovine immunodeficiency virus (BIV) that binds
the Tat peptide, a protein which promotes the enhancement of transcrip-
tional elongation of the viral genes [218]. The two RNA binding domains of
the proteins are fused to fluorescent proteins that form a FRET-pair. The
Tat peptide is fused to the FRET donor mTurquoise2 which is from the
CFP family. The PCP peptide is fused to the FRET acceptor protein YPet
which is from the YFP family. The PCP was chosen for the FRET acceptor
since it forms non-aggregating dimers and in this way there are one donor
and two acceptors per RNA molecule. The scaffold unit was designed in
such a way that proteins are positioned within the FRET radius of about
5.7 nm [219]. In total, the FRET system is fully genetically encoded with
each component being fluorescent on its own or with the help of MG in case
of the RNA nanostructure. This allows for real-time observations of a) the
expression of each component and b) the assembly of the components into
the RNA-protein complex.
The fourth aptamer is a streptavidin binding aptamer. It was tested using
a binding assay with streptavidin coated magnetic beads and subsequent
elution by biotin. The RNA-nanostructure and the RNA-bound proteins can
be localized on the microbeads after expression in droplets via the aptamer.
Co-localization of each component on the bead is another method to verify
assembly of the RNA-protein nanostructure..
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The four aptamers are connected via the three-way junction (3WJ) do-
main of the pRNA molecules of the phage φ29. The three-way junction was
already proven to guide the folding of aptamers attached to its three arms
[220]. Additionally it provides stability against denaturation by temperature
or urea. Even more important for the expression within a cell-free expression
system and cells, it protects the aptamers within the structure against degra-
dation by RNase. We followed the fluorescence intensity of the MG aptamer
for various versions of the RNA structure in the E. coli derived cell-extract.
The closer the aptamers were to the 3’ end of the RNA the faster they were
degraded. The half-life of the middle arm where the protein FRET pair is
assembled was measured to be about τ= 9.55 ± 0.75 hours.
Then the assembly efficiency of the RNA-protein complex was assessed
by titration of purified proteins against the purified RNA with a fluorescence
spectrometer. The donor quenching due to FRET of the scaffolded proteins,
in combination with known concentrations of each component and literature
values for the equilibrium binding constants, allowed for a quantification of
the assembly process. The efficiency of complex assembly was quantified by
considering the fraction of fully assembled complex to the sum of monomers.
This metric captures the fact that the production of monomers that are not
used in the assembled complex is simply a waste of resources. We believe
that this aspect is worth to be taken into account in the process of designing
the production of molecular complexes in closed compartments or even in
cells with finite amount of building blocks.
We chose a cell-free expression system for the expression and assembly of
the RNA-protein nanostructure, as we can easily screen parameters such as
DNA template concentration for different components. Furthermore, it pro-
vides more control over the expression process as individual components and
reaction reagents can be added in a step-by-step manner. After the expression
and assembly of the RNA-protein was optimized for the cell-free expression
system, we encapsulated the genetic constructs encoding the RNA-protein
nanostructure in water-in-oil emulsion droplets together with streptavidin
coated beads. Under a microscope we were able to follow the expression of
the proteins and the RNA nanostructure. In addition we saw a co-localization
of proteins on the streptavidin coated beads, suggesting that the RNA is the
link that assembles the three proteins, the FRET-pair and streptavidin.
Finally we transformed the plasmids encoding the RNA-protein structure
in E. coli. Using a fluorescence spectrometer we were able to verify the
expression of the FRET-pair and the RNA nanostructure in cells. However,
as the expression was not optimized in bacteria, the ratio of the components
was not ideal for assembly. The constraints for the expression of the complex
in bacteria are stronger. We noticed that the protein expression slows down
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the growth rate, and that the relative expression levels of the two proteins
compared to each other can fluctuate between experiments. This had a
significant effect on the reproducibility of the expression levels and reduced
the FRET signal of the assembled complex.
4.3 Introduction
Over the past years there has been tremendous progress in the assembly
of complex and large nanostructures from biomolecules. Structural DNA
nanotechnology, and the DNA origami technique [90] in particular, has en-
abled the creation of large molecular lattices and crystals [145] with tunable
properties, as well as almost arbitrarily shaped discrete molecular objects
[221] [222] [148]. RNA has also been successfully utilized for the creation
of nanostructures [223] [156] [224]. In contrast to DNA self-assembly, which
is most often based on thermal annealing of the constituting DNA strands,
RNA nanostructures can be created enzymatically via transcription from a
DNA template by RNA polymerase [155] [152]. RNA folding occurs intra-
molecularly during transcription, which is under kinetic rather than purely
thermodynamic control. Recently, protein nanotechnology has taken major
strides, and a variety of artificial protein nanostructures [225] as well as de
novo-designed small proteins and protein assemblies have been demonstrated
[226] [227].
Most likely future biomolecular nanostructures will consist of combina-
tions of several types of biomolecules, i.e. RNA or DNA combined with
peptides or proteins [228] [229], possibly involving lipids [230] and small
molecules (“co-factors”) [160] [231] RNA-protein nanostructures are of par-
ticular interest in this context, as both RNA and protein components can be
produced enzymatically via transcription and translation of the correspond-
ing gene sequences. In fact, whereas biological systems barely utilize DNA
in a structural context, RNA nanostructures do occur in nature, where they
are most often found interacting with proteins. Prominent examples of such
structures are the ribosome [232], the spliceosome [233], RNase P [234], or
the portal motor of bacteriophage φ29 [235].
Interactions between RNA and other biomolecules such as proteins are
mediated by small aptamer motifs, and these have already been frequently
utilized for tagging of RNA molecules with fluorescent proteins or enzymes
[162]. Functional aptamers as well as structural RNA motifs can be modu-
larly combined to create RNA nanostructures,[154], which can be utilized as
enzyme scaffolds that increase the flux through metabolic pathways [157] or
perform regulatory actions [236].
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The constituents of RNA-protein nanostructures potentially can be coex-
pressed and assembled within a single reaction compartment or inside of cells
[237]. However, efficient production of multicomponent structures in this way
faces a number of challenges which have not been systematically addressed so
far. For the assembly of multiple proteins along an RNA scaffold one has to
consider the potentially different expression levels of the components as well
as their variable binding strengths. Accordingly, uncoordinated production
of the components under resource-limited conditions decreases the yield of
correctly assembled structures.
In order to address this issue, we here quantitatively study the expres-
sion and assembly of an RNA-protein hybrid structure using a cell-free gene
expression system. The RNA nanostructure investigated here (Fig. 4.1)
is based on the pRNA three-way junction (3WJ) motif [164] and is func-
tionalized with four different aptamers, three of which interact with pro-
teins (streptavidin and two fluorescent proteins), while one binds the small
molecule dye malachite green (MG). Utilizing the fluorescence of the MG
aptamer [238] and Fo¨rster resonance energy transfer (FRET) between the
fluorescent proteins bound to the RNA nanostructure scaffold, we can assess
critical assembly parameters such as the efficiency of protein co-assembly
and the stability of the hybrid nanostructure. Using a variety of genetic con-
structs encoding the RNA and protein components of the structure, we screen
for conditions resulting in the most efficient assembly inside of a cell-free ex-
pression system. We then demonstrate the production of the multifunctional
RNA nanostructures and the fluorescent proteins as well as their co-assembly
in a single cell-free expression reaction, and also their aptamer-mediated lo-
calization onto streptavidin-coated substrates. We finally show that our in
vitro-prototyped hybrid nanostructure can also be assembled in vivo.
In a related study by Jepsen et al. [239], an RNA nanostructure modified
with two fluorescent RNA aptamers (requiring chemically synthesized chro-
mophores) was utilized as a novel type of in vivo FRET sensor. By contrast,
the FRET-generating components of the RNA-protein nanostructure devel-
oped here are fully genetically encoded. While in the present work, FRET
is used merely as an analytical tool for the optimization of protein assembly
along the RNA scaffold, an application as in vivo sensor is also conceivable.
4.4 RNA nanostructure design
We chose the 40 nt-sized pRNA three-way junction (3WJ) as the central
structural motif of our RNA nanoscaffold (Fig. 4.1A) to ensure a compact
tertiary structure and to improve co-transcriptional folding of the four ap-
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Figure 4.1: Design and characterization of the RNA scaffold. A Overview scheme
of the RNA nanostructure. The RNA is functionalized with four aptamers: a
malachite green (MG) aptamer at the 5’ end, TAR and PP7 aptamers, which are
positioned one helical turn away from each other, and a streptavidin aptamer at
the 3’ end. The core of the structure is formed by a three-way junction (3WJ)
motif from bacteriophage phi29 (boxed in red). Two transcriptional terminators
are placed behind the structure. B Native gradient PAGE (4-20%) stained with
malachite green, of the RNA nanostructure after in vitro transcription with T7
RNAP from a linear template with and without terminators.
tamers. The pRNA 3WJ motif has been previously shown to be an unusually
robust structure that dominates the tertiary structure of RNA strands up to
four times its length [220]. The first RNA aptamer attached to the scaffold
is the fluorescent aptamer for Malachite Green (MG) [240], which serves as
a fluorescence reporter for the total amount of RNA nanostructure gener-
ated. Instead of brighter fluorescent RNA aptamers such as Spinach [217],
we chose the MG aptamer for this study since its fluorescence spectrum does
not overlap with the spectra of the protein-based FRET-pair. The second
and third RNA aptamers are used to recruit proteins to the RNA scaffold. In
their biological contexts, the 28 nt long TAR aptamer from bovine immun-
odeficiency virus (BIV) binds the 2 kDa transcriptional activator protein Tat
[241], while the 25 nt long PP7 aptamer forms a complex with a 122 amino
acid (a.a.) peptide subsequence of the phage PP7 coat-protein (PCP) [242].
The two aptamers are placed one helical turn away from each other in order
to minimize the distance between the recruited proteins. Finally, a fourth,
streptavidin-binding RNA aptamer [243] is used to facilitate localization of
the RNA-protein nanostructures onto streptavidin-coated substrates.
For an initial structural characterization, we in vitro transcribed a lin-
ear gene template coding for the RNA nanostructure and purified the RNA
via phenol-chloroform extraction, elution from a spin column, and ethanol
precipitation (see Sec. 4.11). Using transmission electron microscopy, the ter-
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Figure 4.2: A An illustration of the predicted three-dimensional structure of the
RNA without the terminators (image created with Vfold3D [246], scale bar: 5
nm). B AFM image of purified RNA structures on mica. The images in air
confirmed the presence of a compact tertiary structure (white arrows). Scale bar:
100 nm. C Negative stain TEM micrographs of purified RNA nanostructures
without terminators and a EM class average image (right). Scale bar: 20 nm.
tiary structure of the RNA with its three arms and appended aptamers could
be visualized (Fig. 4.2C). Imaging using atomic force microscopy (AFM) in
air confirmed the presence of a compact tertiary structure (Fig. 4.2B). As we
used the strong T7 RNA polymerase (RNAP) [244] for in vitro transcription
of the RNA nanostructure, we had to extend the RNA sequence by two tran-
scriptional terminators [245], resulting in ≈ 70% termination overall (Fig.
4.1B).
4.5 Protein scaffold optimization using FRET
In order to assess the efficiency of co-assembly of two proteins via the TAR
and PP7 aptamers, we tagged two fluorescent proteins with the corresponding
peptides. Specifically, we were interested in the fraction of correctly assem-
bled complexes, which we inferred from the efficiency of FRET between the
fluorescent proteins.
Our FRET pair (with a Fo¨rster radius of about 5.7 nm [219]) consisted
of the CFP variant mTurquoise2 [247] as a donor fused to the Tat peptide
and the YFP variant YPet [248] as an acceptor fused to the PP7 coat-protein
(for the following quantitative treatment of assembly efficiency, RNA scaffold,
CFP and YFP proteins are abbreviated with r, c, and y, respectively).
Binding of the proteins to the RNA was first confirmed using an elec-
trophoretic mobility shift assay (EMSA) and RNA-protein complexes were
imaged using the transmission electron microscopy (Fig. 4.3B and D). The
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Figure 4.3: Characterization of fluorescent protein binding. A Top: Scheme show-
ing mTurquoise2 fused to the Tat peptide (abbreviated c) and YPet fused to the
PP7 coat protein (PCP) (abbreviated y) binding to the corresponding aptamers
on the RNA structure (abbreviated r), resulting in the four-component complex
rcy2. PCP preferentially binds to the PP7 aptamer as a dimer. Bottom: illustra-
tion of the assembled complex rcy2 based on the RNA structure and the crystal
structures of the proteins and peptides (created with UCSF Chimera, scale bar:
5 nm). B EMSA (native gradient PAGE) stained with MG showing the binding
of the His-tag purified proteins c and y to r. C Normalized absorption and flu-
orescence emission spectra of the purified protein FRET-pair, mTurquoise2-Tat
(mTq-Tat) and YPet-PCP. D Negative stain TEM micrographs of purified RNA
nanostructures without terminators and purified proteins (white arrows) and as-
sembled RNA-protein nanostructures (yellow arrows). Scale bar: 20 nm.
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Figure 4.4: Characterization of fluorescent protein binding. A EMSA using
agarose gel electrophoresis, 4% (w/v), stained with an intercalating dye show-
ing the MS2-PP7 RNA and the appearance of a new band while binding to
mTurquoise2-MCP and YPet-PCP (auto-fluorescence is also partially visible). The
concentration of YPet-PCP and mTurquoise2-Tat in lanes 6 and 7 is two times as
high as in lane 2-5. B Fluorescence emission spectra of purified mTurquoise2-Tat
(250 nM) and YPet-PCP (500nM) without any RNA, with RNA combining the
TAR and PP7 aptamers (250 nM). As a comparison, the fluorescence emission
spectra of an RNA with the MS2 and PP7 aptamers (250 nM) plus mTurquoise2-
MS2 (250 nM) + YPet-PCP (500 nM). Samples were excited at 440 nm. The
donor signal at 480 nm is lower for the TAR-PP7 sample and the acceptor signal
at 530 nm is higher, although the same concentrations of the components were
used in both samples, indicating more energy transfer for the RNA with the TAR
and PP7 aptamer.
fluorescence emission spectrum of the FRET donor protein overlaps with the
excitation spectrum of the FRET acceptor protein (Fig. 4.3C).
We also investigated the use of the commonly used peptide binding ap-
tamer from phage MS2 instead of TAR for binding of mTurquoise2 to the
RNA nanoscaffold. Interestingly, even though MS2 has a lower Kd than
TAR for binding to its cognate peptide, we found that in terms of FRET
efficiency the combination of TAR with the PP7 aptamer was superior (Fig.
4.4), which potentially is due to the different spacing and orientation between
the scaffolded proteins in this case.
4.5.1 Determining the complex concentration with
FRET
The yield of correctly assembled complexes was estimated from the decrease
of donor fluorescence intensity due to FRET upon the addition of the RNA
scaffold (Sec. 4.5.1 and 4.5.2). Using literature values for the equilibrium
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constants of the TAR-Tat and PP7-PCP interactions as well as considering
the dimerization of PCP, we calculated the concentration of fully assembled
complexes [r ·c ·y2] as a function of the total concentrations of its components
(c0, y0 and r0) (Table 4.1 and Fig. 4.6C and D).
The FRET efficiency having 1 donor and 2 acceptors [249] as a function
of the distance d between the proteins on the RNA is given by:
E2(d) =
2E1
1 + E1
=
2R60
d6 + 2R60
(4.1)
The total fluorescence intensity of mTurquoise2-Tat + YPet-PCP + RNA
nanostructure at λ = 474 nm is given by
F (474) = m474([c] + [cr] + [rcy2](1− E2)) (4.2)
Where m474 is defined by Eq. 4.17. Therefore, the difference in fluores-
cence intensity ∆F before and after addition of the RNA scaffold is:
∆F
m474
= [rcy2] · E2 (4.3)
→ E2 = ∆F
m474 · [rcy2] (4.4)
In order to calculate [rcy2] we assume that the binding of Tat to the RNA
is independent to that of PCP-dimer to the RNA. Then the concentration of
the fully assembled complex is given by the product of the fraction of RNA
scaffold bound to Tat or PCP and the concentration of the RNA.
[rcy2] = fcr · fry · [r]0 = [cr]
[r]0
· [ry2]
[r]0
· [r]0 (4.5)
Here
[cr] =
1
2
(
[c]0 +Kc + [r]0 −
√
([c]0 +Kc + [r]0)2 − 4[c]0[r]0
)
(4.6)
[ry2] =
1
2
(
[y2] +Ky + [r]0 −
√
([y2] +Ky + [r]0)2 − 4[y2][r]0
)
(4.7)
and taking the dimerization of PCP into consideration:
[y2] =
1
2
(
2[y]0 +K2y −
√
(2[y]0 +K2y)2 − 4[y]20
)
(4.8)
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Plugging Eq. 4.8 into 4.7 and then 4.6 and 4.7 into Eq. 4.5 allows us to
calculate [rcy2] as a function of [c0], [y0], [r0]:
[rcy2] =
1
2[r]0
(
[c]0 + [r]0 +Kc −
√
([c]0 + [r]0 +Kc)2 − 4[c]0[r]0
2
)
·
{
1
2
(
2[y]0 +K2y −
√
(2[y]0 +K2y)2 − 4[y]20
)
+ [r]0 +Ky
−
[(
[y]0 +K2y −
√
(2[y]0 +K2y)2 − 4[y]20 +
[r]0 +Ky
2
)2
− 2
(
2[y]0 +K2y −
√
(2[y]0 +K2y)2 − 4[y]20
)
[r]0
] 1
2
}
(4.9)
Combining Eq.4.4 and 4.1 we can solve for the distance of the proteins
with the values from Table 4.1 and [rcy2] = 320 nM ([c]0 = 428 nM, [y]0 =
1072 nM, [r]0 = 500 nM) :
d = 6
√
2R60
(
m474[rcy2]
∆F
− 1
)
= 5 nm (4.10)
In our experiments, the concentration of YFP-PCP is well above the Kd
of the PP7 aptamer (y >> Ky), and therefore [r ·c ·y2] is simply proportional
to [y]0 until it saturates roughly when the concentration of the RNA scaffold
is reached (Fig. 4.5). Dimerization of PCP effectively reduces the amount of
active binding partners, which shifts the point of saturation towards higher
concentrations of YPet-PCP monomers. Conversely, due to its higher disso-
ciation constant the binding curve of CFP-Tat to the RNA is more sigmoidal
in our experimental regime and therefore saturates substantially above the
RNA scaffold concentration (Fig. 4.5).
4.5.2 The fraction fcomplex
While it is possible to generate any desired concentration of complex by
just producing enough of its components, the fraction of correctly assem-
bled complexes that can be achieved is limited. We here use fcomplex =
[r · c · y2]/([r]0 + [c]0 + [y]0) as a figure of merit that captures the trade-off
between large complex concentrations and efficient use of components. For
simplicity, we assume here that production of proteins and nanostructures
cause comparable “costs” (we will argue below that this is justified). Given
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Figure 4.5: A Binary binding curves for mTurquoise2-Tat (c) and YPet-PCP
(y) forming a complex with the RNA (either rc or ry2) for [r]0 = 500 nM. Cal-
culated with Eq. 4.6 and 4.7 and the dissociation constants from Table 4.1. B
The concentration of dimers as a function of monomers for YPet-PCP for different
dimerization strengths. C The effect of the dimerization strength on the concen-
tration of [rcy2] as a function of the monomers for [r]0 = 500 nM and [c]0 = 700
nM. The point of saturation of complex formation is pushed to higher monomer
concentrations for weaker dimerization. Calculated using Eq. 4.9. D The weaker
the dimerization the lower the maximum of fcomplex and the more monomers of
YPet-PCP are needed to reach the maximum (calculated for [r]0 = 500 nM and
[c]0 = 700 nM with Eq. 4.11).
a limited amount of resources, maximization of fcomplex therefore gives the
largest achievable fraction of assembled complexes.
Using the value for d = 5 nm from above we can determine E2 = 0.81.
This allows us to calculate the value of fcomplex:
fcomplex =
[rcy2]
[r]0 + [c]0 + [y]0
(4.11)
=
1
[r]0 + [c]0 + [y]0
∆F
E2mλ
(4.12)
Eq. 4.11 is only dependent on the dissociation constants (Table 4.1) and
the initial concentrations of the components, which allows calculation by
simply inserting into Eq. 4.9. This was used to create the heat map in Fig.
4.6C and D. On the other hand, Eq. 4.12 is based on fluorescence spectra
shifts like in Fig. 4.6B. The results are compared in Fig. 4.6C.
We used the function NArgMax in Wolfram Mathematica v11.2 to nu-
merically maximize fcomplex (Eq. 4.9) for [r]0 from 1 to 1000 nM (in 1 nM
steps) and find the corresponding concentrations of [c]max and [y]max at each
point. The numerical results for the maximal points for [rcy2] are plotted in
Fig. 4.6E and F .
The concentration of assembled complexes [rcy2] will always be smaller
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Constants Value Reference
Kc 60 nM [241]
Ky 1.6 nM [242]
K2y 20 nM [251]
R0 5.67 nm [219]
∆F/m474 230 nM Fig. 4.6B
Table 4.1: Binding Constants and Fo¨rster radius for mTurquoise2-Tat and
YPet-PCP
(or equal in the case of perfect binding) to the concentration of one of its
components (the limiting species):
[rcy2] ≤ min([r], [c], [y])→ fcomplex ≤ 1
3
(4.13)
Calculations for a fixed RNA concentration of [r]0 = 500 nM indicate
that fcomplex is bounded from above at ≈ 20%, which was experimentally
confirmed in fluorescence spectroscopy measurements using purified compo-
nents (Fig. 4.6B). With rising RNA concentrations fcomplex can maximally
increase up to 1/3 (Fig. 4.6C and Eq. 4.13). If one allows the RNA concen-
tration to exceed the protein concentrations, the amount of fully assembled
complexes starts to decrease again due to the accumulation of scaffolds with
only one protein bound (cf. the so-called “prozone” effect [250], Fig. 4.6G).
Maximization of fcomplex under constraints can be used to define the op-
timum expression levels of each component. For a total RNA concentration
of [r]0 ≥ 400 nM, the concentrations of mTurquoise2-Tat and YPet-PP7 re-
quired for a maximum fcomplex are found to be approximately equal, since
in this concentration regime, both proteins are well above the Kd values of
their respective aptamers. For RNA concentrations [r]0 < 400 nM, more
mTurquoise2 is needed than YPet (i.e., [c] > [y]) (Fig. 4.6F), since then the
Kd and the concentrations of the TAR-Tat components are of similar size.
In order to increase fcomplex above 1/3, cooperative interactions between the
scaffolded proteins themselves would have to be established [252] (Fig. 4.6H
and Sec. 4.5.3).
4.5.3 Cooperative equilibria
Cooperativity in ternary complex formation can be described with a parame-
ter α. For positive cooperative interaction between the proteins on the RNA
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Figure 4.6: A Emission spectra of purified proteins ([c]0 = 500 nM and [y]0 = 700
nM) before, after the addition of the RNA ([r]0 = 500 nM and after 10 minutes of
incubation with Proteinase K. B Normalized emission spectra of purified [c]0 = 430
nM and [y]0 = 1070 nM before and after the addition of the RNA ([r]0 = 500 nM)
and after the degradation of the RNA by RNase (solid lines: mean value of n=3;
transparent area represents the SD). C The fraction of fully assembled complexes
fcomplex, as a function of [c]0 and [y]0 for [r]0 = 500 nM. The heat map shows
calculated values of fcomplex, whereas the circles represent values obtained from
experiments (such as the spectra shown in B.). D Calculated heat map of the
complex concentration [rcy2] as a function of the protein concentrations [c]0 and
[y]0 using the constants from Table 4.1. E Calculation of the maximum fcomplex
as a function of [r]0. fcomplex approaches 1/3 (dotted line) as the concentration of
the components approach infinity. F At maximum fcomplex, the ratio of [c]0 to [y]0
approaches 1 as [r]0 increases. On the right y-axis: Sum of protein concentrations
[c]0 + [y]0 as a function of [r]0 at maximal fcomplex. G The concentration of fully
assembled complexes [rcy2] decreases again if the RNA concentration exceeds the
concentration of the proteins, due to the fact that the probability of having an
RNA bound with only one protein increases, effectively diluting the fully assembled
complexes (known as the “prozone” effect) – curve calculated with Eq. 4.9. H
The strength of additional interaction between the proteins, quantified by α > 1,
increases the maximum of fcomplex, here shown for [r]0 = 500 nM, [c]0 = 700 nM
and [y]0 = 700 nM and calculated with Eq. 4.15, whereas an repulsive interaction
α < 1 decreases [rcy2]max.
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α > 1 and for negative interactions α < 1. Then derived from the law of
mass action, the new equilibrium is given by:
KcKy
α
=
[c][r][y2]
[rcy2]
(4.14)
It has been shown that an expression for [rcy2] cannot be obtained alge-
braically in terms of cooperativity α and known parameters such as dissoci-
ation constants and initial concentrations [252]. However, an expression for
the maximal concentration of [rcy2] as a function of [c]0, [y]0 and α can be
found:
[rcy2]max =
1
2
[
[c]0 +
1
2
(
2[y]0 +K2y −
√
(2[y]0 +K2y)2 − 4[y]20
)
+
√
Kc +
√
Ky
α
]
−
{[
[c]0 +
1
2
(
2[y]0 +K2y −
√
(2[y]0 +K2y)2 − 4[y]20
)
+
√
Kc +
√
Ky
α
]2
− 4[c]0 1
2
(
2[y]0 +K2y −
√
(2[y]0 +K2y)2 − 4[y]20
)} 12
(4.15)
Eq. 4.15 has been used to calculate the dependence of [rcy2] on α in Fig.
4.6H. Similarly, it has been shown that the concentration of the RNA scaffold
at [rcy2]max is given by:
[r]max =
√
Ky√
Kc +
√
Ky
([c]0 +Kc) (4.16)
+
√
Kc√
Kc +
√
Ky
[
1
2
(
2[y]0 +K2y −
√
(2[y]0 +K2y)2 − 4[y]20
)
+Ky
]
4.6 RNA stability in a cell-free expression
system
In order to prototype expression and assembly of the RNA-protein nanos-
tructure in a cell-free expression system, we used an E. coli based crude
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Figure 4.7: RNA degradation in cell extract. A Exponential degradation of dif-
ferent RNA structures ([r]=500 nM) by RNases present in the cell-free expression
system reported by MG fluorescence. τ : Mean lifetimes for the RNA nanostruc-
ture, the four RNA aptamers without the 3WJ and the MG RNA aptamer alone.
Mean and standard deviations of three replicates are indicated as full lines and
shaded areas, respectively exponential fits are shown as broken lines). B MG flu-
orescence time traces in cell-free expression system for three different versions of
the RNA nanostructure, for which the position of the MG aptamer was varied.
cell-extract [68], which had been previously used for the assembly of protein
filaments [253]or of virus particles [64]. An important factor affecting the
assembly yield in a one-pot expression reaction is the chemical stability of
the RNA scaffold. Degradation of mRNA in the cell-extract based expres-
sion system was previously found to be well described by a mono-exponential
decay with a half-life ranging from 12 to 18 minutes [189] [79]. While such
short lifetimes would be unsuitable for applications in protein scaffolding, we
surmised that the presence of strong secondary structure could increase the
stability of our RNA scaffold considerably [254] [255].
To assess its stability, we studied the fluorescence of the MG aptamer
for various aptamer positions on the scaffold. As shown in Fig. 4.7A, the
half-life of an un-scaffolded MG aptamer was τ ≈ 30 min. In stark contrast,
the fluorescence of the MG aptamer embedded into the RNA nanostructure
decays with a half-life of τ ≈ 16.0 hours (Fig 4.7A). We checked the specific
influence of the 3WJ motif by replacing it with a random sequence, which re-
duced the half-life to τ = 9.2 hours. Experiments with different permutations
of the four aptamers on the arms of the 3WJ (Fig. 4.7B) showed a faster
fluorescence decay when the MG aptamer was positioned closer towards the
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3’ end of the RNA structure, suggesting that exonuclease degradation from
the 3’end is a dominating factor [254]. Considering the production times
of RNA and proteins, the observed stability of the RNA nanostructure is
sufficient to serve as a protein scaffold (Fig. 4.9).
4.7 One-pot expression and assembly of the
RNA-protein nanostructure
We next characterized the production of the individual components in the
expression system. Expression levels of the fluorescent proteins were varied
by changing the concentrations of their respective genetic templates. The
sequences coding for mTurquoise2-Tat and YPet-PP7 were each placed into
a pUC19-derived expression vector and put under the same constitutive E.
coli RNA Polymerase (RNAP) promoter and the same ribosome binding site
(Fig. 4.8). By changing the concentration of the plasmid for one of the
proteins while fixing the other at 5 nM, we found that the optimum ratio of
the protein end levels was reached for approximately equal concentrations of
genetic templates (Fig. 4.8B). Even though this appears to be a relatively
straightforward result, it is not trivial due to the complexity of the whole
expression reaction [256]. Specifically, it is hard to make quantitative pre-
dictions of loading and crosstalk effects that result from the expression of
multiple genes in parallel [79].
In order to verify the assembly of the fluorescent proteins on the RNA
scaffold inside the expression system, we stopped protein translation after 14
hours by adding the ribosomal inhibitors spectinomycin and streptomycin
(Fig. 4.9A) and only then added the gene construct of the RNA structure
(Fig. 4.8B). To reliably observe fluorescence changes caused by FRET, we
waited until the fluorescence signals had stabilized (Fig. 4.8C) and then
supplemented the reaction with r-plasmids that contained the sequence for
the RNA nanostructure under a T7 RNAP promoter, together with purified
T7 RNAP and rNTPs. During the expression of the RNA scaffold, monitored
by MG fluorescence, the donor signal in the CFP channel dropped whereas
the signal in the FRET channel (excitation at 430 nm, emission at 540 nm)
increased, indicating Fo¨rster transfer between the proteins that are scaffolded
by the RNA.
We found that for optimal assembly of the RNA-protein nanostructure
the protein concentrations were too low compared to the concentration of
RNA scaffold. Increasing the amount of both genetic templates, the c-and
y-plasmids, did not substantially increase the final concentrations of the pro-
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Figure 4.8: Optimization of expression and assembly of the RNA-protein nanos-
tructure. A Genetic constructs encoding c, y and r. Both c and y are under a
constitutive E. coli RNAP promoter (pJ23106) and have a self-cleaving ribozyme
upstream of the RBS (PimJ for c and RiboJ for y). The RNA scaffold is tran-
scribed from a T7 RNAP promoter. The cy-plasmid encodes the genes for both
c and y. B Prototyping the expression of c and y in cell-free expression system
by titration of either c or y-plasmid. Mean from three independent repeats with
standard deviation shown as the error bars. In the presence of the c-plasmid,
YPet-production is reduced with respect to the value obtained with only the y-
plasmid. The concentration of mTurquoise2 is highest for ≈ 5-7 nM c-plasmid.
On the other hand, when the y-plasmid is titrated, mTurquoise2 production is
significantly reduced compared to expression from only the c-plasmid, and the
YPet concentration is highest for 7-10 nM y-plasmid. The observed deviations
are significantly higher than the standard error of the mean. C The mean total
expression level ([c]+[y]) after 14 hours is increased if the cy-plasmid is used in
comparison to expression from two different plasmids: c-plasmid and y-plasmid
(shown are the mean and std. dev. from min. 3 repeats)
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Figure 4.9: Optimization of expression and assembly of the RNA-protein nanos-
tructure. A Testing the effect of different antibiotics on the expression of
mTurquoise2-Tat (upper) and YPet-PCP (lower) by addition to the cell-free ex-
pression system after 150 minutes of expression (indicated by the arrow). The
c-plasmid and y-plasmid both encode a chloramphenicol resistance. B Transcrip-
tion of the RNA nanostructure from the r-plasmid in the cell-free expression system
using T7 RNAP. If the plasmid is added 1 hour after the extract has been thawed
and exposed to 29◦C, the final expression level is reduced and after 2 hours there is
no visible expression anymore. However, by adding purified T7 RNAP and rNTPs
expression could be recovered again after 3h, even though not to the same level as
expression at t=0. By supplementing purified T7 RNAP, rNTPs and MgCl2 after
5 hours the expression level was recovered almost completely compared to t=0.
C Fluorescence time traces reporting the expression of c-plasmid and y-plasmid
(5 nM each) in the cell-free expression system. After 14 hours protein translation
is stopped by the addition of spectinomycin and streptomycin. Approximately 45
minutes later, r is produced by the addition of the r-plasmid, T7 RNAP, rNTPs
and MgCl2. With the expression of RNA scaffold the donor signal decreases and
the FRET signal increases, which indicates formation of the rcy2 complex.
94
0100
200
300
400
500
600
c
y
r
C
on
ce
nt
ra
tio
n 
(n
M
)
r-plasmid: 1 nM r-plasmid: 3 nM r-plasmid: 5 nM r-plasmid: 7 nM r-plasmid: 10 nM
0 2 4 6 8 100 2 4 6 8 100 2 4 6 8 10 0 2 4 6 8 100 2 4 6 8 10
0
40
80
120
calculated [rcy2] (nM
)FR
ET
 c
h.
 / 
C
FP
 c
h.
0.30
0.34
0.38
0.42
Time (h) Time (h) Time (h) Time (h) Time (h)
non-functional
RNA 
r
Figure 4.10: Upper plots: fluorescence time traces recorded during expression
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is shown in red.
teins (Fig. 4.8C). Furthermore, the strong expression of the RNA scaffold
with T7 RNAP reduced the final concentrations of mTurquoise2-Tat and
YPet-PP7 either below detection or below the levels required for maximal
fcomplex. In order to resolve this issue, the gene sequences for the two proteins
were inserted into a single plasmid behind separate transcriptional promoters,
which we found to increase the total amount of fluorescent proteins expressed
by a factor of approximately 2 (Fig. 4.8C).
We then studied the expression and assembly of the RNA-protein nanos-
tructure encoded on two plasmids – the cy-plasmid for the proteins and
the r-plasmid for the RNA scaffold – in a one-pot reaction (Fig. 4.10).
We screened the genetic template concentration of the r-plasmid for a con-
stant cy-plasmid concentration to find the optimum relative expression levels.
Based on the fluorescence levels of the single components we calculated that
the largest concentration of complexes, nM, was expected to form for 5 nM
of cy-plasmid and 3 nM of r-plasmid. Indeed, the background subtracted
FRET signal obtained for this sample was found to be the highest. The
results shown in Fig. 4.10 also demonstrate that the ‘load’ on the expres-
sion system caused by RNA expression is approximately equal to that by the
expression of proteins, which justifies the assumption initially made for the
definition of fcomplex.
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4.8 Co-expression and localization of RNA-
protein complexes on streptavidin beads
We utilized the fourth aptamer function on the RNA structure by employing
the streptavidin-binding aptamer for the localization of RNA-protein nanos-
tructures onto streptavidin-coated beads. To this end, we encapsulated pu-
rified proteins together with streptavidin-coated beads and either the full
RNA nanostructure or only the protein scaffolding TAR-PP7 aptamer part
(i.e., without streptavidin aptamer) inside of water-in-oil emulsion droplets
(Fig. 4.11A). As desired, co-localization of the proteins in the CFP, YFP
and FRET channel on the microbeads is observed only in the presence of
the streptavidin aptamer (Fig. 4.11B). We then co-encapsulated the r- and
cy-plasmids, cell-free expression system and the streptavidin coated beads
into water-in-oil emulsion droplets. Also in this case we were able to follow
the expression and assembly of the RNA-protein nanostructure on the beads
(Fig. 4.11C). Finally, we investigated the interaction of the RNA nanoscaf-
fold with streptavidin alone.
4.9 Expression of the RNA-protein structure
inside bacteria
Cell-extract based gene expression systems have been previously used suc-
cessfully to prototype synthetic gene circuits, which were still functional when
operated inside of bacterial cells [77]. We therefore transformed the two-
plasmid system encoding the RNA-protein nanostructure into E. coli cells
(strain BL21 STAR (DE3)), containing an IPTG inducible T7 RNA poly-
merase. We first verified that each component was expressed in bacteria (Fig.
4.12A). As shown in Fig. 4.12B, we were able to follow expression of the RNA
nanostructure in bacteria by monitoring the fluorescence of the MG aptamer
after induction with IPTG. Along with the production of the RNA struc-
ture, the relative fluorescence intensity of the FRET-acceptor (YPet-PCP)
increased compared to the donor intensity (Fig. 4.13A and B), suggesting in
vivo assembly of the peptide-tagged fluorescent proteins on the RNA scaffold.
We found that the FRET signal observed in vivo was strongly reduced com-
pared to the in vitro system, and the FRET effect also varied considerably
between experiments. In contrast to the in vitro experiments, however, the
plasmid copy numbers were not optimized. Furthermore, bacterial growth
has a strong influence on the expression levels of the components of the
nanostructure. We found that mTurquoise2-Tat expression had a negative
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Figure 4.11: Expression, assembly and spatial localization in emulsion droplets. A
Purified components c and y are co-encapsulated in water-in-oil emulsion droplets
with streptavidin coated magnetic beads (SCMB) and i) the complete RNA scaf-
fold r or ii) RNA with only the PP7-TAR aptamer (FRET-arm). Lower plots:
emission spectra from the samples before encapsulation of the purified proteins
([c]0 = [y]0 = 700 nM), i) with complete RNA scaffold (500 nM) added or ii) with
FRET-arm (500 nM) added. B Epi-fluorescence microscopy images of encapsu-
lated samples from (A) in water-in-oil emulsion droplets in bright field and four
different fluorescence channels CFP, YFP, FRET and MG. i) with the complete
RNA scaffold an increased fluorescence and FRET signal is co-localized with the
beads (arrows). ii) with the FRET-arm only there is no co-localization with the
beads. The fluorescence in the MG channel indicates non-specific binding of MG
to the beads. Scale bar: 5 µm. C Scheme of the multi-component nanostruc-
ture expressed from two plasmids within an emulsion droplet containing cell-free
expression system and SCMBs. (D) Time series of epi-fluorescence microscopy
images showing the expression of c, y and r and assembly of cry2 on the SCMB
(arrow) in bright field and CFP, YFP, FRET and MG channel. Scale bar: 5 µm.
Some binding of the fluorescent proteins to the beads might be due to unspecific
interactions from components in the cell-free expression system.
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Figure 4.12: Expression of the RNA-protein nanostructure in bacterial cells.
A Fluorescence emission spectra of mTurquoise2-Tat, YPet-PCP and the RNA
nanostructure (MG aptamer) expressed in E. coli (BL21 STAR (DE3)) in M9
minimal medium at OD=0.5, excited at the indicated wavelengths. B Corre-
sponding fluorescence time traces of the bacteria with the r-plasmid and without
the r-plasmid (negative control, but with the cy-plasmid) (for all samples: mean
and std. dev. from 3 repeats).
influence on cell growth. Removing the self-cleaving ribozyme PlmJ in front
of the coding region improved the expression of mTurquoise2-Tat. This also
indicates that optimized conditions for in vitro assembly of an RNA-protein
nanostructure cannot be directly transferred to the in vivo case, for which
further adjustments would be required.
4.10 Conclusion
Our results demonstrate that a multi-functional RNA-protein nanostructure
can be expressed, assembled and spatially organized in a one-pot cell-free
reaction, which is a crucial step for the implementation of genetically en-
coded multi-component nanostructures in artificial cellular systems. Our
study highlights several of the challenges which have to be addressed for
efficient production and assembly of such structures such as binding equilib-
ria, stoichiometry, chemical stability, expression strength and competition for
resources. We show that a cell-free expression system facilitates the quantita-
tive study of these aspects under well-controlled conditions, which is essential
for the development and optimization of in vitro expressed nanostructures,
as well as for prototyping structures for potential applications in living cells.
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Figure 4.13: A Fluorescence intensity time traces of the transcription of the RNA
nanostructure in bacteria reported by MG with and without the induction of T7
RNAP via IPTG at t=0 min in M9 minimal medium at OD=0.5. Mean and SD
from min. 4 technical repeats are shown. B Upper row: FRET output, absolute
value of the mean fluorescence in the CFP channel (λex=440 nm, λem=474 nm)
and YFP channel (λex=500 nm, λem=530 nm) for the bacteria without and with
IPTG at the time of induction (t=0 min). Lower row: FRET output and absolute
value of the mean fluorescence in the CFP and YFP channel for bacteria without
and with IPTG after t=180 min. The mean and 95% confidence interval for min.
4 technical repeats are shown. C Fluorescence emission spectra of the fluorescent
proteins (c and y) at t=0 min (top panel) without and with IPTG for induction
of the RNA nanostructure and after t=180 min (bottom panel). The spectra are
normalized to the intensity of the FRET-donor protein (λ=474 nm. Mean (solid
line) and s.e.m. (shaded area) for min. 4 technical repeats are shown.
4.11 Materials and Methods
4.11.1 In vitro transcription
Linear DNA templates were purchased from IDT (USA) and amplified with
primers from Biomers (Germany) by a polymerase chain reaction (PCR)
using Phusion®High-Fidelity PCR Master Mix (NEB, USA) followed by
QIAquick PCR Purification kit (Qiagen, USA). A typical transcription reac-
tion has a volume of 100 µl, is kept at 37◦C overnight and contains: 100 nM
template DNA, 4 mM of each rNTP (Epicentre, Singapore), 14 mM MgCl2
(Sigma Aldrich, USA), 1 x RNAPol Reaction Buffer (NEB, USA),1 U/µl
RNase Inhibitor (NEB) and 2 U/µl T7 RNA Polymerase (NEB, USA). In
order to digest the DNA template after transcription, the reaction was sup-
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plemented with 1 x DNase I reaction buffer (NEB, USA) and 1 U/µl DNase
I (NEB, USA) for 30 minutes.
4.11.2 RNA purification and quantification
The RNA was extracted from an in vitro transcription mix using Phenol
Chloroform and 5PRIME Phase Lock GelTM tubes (Quantabio, USA) for
improved phase separation, followed by ethanol precipitation. RNA was
stored in nuclease free water at -20◦C for about one month. RNA con-
centrations were estimated by denaturing polyacrylamide gel electrophoresis
(PAGE). 2 µl of purified RNA in loading gel buffer (0.25% bromophenol blue
(BPB), 0.25% xylene cyanol (XC), 30% glycerol) was loaded on a 10% (w/v)
of 27.5:1 acrylamide/bisacrylamide gel with 8M urea in 1 x TBE buffer for
90 minutes with 9 V/cm at 25◦C. The gel was stained with SYBR Green II
(Invitrogen, S7564, USA) and the concentration was determined by compar-
ing the fluorescence intensity of the relevant band to the standard molecular
weight ladder Low Range Riboruler (Bio-Rad, USA) with ImageJ.
4.11.3 Protein purification
The bacterial expression vector (pJ431) for YPet-PCP and mTurquoise2-Tat
provides a T7 promoter, a His-tag (6xHis) and Kanamycin resistance (DNA
2.0, USA). The proteins were expressed in E. coli strain BL21(DE3) pLysS
(Promega, USA) in 25 ml LB medium and induced with 1 mM IPTG at
OD=0.6. mTurquoise2-Tat was expressed at 37◦C for 2 hours and YPet-
PCP at 20◦C for 6 hours. Cells were pelleted and lysed by bead beating
in a Minilys device (Peqlab, Germany). Here 0.25 %(w/v) of 0.1 mm glass
beads are added to the cells which are then shaken at 5000 rpm for 30 sec and
relaxed on ice for 30 sec five times in a row. Then both proteins were purified
by gravity-flow chromatography with Ni-NTA Agarose Beads (Qiagen, USA).
After purification, the proteins were dialyzed overnight at room temperature
using a dialysis cassette (MWCO 7 kDa, Thermo Fisher Scientific, USA) in
RNA binding buffer (10mM HEPES/KOH (pH 7.5), 100 mM KCl and 1 mM
MgCl2). mTurquoise2-Tat was stored at 4
◦C while YPet-PCP was stored at
room temperature.
4.11.4 Electrophoretic mobility shift assay (EMSA)
For the EMSA in Figure 2B, a gradient polyacrylamide gel 4-20 % (Mini-
PROTEAN ®TGX Precast Protein Gel, #4561096, Bio-Rad, USA) was
loaded with purified RNA (100 ng), mTurquoise2-Tat (5x molar excess to
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RNA) and YPet-PCP (10x molar excess to RNA) were incubated in RNA
binding buffer supplemented with 2 U/µl Murine RNase Inhibitor (NEB)
for about 10 minutes at room temperature. The running buffer consisted of
25mM Tris, 192 mM glycine, pH 8.3, 10 mM KCl and 2 mM MgCl2 and 1x
Purple (no SDS) Gel Loading Dye (NEB, USA) was used. The gel was run at
200 V for 35 minutes. Gels were first scanned on a Typhoon FLA 9500 Gel
Laser Scanner (General Electrics, USA) to detect the proteins fluorescence,
then stained either with SYBR Green II (Invitrogen, S7564, USA) or 1 mM
Malachite Green (Sigma Aldrich, USA) and scanned again. For the EMSA
in Figure S2, 4 % (w/v) agarose gel was used with 7 V/cm for 135 min. The
running buffer contained 2 mM MgCl2 and the loading buffer consisted of
7 % (w/v) sucrose and 4 mM Bromphenol Blue. The first lane was loaded
with 80 ng Low Molecular Weight DNA Ladder (NEB, USA).
4.11.5 Plasmid construction and purification
The genes for mTurquoise2-Tat and YPet-PCP were ordered as linear frag-
ments (IDT DNA) and cloned into the BioBrick backbones pSB1C3, and the
RNA nanostructure similarly cloned into pSB4K5 using standard restriction
and ligation protocols (NEB, USA). The DNA sequences used can be found
in the appendix. Fluorescence Spectra. Fluorescence experiments with puri-
fied RNA and fluorescent proteins were performed on a Horiba/Jobin Yvon
Fluorolog 3 system in 45 µl quartz glass cuvettes in 1x RNA binding buffer.
Conversion from fluorescence intensity to concentration was done using the
following relationship
F (λ = 474) = m474ctot (4.17)
where ctot is the concentration of the fluorescence protein and m474 is the
slope of the linear fit to the calibration data at excitation wavelength 440
nm and emission wavelength 474 nm (Fig. 4.14). For the degradation of the
RNA in the presence of the fluorescent proteins 1.5 U/µl RNase 1f (NEB,
USA) were added to the cuvette and the spectrum was taken about 10 min
after incubation at 37◦C. For the protease control, 0.01 U/µl of Proteinase
K (NEB, USA) was added to the sample with 10 min incubation at 37◦C.
4.11.6 Cell-free expression system
The cell-free gene expression system was prepared according to the protocol
provided by Sun et al. [68]. Briefly, crude S30 cell extract was obtained by
bead beating a BL21- Rosetta2(DE3) mid-log phase culture with 0.1 mm
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Figure 4.14: Calibration curve relating the concentration of purified mTurquoise2-
Tat (c) to the fluorescence signal in the fluorescence spectrometer.
glass beads in a Minilys device (Peqlab, Germany). After centrifugation, the
supernatant was incubated at 37◦C for 80 minutes and again centrifuged in
order to remove endogenous DNA. The supernatant was dialyzed for four
hours against a buffer (pH 8.2, 2mM DTT, 14 mM Mg-glutamate, 60 mM
K-glutamate, 5 mM Tris) in a cassette with a molecular weight cut-off of
10kDa. Using a Bradford assay, the protein concentration was determined to
be 30 mg/ml. For the reaction buffer we used phosphoenolpyruvate (PEP)
as an energy source instead of 3-phosphoglyceric acid (3-PGA) [213]. The
reaction buffer thus contains 50 mM Hepes pH 8, 1.5 mM ATP and GTP, 0.9
mM CTP and UTP, 0.2 mg/ml tRNA, 26 mM coenzyme A, 0.33 mM NAD,
0.75 mM cAMP, 68 mM folinic acid, 1 mM spermidine, 30 mM PEP, 1 mM
DTT, 2 % PEG-8000. All components were flash-frozen in liquid nitrogen
and stored at -80◦ before thawing on ice. The composition of a single cell-
free reaction was: 33 % (v/v) S30 cell extract mixed with 42 % (v/v) buffer
and 25 % (v/v) DNA plus additives. The plasmids were purified using a
Midi-Prep kit (Macherey-Nagel, Germany).
4.11.7 Fluorescence intensity time traces
To follow the expression in the cell-free expression system we loaded 15 µl
of our samples in a 384-well plate (IBIDI, Germany) into a plate reader
(ClarioStar, BMG Labtech) at 29◦C. To stop the translation, 50 µg/ml of
Spectinomycin (Sigma-Aldrich, USA) and 10 µg/ml of Streptomycin sulfate
(Sigma-Aldrich, USA) were added after 14 hours to the sample. For the other
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antibiotics, we supplemented the cell-free expression system with 20 µg/ml
Chloramphenicol (Sigma-Aldrich, USA) and 50 µg/ml Kanamycin (Sigma-
Aldrich, USA). In order to start a transcription reaction on top of finished
cell-free expression reaction, we added 5 nM of plasmid, 200 nM of T7 RNAP
(purified), 2 mM of each rNTP (Epicentre, USA) and 10 mM MgCl2.
4.11.8 Encapsulation study using streptavidin coated
beads
The samples containing purified components consisted of [c]0 = 700 nM and
[y]0 = 500 nM and either RNA nanostructure (r) or the FRET-arm RNA
in 1xRNA binding buffer and 5 µM Malachite Green. The samples con-
taining the cell-free expression system consisted of 5 nM cy-plasmid, 3 nM
r-plasmid, 250 nM T7 RNAP (produced and purified in the lab), 5 µM Mala-
chite Green (dissolved in DMSO) and 75 % (v/v) of the cell-free expression
system. Both samples were then supplemented with micrometer-sized strep-
tavidin coated magnetic beads (DynabeadsTM MyOneTM Streptavidin C1,
Thermo Fisher Scientific, USA). 5 µl of the sample were then mixed with
45 µl of FC-40 Fluorinated oil (F9755, Sigma-Aldrich, USA) containing 2
% (w/w) E2k0660 non-ionic surfactant (RainDance Technologies, USA) in
Protein LoBind tubes (Eppendorf, Germany). In order to create emulsion
droplets, the sample was vortexed for 30 seconds (with 10 second intervals on
ice). The droplets were then transferred to an observation chamber consisting
of two melted Parafilm®(Brand, Germany) strips between two microscopy
cover slides using a pipette. The chamber was sealed with vacuum grease and
nail polisher and placed in an inverse fluorescence microscope (Nikon TI-2).
Time-lapse microscopy images for bright field and fluorescence (SOLA, Lu-
mencor, USA) were performed at T=29◦C using an incubator cage around
the microscope (Okolab, Italy) and analyzed with ImageJ. The fluorescence
intensity profiles were measured with ImageJ, normalized and fitted to the
equation FI = 1
r
√
r2s − x2 with MATLAB 2017a, which is the expected nor-
malized intensity profile of a dye homogeneously distributed within a sphere
of radius rs.
4.11.9 TEM and AFM imaging
Purified RNA nanostructures (300 nM) diluted in Tris-HCl buffer (40 mM
pH 7.2) with 10 mM MgCl2 and 100 mM KCl were applied to glow discharged
formvar-supported carbon-coated Cu400 TEM grids (Science Service Munich,
Germany), using a standard negative staining protocol. For the images with
streptavidin (N7021S, NEB, USA), mTurquoise2-Tat and YPet-PCP, 300 nM
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of each purified protein was added to the sample. AFM imaging was done on
an AFM (Asylum Research Cypher, UK) and the RNA nanostructure was
diluted in 15 mM Tris-HCl (pH 7,2) buffer containing 10 mM MgCl2 and
50 mM KCl. The samples were placed on a specially modified mica surfaces
(APS mica) [257] and imaged in air in tapping mode.
4.11.10 Bacterial cultures
All experiments were performed in E. coli strain BL21 StarTM (DE3) (Thermo
Fisher Scientific, USA). The r-plasmid and cy-plasmid were transformed into
electrocompetent cells, grown in SOC-Medium for two hours and plated on
LB-Agar plates containing Kanamycin (50 µg/ml) for the r-plasmid and
Chloramphenicol (25 µg/ml) for the cy-plasmid overnight at 37◦C. Single
colonies were sequenced (Sanger sequencing, GATC, Germany) before and
after they were used for glycerol stocks (25 % w/v glycerol) in LB medium
at -80◦C. Overnight cultures were grown from glycerol stocks in M9 min-
imal medium supplemented with 20 mM glucose and 300 µg/ml thiamine
hydrochloride (Sigma-Alrich, #T1270) and Kanamycin (25 µg/ml) for the
r-plasmid and Chloramphenicol (15 µg/ml) for the cy-plasmid. The next
morning the cells were diluted and re-grown to an OD of 0.5 and then again
diluted to an OD between 0.2-0.4 and 300 µl per well were added in a 96-
well plate (IBIDI, Germany), sealed with sealing tape (Bio-Rad #2239444,
USA) and placed in the plate reader (ClarioStar, BMG Labtech, Germany)
at 37◦C.
4.12 Contributions
The idea for a RNA-mediated FRET pair assembly was brought up by Fabio
Chizzolini (F.C.) and Sheref Mansy (S.M.) and was further developed by
Matthaeus Schwarz-Schilling (M.S.) and Friedrich C. Simmel (F.S.). M.S.
and F.C. designed the RNA nanostructure and performed preliminary ex-
periments to express and assemble the RNA-protein structure. Guido Grossi
and M.S. designed and purified the fluorescent proteins and performed ini-
tial binding assays. Swati Krishnan acquired the transmission electron mi-
croscopy (TEM) images and Ali Aghebat Rafat performed measurements on
the AFM. Analysis of TEM images was done by M.S. Fabrication of genetic
constructs was done by Aurore Dupin (A.D.) and M.S. Experiments on chem-
ical stability of the RNA in the cell-free expression system were designed and
performed by A.D. and M.S. Preparation of the cell-free expression system
was done by A.D. and M.S. Optimization of the expression and assembly in
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the cell-free expression system was performed by M.S. Experiments on the
expression of the RNA-protein structure in bacteria were done by M.S.
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Chapter 5
CRISPR interference:
filamentation and restoration of
normal growth in bacteria
5.1 Summary
The contents of this chapter have been published in the article: ”Filamenta-
tion and restoration of normal growth in Escherichia coli using a combined
CRISPRi sgRNA/antisense RNA approach” by Andrea Mu¨ckl, Matthaeus
Schwarz-Schilling, Katrin Fischer, Friedrich C. Simmel in PLOS ONE, 2018,
13(9): e0198058.
Gene regulation is a crucial tool to enable cells to respond to changing ex-
ternal conditions. Synthetic biologists use natural gene regulation elements
to build synthetic genetic constructs in addition to new molecular tools cre-
ated by design. CRISPR interference (introduced in section 2.6) is a new tool
to control the expression of genes by either blocking transcription elongation
or inhibiting transcription initiation.
In contrast to other transcription factors, which bind directly to operator
sites with a sequence specific to that protein. The binding of dCas9 only
requires the sequence ”GGN” adjacent to the target site. This sequence
is called the proto-adjacent motif (PAM) and can vary from different Cas
proteins that bind to DNA. The rest of the binding site is determined by the
sequence of the sgRNA molecule that is bound to dCas9.
This mechanism opens up the possibility to knockdown genes on the
chromosome of bacteria without having to change the DNA sequence of the
chromosome itself. Any sequence next to a PAM can be targeted.
It has been shown that a knockdown of the ftsZ gene results in an arrest of
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cell division in E. coli but not of cell growth. The chromosome still replicates
and while the width of the bacteria does not change largely, the length can
increase significantly due to the absence of division events [258]. By having
an inducible version of ftsZ in E. coli, Sanchez-Gorostiaga et al. were able
to show that a recovery of FtsZ levels can rescue bacterial division [259].
Without restoration of FtsZ the filamentous bacteria will lyse. This target
opens the possibility to study the reversibility of CRISPRi on bacterial genes.
Hence we used an inducible CRISPRi construct to target the ftsZ gene.
Three different sgRNAs were targeted at the template strand of three dif-
ferent promoters of ftsZ. The expression of the sgRNAs was controlled via
the induction of T7 RNAP and a pLysS plasmid. There were, however, no
transcriptional terminator between the different sgRNA sequences.
When the CRISPRi plasmid was first cloned in the bacteria, they grew
filamentous even without induction of the CRISPRi. This problem was solved
by introducing decoy-binding sites for the sgRNA-dCas9 complex on a high
copy plasmid. Stopping cell division was then achieved by inducing both
sgRNA and dCas9, and resulted in filamentous bacteria.
The reversibility of CRISPRi was tested, first by introducing an anti-
sense RNA that is complementary to the sgRNA. The approach has been
shown to work in bacteria for fluorescent proteins [141]. We first tested
the inhibitory effect of anti-sgRNA on the CRISPRi process in a cell-free
expression system with the expression of a fluorescent protein (mVenus).
The non-template strand within the coding region was targeted. Here dCas9,
sgRNA, anti-sgRNA and the genetic template for mVenus were added to the
cell-free expression reaction as purified components. The ratio of anti-sgRNA
to sgRNA added to the reaction was 5:1 and resulted in full inhibition of
the sgRNA-dCas9 assembly. However, when the anti-sgRNA was added 15
minutes or 30 minutes later than the rest of the components, the de-repression
was significantly reduced.
In bacteria, the anti-sgRNA, which was inducible by the quorum-sensing
molecule AHL, was placed on a plasmid with a high copy number. We ex-
plored whether filamentous cells can be switched back to normal growth by
inducing the anti-sgRNA while having the CRISPRi induced. In microflu-
idic chambers which allow to follow individual cells, we found that cells did
not revert to normal cell growth but lysed. It was possible to revert to nor-
mal cell growth only by transiently inducing the filamentation (for about 2
hours), and then removing the CRISPRi inducers. About 1-3 % of the ana-
lyzed cells reverted to normal growth with a delay of about 5 hours after the
CRISPRi inducers were removed. The addition of AHL (which induces the
anti-sgRNA) after the removal of the CRISPRi inducers allowed the bacteria
to revert to normal growth slightly faster. With filamentation, heterogene-
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ity between cells in regard to cell length and expression of two fluorescent
reporter proteins increased.
In addition, the sensitivity to the inducer concentration of CRISPRi var-
ied between two different glycerol stocks. The glycerol stock of the bacteria,
which used for all the results in this chapter unless stated otherwise, was sen-
sitive to low CRISPRi inducer concentration. The other glycerol stock was
not as sensitive, meaning that low CRISPRi induction did not completely
arrest cell division for all cells.
5.2 Introduction
Before an E. coli cell divides into two identical daughter cells, proteins of the
cell division machinery accumulate at its center with an accuracy of about
2 % and form the so-called ‘Z ring’ [260].The Z ring serves as a scaffold at
the future division site for the other over 20 known proteins that constitute
the divisome [261]. The Z ring itself is assembled from at least six proteins,
including the filament forming protein FtsZ and its membrane anchoring
proteins FtsA and ZipA [262] [263] [264] [265]. The cellular content of FtsZ
needs to be regulated, as under- or over-expression leads to filamentous bac-
teria or minicells without a genome [266] [267]. Moreover, an imbalance
between FtsZ and FtsA results in cell division arrest and bacterial filaments
that contain multiple copies of the bacterial chromosome [258] [268]. Since
FtsZ is one of the earliest proteins to initiate the assembly of the division
machinery, mutations or knock-downs of FtsZ result in filaments with stalled
constriction sites or partially divided regions [269]. One of the earliest studied
strains with a mutation in FtsZ, ftsZ84, displays filamentous growth at 42◦C
and can be switched back to normal growth at 30◦C [270] [271]. Aborted
constriction sites do not seem to be continued after temporary upshifts from
30◦C to 42◦C for 2 minutes, but newly formed division sites are used [272].
However, the ftsZ84 mutant lyses or loses its viability after about 3 hours
after the temperature shift.
Recently, Sa´nchez-Gorostiaga et al. studied the response of E. coli when
FtsZ falls below a critical level, followed by its restoration using an IPTG
inducible promoter in front of the ftsZ gene [259]. They show that besides
forming filaments, FtsZ deprived cells are more prone to improper chro-
mosome segregation, show global changes in transcription levels and lose
integrity of their membrane. A convenient technique for the regulation of
chromosomal gene expression has been recently provided through CRISPR
interference (CRISPRi) using dCas9, a non-cleaving mutant of the CRISPR
associated nuclease Cas9 [53]. The protein can be directed to any position
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on the chromosome by a single guide RNA (sgRNA) molecule, provided that
the target sequence neighbors a protospacer adjacent motif (PAM) with the
canonical sequence NGG. Depending on the binding site, the dCas9-sgRNA
complex can repress transcription by either preventing transcription initi-
ation by RNA polymerase or by acting as a roadblock for transcriptional
elongation.
Elhadi et al. have recently used the CRISPRi mechanism to change the
morphology of E. coli by targeting the ftsZ gene and the mreB gene, a gene
found to control the width of the cells [138] [273]. Focusing on microbial
bioproduction of plastics, they found that the morphologically altered cells
provide a larger volume for the accumulation of intracellular polyhydrox-
ybutyrate (PHB) inclusion bodies. However, the CRISPRi mediated gene
knockdown had a negative impact on bacterial growth rate.
In order establish a reversible knockdown system based on CRISPRi, Lee
et al. utilized antisense RNA to target the sgRNA [141]. They were able to
show that the expression of fluorescent proteins could be successfully sup-
pressed and reactivated in bacterial cells, with each step having a response
time of ≈ 3 hours. Using RNA instead of proteins to regulate gene expres-
sion can have several advantages. They are straightforward to design since
RNA-RNA interactions can often be reduced to base-pair interactions and
their secondary structure can be predicted with software tools [274] [275].
Moreover, RNA is expressed faster than proteins and requires less of the
cell’s resources [77].
In the present work, we reversibly induce filamentation in E. coli by tar-
geting FtsZ using the CRISPR/dCas9 interference mechanism combined with
an antisense RNA strategy. We first switch bacteria into the filamentous cell
growth mode and subsequently reverse this process, such that the cells re-
turn into a normal growth phenotype. We quantify the switching process
and dynamically control the system by the inducible expression of antisense
RNAs that are complementary to the sgRNAs engaged in ftsZ knockdown.
We use single-cell fluorescence microscopy experiments from which we derive
bacterial length distributions [276], growth and division rates, as well as re-
porter gene expression levels. This allows us to identify factors that affect the
switching process. In particular, we find that bacteria strongly respond to the
CRISPRi knockdown of ftsZ, but only few bacteria revert to normal cell divi-
sion several hours after termination of CRISPRi induction. Antisense-sgRNA
expression supported the recovery process and facilitated considerably faster
switching than in the absence of the antisense RNAs. Antisense-sgRNA thus
provides a relatively straightforward means to control and adjust the kinet-
ics of CRISPRi de-repression, which is of great interest for the realization of
gene circuitry, in which cellular processes have to be dynamically switched
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on or off in response to endogenous signals or external cues.
5.3 Results
5.3.1 Experimental design with decoy-binding sites
In order to reversibly switch bacteria to filamentous growth, we disturbed the
FtsZ/FtsA ratio through CRISPR interference using appropriate sgRNAs
(Fig. 5.1A). Three of at least six known promoters for ftsZ (ftsZ2p, ftsZ3p,
ftsZ4p) lie within the ftsA coding region [277]. We targeted the template
strand of these three promoters for ftsZ transcriptional initiation blockage.
In contrast to tunable CRISPRi (tCRISPRi) with an inducible chromosome-
integrated dCas9 [140], we here use plasmid-encoded inducible dCas9 and
sgRNA. The sgRNAs are induced by isopropyl β-D-thiogalactopyranoside
(IPTG) via T7 RNA polymerase and were encoded on the ‘CRISPRi plasmid’
together with TetR-controlled dCas9 and mVenus reporter protein.
We then restored cell division by removing CRISPRi inducers aTc and
IPTG and thus turning off dCas9 and sgRNA expression or by removing
CRISPRi inducers and adding anti-sgRNA inducer (the ‘active’ approach).
The anti-sgRNAs were designed to absorb the sgRNAs via duplex formation
(Fig. 5.1A) in a similar manner as previously demonstrated [141]. In our
approach, the anti-sgRNAs are transcribed from the ‘anti-sgRNA plasmid’
and induced by AHL (acyl homoserine lactone (HSL) 3-oxo-C6-HSL) from
pLux promoters.
Transformation of bacteria with the CRISPRi plasmid resulted in fila-
mentous cells even without induction of the expression of dCas9 and sgRNA.
In order to create a threshold for dCas9-sgRNA below which ftsZ is not reg-
ulated down, we introduced decoy-binding sites (‘sponges’) for the dCas9-
sgRNA complex. However, the addition of sponges to the CRISPRi plasmid
did not stop filamentation in the absence of inducers (Fig. 5.2). Only after
the introduction of additional sponge elements on the high copy number plas-
mid (about 500-700 per cell [13]) that encodes the anti-sgRNA, the bacteria
exhibited the intended normal growth morphology.
Expression of dCas9 in the absence of sgRNA or with sgRNAs of different
sequence does not lead to filamentous growth under our experimental condi-
tions (5.2C). This can be important, since changes in cell morphology were
reported previously for high level expression of the dCas9 [142].
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Figure 5.1: A Schematic representation of E. coli switching into filamentous
growth after induction of single guide RNA (sgRNA) via IPTG and dCas9 via
aTc. The dCas9-sgRNA complex blocks the expression of FtsZ, stopping the
formation of the septal ring that is essential for cell division in E. coli. Cell di-
vision can be rescued by inducing appropriate antisense sgRNAs (‘anti-sgRNA’)
with AHL and by removing the inducers for the dCas9 and sgRNA. B Details
of the genetic constructs involved: the CRISPRi plasmid codes for dCas9 under
aTc-inducible promoters and three different sgRNAs under T7 promoters which
target three different promoters of the ftsZ gene on the genome of the E. coli. T7
RNA polymerase is inducible with IPTG. The anti-sgRNA plasmid codes for anti-
sgRNAs under the control of an AHL-inducible promoter. The sponge elements
on the plasmids act as decoy binding sites for the corresponding dCas9-sgRNA
complexes.
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Figure 5.2: A Filamentation control tests. First, we tested the decoy-binding
site strategy under the non-induced state. The liquid culture bacteria contained
the CRISPRi-plasmid without A and with B a high copy number sponge plasmid.
Only with additional sponge elements, the cells grow and divide. C In we tested
dCas9 influence on cell morphology. The cells with CRISPRi and anti-sgRNA
plasmids grow normal under dCas9 induction (107 nM aTc) for 3 hours. The
corresponding reporter gene mVenus is also expressed from a tet-promoter as well
as constitutive mRFP. The image is an overlay of phase contrast, mRFP and
mVenus fluorescent channels.
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5.3.2 Reversal of CRISPR interference using anti-sense
RNA
To test the effect of anti-sgRNA on CRISPRi, we initially performed a se-
ries of in vitro experiments in homemade bacterial cell extract [68]. First,
we tested two different designs for the anti-sgRNAs, which differed in their
lengths and bound to different complementary regions of the sgRNA, one
creating a 42 bp and the other a 56 bp duplex with the sgRNA (Fig. 5.3A).
We regulated the expression of mVenus using purified dCas9 together with
sgRNA and anti-sgRNA. As shown in Fig. 5.3B, mVenus expression is effi-
ciently suppressed in the presence of dCas9 and sgRNA, while the addition
of the anti-sgRNA variants inhibits the repression of mVenus expression (cf.
Appendix for the corresponding sequences). Our experiments confirmed that
sequestration of the spacer region and only part of the dCas9 handle by the
short anti-sgRNA is sufficient to de-activate the CRISPRi mechanism (Fig.
5.3B). In a second experiment, we delayed the addition of anti-sgRNA relative
to dCas9-sgRNA. We found that mVenus fluorescence is recovered compared
to the knockdown case, however the recovered level is already halved for a
delay time of 15 minutes (Fig 5.3C).
5.3.3 Single-cell analysis of filamentation
After induction of the CRISPRi mechanism with aTc and IPTG, bacterial
cells rapidly stopped division and started the expression of mVenus (which
also was under the control of a pLTetO promoter). The cell length distribu-
tion of ftsZ -knockdown bacteria broadens and shifts towards greater lengths
(Fig. 5.4). The mean cell length increases from < L >= 3 µm to < L >= 21
µm in three hours with 500 µM IPTG and 107 nM aTc (which we defined as
the 100 % induction level).
5.3.4 Efficiency of restoration of normal cell division
We performed time-lapse video microscopy studies (see Sec. 5.5) to observe
the growth and fluorescence of individual filamentous bacteria over time.
Microfluidic trap chambers were connected to fresh medium supply channels
(Fig. 5.5A). Filamentous growth of E. coli proceeded up to 10 hours after
which all bacteria burst [97].
We investigated the process of reverting filamentous cells back to normal
growth by stopping the production of dCas9-sgRNAs via removal of CRISPRi
inducers aTc and IPTG (passive switching) or by removal of CRISPRi induc-
ers and addition of anti-sgRNA inducer (the active approach). Inducing the
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Figure 5.3: Experimental validation of the anti-sgRNA strategy. (A) Secondary
structures of free and complexed sgRNA and anti-sgRNA variants. The dCas9
handle is destroyed by duplex formation, which prevents dCas9 from binding. (B)
Prototyping of the CRISPRi knockdown and rescue system in a cell-free gene ex-
pression system using mVenus as a fluorescent reporter protein. The restoration
of mVenus expression is shown with truncated anti-sgRNA versions (the number
indicates the number of base pairs in the resulting sgRNA:anti-sgRNA duplex).
The expression of mVenus ([template DNA] = 5 nM) is blocked by the supplemen-
tation of purified dCas9 (70 nM) and sgRNA (100 nM) and is re-activated upon
addition of anti-sgRNA (0.5 µM). Fluorescence levels for three different samples
are taken at t = 15.5 hours or t = 11 h. Error bars are plotted as SD from 3
individual replicates. (C) Delaying the time of anti-sgRNA addition relative to
dCas9-sgRNA results in lower mVenus fluorescence intensities. (taken at t = 12
hours). Error bars are plotted as SD from 3 replicates (c(sgRNA) = 250 nM,
c(anti-sgRNA) = 1 µM).
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Figure 5.4: Filamentous bacteria. Histogram of the cell length (calculated from
1000 cells each) at different time points at 100 % induction level (corresponding
to 500 µM IPTG and 107 nM aTc). Over time the distribution broadens and the
whole population shifts to larger lengths.
anti-sgRNA with AHL in the presence of CRISPRi inducers did not result
in arrest of filamentation in microfludic cell trap experiments.
The removal of the CRISPRi inducers – both with or without AHL –
allowed a fraction of about 1.5-3 % of all analyzed cells (about 2000 for each
condition) to resume normal cell division (Fig. 5.6). However, in the presence
of AHL some cells started to divide again after filamentous growth faster
than in the absence of AHL. Furthermore, full induction of the CRISPRi
compared to 43 % induction level for about 2 hours delayed the timing of
the first division event even in the presence of AHL.
Our experiments in microfluidic cell traps revealed a considerable phe-
notypic heterogeneity upon induction of filamentation, which was reversed
once normal growth was restored (Fig. 5.7A and B). In addition to their
size, we characterized the cells with respect to their fluorescence intensity.
After 2 hours of continuous induction with IPTG/aTc, the coefficient of vari-
ation (CV=standard deviation/mean) of the cell size as well as of mVenus
and mRFP expression increased considerably (Fig. 5.7B). In contrast to
aTc-induced mVenus (on the CRISPRi plasmid), the constitutively expressed
mRFP (on the anti-sgRNA plasmid) level dropped during filamentation (Fig.
5.7C).
We characterized the bacteria from experiments using the active approach
to revert to normal growth in respect to the fluorescence of the reporter
proteins.
First, the mRFP expression of the cells can be fitted by a Gaussian dis-
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Figure 5.5: Restoration of cell division. A Microfluidic trap dimensions for single
cell measurements. The medium inlet direction is indicated with arrow marks.
The exchange of nutrients and waste products occurs via diffusion. The channel
width and trap dimensions are given in the layout. The trap height is 1 µm.
The traps are incorporated in a microfluidic gradient mixer [278]. B Histogram
of cell lengths. Actively switched cells regain normal cell length distributions
similar to t = 0 hours of starting induction of filamentous growth. C Left column:
Fluorescence microscopy time series in the mRFP channel of an E. coli cell in a
microfluidic chamber in the absence of inducers. Prior to the first image (top), the
bacterium was grown filamentous for two hours at 43% induction level followed by
a 140-minute exposure to growth medium without any inducers. At 300 minutes
of growth, the bacterium resumes cell division. The new daughter cells quickly
approach the normal cell size. Right column: images (a)-(e) show bright field
images corresponding to the boxed regions on the left.
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Figure 5.6: Single cell analysis of cell division switching. The time delay between
the removal of IPTG/aTc with and without AHL at the first cell division event for
different inducer concentrations of IPTG/aTc. The pie charts show the fraction
of cells that divided compared to the cells that did not divide for each condition.
tribution on a logarithmic scale, which corresponds to lognormal distribution
on a linear scale (Fig. 5.8A). As stated in Sec. 2.3, the lognormal distribution
is frequently observed in biology, as any quantity that depends exponentially
on the product of several independent rates can be well approximated by a
lognormal distribution [279]. In theory, only the limiting distribution of the
product of the several independent quantities will approach a Gaussian dis-
tribution (central limit theorem), but in practice this can already be applied
in cases with several independent rates such as in gene expression.
Second, the mVenus expression could only be fitted with two Gaussian
distributions using the Gaussian mixture fitting procedure on a logarithmic
scale, indicating that there is a subpopulation of bacteria that has mVenus
expression levels differing from those of the bulk of the population (Fig.
5.8B). Most of the bacteria that switch back after being filamentous have
a mean mVenus fluorescence that is 0.2 times lower than the average of the
main population that does not change back. Low mVenus fluorescence should
correlate with low dCas9 concentration (mVenus and dCas9 on the CRISPRi
plasmid are both under TetR-control), which provide an explanation to why
this subpopulation is more prone to restoration.
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Figure 5.7: A 3D scatter plot with the mean mRFP and mVenus fluorescence lev-
els of single bacteria plotted against the observed area of the corresponding cells for
about 1000 cells at three different points in time: 10 minutes after induction (43%
induction level), after 2 hours of continuous induction and after additional 9 hours
without aTc/IPTG. About 5% of the analyzed filamentous cells divide (‘dividers’:
black dots) again after the inducers have been removed from the growth medium.
B The coefficient of variation was calculated for the fluorescence intensities of
mVenus and mRFP and the cell area. The variability of the population increases
during the 2 hours induction period and drops again for the new population emerg-
ing by switching, i.e., after removal of IPTG/aTc. C Upon aTc/IPTG induction,
the cells shift towards higher mean mVenus fluorescence intensities, lower mean
mRFP and higher mean cell area. After 9 hours without inducers the mean values
return to the level of the first measurement (t=10 min ind.).
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Figure 5.8: A Histogram of the mean mRFP fluorescence value for single cells
after 2 hours of aTc/IPTG induction using a logarithmic scale on the x-axis.
The bacteria that will later divide are differently colored. The mRFP expression
levels can be fitted with a lognormal distribution (solid line). B Histogram of
the mean mVenus fluorescence value for single cells after 2 hours of aTc/IPTG
induction using a logarithmic scale on the x-axis. The mVenus expression levels
could only be fitted using two lognormal distributions (solid line), indicating that
there is a subpopulation with lower mVenus F.I. The bacteria that will later divide
(differently colored) are predominately in this subpopulation.
5.3.5 Glycerol stocks
The behavior for intermediate induction level (below 100% induction level)
differed between two different glycerol stocks. In the one glycerol stock, which
was used for all the experiments in this chapter, except for Fig. 5.9B and C,
an induction level of 30% already stopped cell division in nearly all cells so
that the length distribution is the same as for 100 % induction level. For the
other glycerol stock, a medium induction level (43 %) results in a constant
average cell length which means that there is still cell division occurring. The
mean cell division rate is reduced in a continuous fashion between zero and
full induction (Fig. 5.9C). As found by Li et al. [140], at low induction levels
there is a co-existence of subpopulations of normal growing and filamentous
cells.
5.4 Discussion
In E. coli cells, a knockdown of the ftsZ gene stops cell division while still
allowing cell growth, resulting in long filamentous cells. Restoration of FtsZ
levels, in principle, allows cells to return back to normal growth. This opens
up the possibility to implement a genetic switch that can turn cell divi-
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Figure 5.9: A Here bacteria come from the glycerol stock that was also
used for the other cell-division switching experiments in the chapter. Even
a induction level of 30% cells stop to divide and the cell length distribution
does not differ from the one at full induction level (t=3h). B A different
glycerol stock and a different experiment. Tracking the cell length at different
induction levels within microfluidic traps. C Division rates decrease smoothly
with increasing inducer concentrations. Results are mean values over 100
min. Upon 100 % induction of the CRISPRi mechanism, we were able to
switch to filamentous cell growth (with a division rate approaching zero).
sion in E. coli off and on again. We here used a plasmid-based inducible
CRISPRi system to reduce the FtsZ levels in E. col i and stop cell divi-
sion. To implement the circuit in viable bacteria, decoy-binding sites for
the FtsZ-suppressing dCas9-sgRNA complexes had to be introduced as ge-
netic buffer elements. We then reverted the knockdown by removing the
CRISPRi inducers and counter-acted CRISPRi utilizing inducible antisense-
sgRNA molecules that could be used to adjust the threshold for bacterial
filamentation and thus modulate the switching process. Due to the critical
role of cell division in the bacterial life cycle, however, our CRISPRi-based
approach strongly interfered with the physiology of the bacterial host chassis
including slowing down cell division restoration in the majority of the cells.
We used microscopy time lapse experiments to follow thousands of cells
through the switching process to understand the response to the genetic
switch on the single cell level. We found that at best only about 1.5-3 %
of the analyzed cells revert back to normal growth whereas the rest of the
cells lyse. However, expression of anti-sgRNAs can rescue cell division faster
than in experiments, in which only the CRISPRi inducers are removed. Our
experiments demonstrate both the possibilities and limitations of using dCas9
as a switchable repressor for genes such as ftsZ that affect bacterial fitness.
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5.4.1 Switching cell division off
The CRISPRi-mediated knockdown of ftsZ was a surprisingly efficient method
to stop cell division. The microfluidic time-lapse videos of the filamentation
process revealed that the distribution of cell lengths broadens with continu-
ing CRISPRi induction. We were able to identify at least three contributions
to such a broadening distribution: filamentous cells do not necessarily divide
symmetrically [280], larger cells can produce cell mass faster than smaller
cells [281] and filamentous cells start to slow down their growth rate at some
point and eventually lyse.
It was found that when the FtsZ level falls below≈ 28 % of its initial value,
the cell is not able to form FtsZ rings [259]. We targeted the template strand
of the promoters (ftsZ2p, ftsZ3p, ftsZ4p) that, however, only account for
about 14 % of the total transcription of ftsZ in the cell [282]. Hence, a major
fraction of the FtsZ level reduction may be caused by dCas9-sgRNA blocking
the transcriptional elongation also from upstream promoters, although it was
previously found that targeting the template strand with the sgRNA does
not result in strong repression of transcriptional elongation [53].
In this context, dCas9 off-target kinetics have been previously studied
[283]. Off-target binding strongly affects dissociation and association kinetics
and thus occupancy of DNA sites, which could further contribute to gene
expression heterogeneity. In addition, Cho et al. reported dCas9 binding to
several genes even in the absence of guide RNA [142].
To our surprise, the introduction of the plasmid-based inducible CRISPRi-
system without decoy-binding sites led to filamentous growth even in the ab-
sence of inducers (Fig. 5.2). This stands in contrast to ftsZ knockdown using
tunable CRISPRi (tCRISPRi) or other previously employed plasmid-based
CRISPRi systems [138] [140]. One major difference is that we used an in-
ducible T7 RNAP for the expression of the sgRNAs rather than constitutive
E. coli promoters. We assume that the leaky expression of the T7 RNAP
together with the leaky expression of dCas9 produces enough dCas9-sgRNA
complexes to already sufficiently knock down ftsZ on the chromosome. Previ-
ously, strongly binding TFs such as TetR were buffered by the introduction of
DNA sponges [20]. In a similar way, we here set the threshold for CRISPRi-
based ftsZ knockdown via the sponge copy number, solving the problem of
non-induced filamentation (Fig. 5.2). Thus, cellular filamentation in the
present study could be clearly linked to the CRISPRi. Potential CRISPRi
off-target effects have not been studied in the context of this work, however.
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5.4.2 Restoration of E. coli to normal growth
Microfluidic time lapse videos showed that switching cell division back on was
not very efficient. Methods that lack an appropriate time resolution do not
allow to distinguish between cells that have just switched back and daughter
cells from already restored cells. This could lead to an overestimation of
the switching efficiency, in particular when the new state of the bacteria is
associated with increased fitness (which is the case here).
In all our switching strategies, restoration of normal growth for most cells
occurred within a few hours, which is slower than in studies where ftsZ was
directly put under the control of an IPTG-inducible promoter [259]. In our
case, the removal of the inducers stops new dCas9-sgRNA complexes from
being expressed and assembled, but does not influence already bound com-
plexes. In particular, it has been shown that activated dCas9 binds to its
recognized DNA target site very strongly (Kd ≈ 0.5 nM) [283] [284]. In gen-
eral, transcription factors (TFs) with strong affinity for their DNA-binding
site such as TetR do not unbind from their target site until an extremely low
amount of only a few molecules per cell (corresponding to low nanomolar
concentrations) is reached. In agreement with this consideration, Boyle et
al. found that dissociation of dCas9 from on-target sites with strong affinity
can take many hours [135]. Recovery of FtsZ levels is thus expected to be
governed by the dilution of the dCas9-sgRNA complexes which is automat-
ically provided by cell growth. In addition, it has been shown that RNAP
or DNA replication machinery knock the dCas9-sgRNA complex from the
target site [137]. Thus, cell division can resume at potential division sites as
soon as FtsZ levels recover. Other studies aiming at the reversal of CRISPRi
due to dilution, reported full restoration of expression levels of targeted flu-
orescent proteins after washing away CRISPRi inducers at around 350-480
min [53] [140]. Interestingly, with our approach, it took only about 260
minutes on average to observe the first division events after the removal of
CRISPRi inducers, suggesting that cell division resumes even before the ftsZ
levels are fully recovered. However, in microfluidic devices we also observe
that the main part of the population does not survive the slow knockdown
and recovery process (Fig. 5.6). Importantly, the expression of anti-sgRNA
allows some cells to resume cell division faster than without anti-sgRNA.
As suggested by the results from the in vitro experiment (Fig. 5.3), the
anti-sgRNA inhibits complex formation of dCas9 and sgRNA by binding to
the sgRNA. Hence, the FtsZ levels is probably recovered faster in some cells
with dCas9-sgRNA being kicked off the target site in combination with the
expression of anti-sgRNA.
Another CRISPRi anti-sgRNA approach was recently conducted by Lee
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et al. [141]. The anti-sense RNA in this study was shown to fully recover the
expression of a fluorescent reporter within 360 minutes, even in the presence
of continuously expressed sgRNA. Furthermore, they were able to establish
a relationship between the de-repression efficiency and the binding affinity of
the anti-sgRNA to the sgRNA, supporting the hypothesis that de-repression
by anti-sense RNA can be partially explained by equilibrium thermodynam-
ics. In contrast to the simple strand invasion approach taken in our study,
Lee et al. augmented their antisense-sgRNA with binding sites for the RNA
chaperone Hfq, which apparently increased its de-repression efficiency.
Rather than increasing sgRNA-anti-sgRNA interactions in this manner,
alternatively the binding strength of dCas9-sgRNA to its target may be weak-
ened. For instance, Vigouroux et al. recently demonstrated that reduced
complementarity between target DNA and sgRNA increases the probability
of the dCas9-sgRNA complex being kicked off by RNA or DNA polymerase
[137]. This could help in the release of kinetically trapped dCas9-sgRNA
complexes on the DNA target site to the cytosol where they might be more
accessible to anti-sgRNA.
5.4.3 Heterogeneity in gene expression
After switching to filamentous growth, we observed an increase in population
heterogeneity, which is reflected by altered reporter fluorescence levels, an
increase in their coefficients of variation, and by varying bacterial length
distributions (Fig. 5.7). The measured decrease in constitutively expressed
mRFP fluorescence intensity could be caused by plasmid dilution, a reduced
protein expression rate or both.
Although all the plasmids copy number controls are based on a negative
feedback mechanism that measures the concentration of the plasmids in the
cells, it is unclear what happens to the copy number in filamentous cells
[285] [286]. Furthermore, only the copy number of the sum of the pLysS and
CRISPRi plasmid should remain fixed, allowing for larger ratios between the
two. We continuously selected with the antibiotics of the CRISPRi plasmid,
to guarantee the presence of the plasmid. We assume that the subpopulation
of bacteria that switches faster than the rest of the cells, and which can be
characterized by low mVenus fluorescence (Fig. 5.8), has a low copy number
of the CRISPRi plasmid. After switching back to normal cell growth, the
new population of growing cells displayed CV values similar to the starting
population.
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5.5 Materials and Methods
5.5.1 Plasmids
We constructed plasmids by Gibson assembly of synthetic DNA fragments
into the target vector (pSB1K3 and CRISPRi plasmid 44249 from addgene).
The final plasmid sequences can be found in the appendix. The sender strain
was constructed in an earlier study and contains the gene for LuxI synthase
(BioBrick part BBa C0261). The sgRNA, anti-sgRNA and sponge element
sequences are listed in Appendix.
5.5.2 Bacterial cell culture
Experiments with filamentous cells were performed in Escherichia coli BL21
(DE3) pLysS. Although the pLysS plasmid has the same origin of replication
as the CRISPRi plasmid we select with the antibiotics (Carbenicillin) for the
CRISPRi plasmid to ensure its presence in the cells. Furthermore, we de-
tect the inducible mVenus expression from the CRISPRi plasmid in the cells.
Cells from glycerol stock were grown in 5 ml Luria-Bertani medium contain-
ing antibiotics selecting for both plasmids (CRISPRi and asgRNA plasmid)
and incubated over night at 37◦C and 250 rpm. The following day, cells
were diluted 1:1000 and incubated for additional 4 h. Optical density (OD
600nm) values between 0.4-0.6 were obtained. From this batch, 1 ml of the
culture was centrifuged and the pellet resuspended in 300 µl growth medium.
The concentrated cells were immediately loaded on a microfluidic chamber
until single or few bacteria were captured in the traps. In such a microfluidic
chemostat with defined bacterial trap dimensions, we supplied the bacterial
suspension constantly with fresh nutrients (LB medium, antibiotics and/or
inducer chemicals or dyes) using a pressure flow controller (OB1, Elveflow).
5.5.3 Fluorescence time-lapse microscopy
The microfluidic PDMS (Sylgard 182, Dow Corning) device was fabricated
using standard soft lithography as previously described [287]. The microflu-
idic device is a combination of a gradient mixer [278] and bacterial traps
designed with dimensions of 200 µm x 10-50 µm x 1 µm as a H-shaped chemo-
stat (Fig. 5.5). Time-lapse microscopy measurements were conducted on a
Nikon Ti-Eclipse epi-fluorescence microscope controlled with NIS-Elements
Imaging Software. The microscope was equipped with a sCMOS camera
(Zyla, Andor), an automated x-y-stage (Prior Scientific, Cambridge, UK)
and an incubator box (Okolab) to maintain an operation temperature of
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37◦C. All videos were recorded with 40x apochromatic magnification ob-
jectives. Every 5 to 20 min, images in phase contrast mode, YFP as well
as RFP fluorescence mode (in combination with the appropriate filter sets)
were taken for a total run time of up to 20 hours. The exposure times were
automatically adjusted.
5.5.4 Cell-free expression
For the cell-free assay, the sgRNA sequences were designed complementary
to the non-template strand (sequences can be found in the appendix. Anti-
sgRNA and sgRNA where transcribed in vitro by T7 RNA Polymerase (NEB)
from linear DNA (IDT DNA) overnight and then extracted with Phenol-
Chloroform. The concentration of the RNA was determined by comparing
a SYBR Green II stained band in a denaturing PAGE (8M Urea at 45 ◦C)
to the RNA Ladder (NEB, N0364S). The plasmid with mVenus was purified
using Phenol-Chloroform prior the reaction in the cell extract. The crude
S30 cell extract was obtained by beat beating of a BL21- Rosetta2(DE3)
mid-log phase culture with 0.1 mm glass beads in a Minilys device (Peqlab)
and supplemented with an energy mix and reaction buffer as described in
ref. [68]. Instead of 3-phosphoglyceric acid (3-PGA), phosphoenolpyruvate
(PEP) was utilized as an energy source. dCas9 was His-tagged and purified
by gravity- flow chromatography with Ni-NTA Agarose Beads (Qiagen). The
fluorescence intensity was measured with a FLUOstar Omega plate reader
(BMG) in 96-well plate (ibidi) at 37◦C. The composition of a single cell-free
reaction was: 33 % (v/v) S30 cell extract mixed with 42 % (v/v) buffer and
25 % (v/v) DNA plus inducers.
5.5.5 Data analysis
Image analysis was performed using NIS-Elements (Nikon) and customized
MATLAB software.
5.6 Contributions
The experiments were conceptualized by Andrea Mu¨ckl (A.M.), Friedrich
C. Simmel (F.S.) and Matthaeus Schwarz-Schilling (M.S.). The plasmids
were designed and constructed by A.M. and Katrin Fischer. The microscopy
images of the bacteria with/without decoy binding sites and the control with
aTc and without IPTG were acquired by A.M. As well as the experiments
and the analysis of the Fig. 5.9B and C. Unless specifically stated otherwise,
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the experiments in the cell-free exression system or with bacteria that are
presented in this chapter were conducted and analyzed by M.S.
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Chapter 6
Conclusion and outlook
In summary, we have used cell-free gene expression to prototype functional as-
pects of genetic constructs. We have shown that cell-free expression systems
provide a simpler and more controllable environment for gene expression and
regulation than bacteria. Furthermore, limitations of the proclaimed goal
to use cell-free expression as a prototyping platform for in vivo applications
have been demonstrated.
In the first project, we compared the function of a plasmid-based sender-
receiver system in bacteria and a cell-free gene expression system. We en-
capsulated both expression systems in water-in-oil droplets, which we then
loaded into a glass capillary. This linear arrangement of droplets allowed
us to study gene expression based on the diffusion of two different chemical
inducers, AHL and IPTG, in a quantitative manner. We here found that
for characterization of the response of the receiver plasmid to chemical in-
ducers the cell-free expression system is better suited than bacteria. The
sender plasmid was successfully implemented in the cell-free expression sys-
tem, so that we were able to produce sufficient amounts of AHL to establish
and demonstrate chemical communication between the cell-free senders and
bacterial receivers. The direction of the communication could be reversed,
with cell-free receivers listening to bacterial senders. The possibility of com-
munication between cells and artificial non-living cells opens up a field for
many applications from sensing of pathogenic bacteria to inhibiting biofilm
formation. These experiments show that artificial cellular systems are easier
to control in certain aspects than living organisms. The chemical interface
between artificial cells and cells could be used to create multicellular hybrid
system, in which different modules that are easier to implement in one or the
other can be combined.
In a second project, the design, expression and assembly of a RNA-protein
hybrid structure in buffer solutions, a cell-free expression system and bacteria
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was demonstrated. We found that assembly of the protein-based FRET pair
on the RNA structure was more efficient in buffer solution than in a cell-free
expression system. However the cell-free expression system proved superior
to bacteria. Unwanted cross-talk with other molecules or sub-optimal con-
centration of components are common reasons for less efficient assembly in
more complex environments. We show that a cell-free expression system
allows to address the challenges of designing and expressing artificial multi-
component nanostructures in a systematic fashion. We believe that there will
be more new functional nanostructures made from assembling different kind
of molecules. Intricate molecular machines like the ribosome, which consists
of three RNA molecules and about 52 proteins demonstrate the potential
[103]. We believe that cell-free expression systems are an important tool in
bottom-up synthetic biology to develop and create these genetically encoded
multi-component nanostructures.
In the third project, CRISPRi and an anti-sgRNA were used in a cell-
free expression system to knock-down the expression of a fluorescent protein.
Reversibility of CRISPRi was tested in bacteria by targeting the expression
of ftsZ, which halts cell division if its concentration falls below 28 % of its
initial value [259]. We successfully implemented sponge elements to buffer the
effect of leaky CRISPRi in an uninduced state. The anti-sense RNA strategy
proved to not be efficient in de-repressing gene expression, neither in the cell-
free expression system nor in cells. The CRISPRi mediated knockdown of
ftsZ strongly interfered with the physiology and gene expression levels of
reporter proteins in the cell. Hence a cell-free expression system will not be
able to predict the response of bacteria to a genetic switch. For synthetic
gene switches that perturb the cell cycle, the response of the cells is often
complex. This directs the focus of the research away from the synthetic
switch to the response of the organism. We believe that cell-free synthetic
biology allows to re-direct the focus on the development of tools by providing
a controlled and open environment. As the field of cell-free synthetic biology
is growing, we can envision that more tools that are designed in cell-free
environments will not be transferred to cells but will actually be applied in
a cell-free context. In effect, as applications of cell-free synthetic biology are
on the rise, we can foresee new biology and biochemistry happening outside
of cells.
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Appendix
DNA, RNA and protein sequences for Ch. 4
The sequences used in the constructs for the experiments shown in Chapter
4.
RNA sequences
MG aptamer GGAUCCCGA CUGGCGAGAG CCAGGUAACG
AAUGGAUCC
TAR aptamer GGCUCGUGUAGCUCAUUAGCUCCGAGCC
PP7 Aptamer GGCACAGAAGAUAUGGCUUCGUGCC
MS2 Aptamer GCGCACAUGAGGAUCACCCAUGUGC
Streptavidin Aptamer AUGCGGCCGCCGACCAGAAUCAUGCAAGUG
CGUAAGAUAGUCGCGGGUCGGCGGCCGCAU
pRNA-3WJ 1st Part: TTGTCATGTGTATGTTGGG
2nd Part: CCCACATACTTTGTTGATCC
3rd Part: GGATCAATCATGGCAA
RNA nanostructure GGGTTGTCATGTGTATGTTGGGGGATCCCGAC
TGGCGAGAGCCAGGTAACGAATGGATCCCCC
ACATACTTTGTTGATCCCGCAGGATTCGGCTC
GTGTAGCTCATTAGCTCCGAGCCGAGTCCTCGAA
TACGAGCTGGGCACAGAAGATATGGCTTCGTGCCCA
GGAGGTGTTCGCACTTCTCTCGTGTTC
GATTGTGGGATCAATCATGGCAAATGCGGCCG
CCGACCAGAATCATGCAAGTGCGTAAGATAGTCG
CGGGTCGGTGGTCGCAT
TAR-PP7 RNA GGGCGCAGGATTCGGCTCGTGTAGCT
CATTAGCTCCGAGCCGAGTCCTCGAATACGA
GCTGGGCACAGAAGATATGGCTTCGTGCCCAG
GAAGTGTTCGCACTTCTCTCGTATTCGATTG
CGTGATACCTACGAC
MS2-PP7 RNA GGGCGCAGGACTCGCGCACATGAGGAT
CACCCATGTGCGAGTCCTCGAATACGAGCTGG
GCACAGAAGATATGGCTTCGTGCCCAGGAAGT
GTTCGCACTTCTCTCGTATTCGATTGCGTGA
TACCTACGAC
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Peptide sequences
PP7 Coat Protein MSKTIVLSVGEATRTL
TEIQSTADRQIFEEKVGPLVGRL
RLTASLRQNGAKTAYRVNLKLDQAD
VVDSGLPKVRYTQVWSHDVTIVANS
TEASRKSLYDLTKSLVATSNVE
DLVVNLVPLGRK
Tat peptide SGPRPRGTRGKGRRIRR
MS2 Coat Protein MASNFTQFVLVDNGGT
GDVTVAPSNFANGIAEWISSNSRSQAYKVTCSVRQ
SSAQNRKYTIKVEVPKGAWRSYLNMEL
TIPIFATNSDCELIVKAMQGLL
KDGNPIPSAIAANSGIY
Peptide-Linker TRGGGGS
mTurquoiuse2 MVSKGEELFTGVVPIL
VELDGDVNGHKFSVSGEGEGDATYG
KLTLKFICTTGKLPVPWPTLVTTLSWGVQC
FARYPDHMKQHDFFKSAMPEGYVQERTIFF
KDDGNYKTRAEVKFEGDTLVNRIELKGIDF
KEDGNILGHKLEYNYFSDNVYITADKQKNGI
KANFKIRHNIEDGGVQLADHYQQNTPIG
DGPVLLPDNHYLSTQSKLSKDPNEKRDHMV
LLEFVTAAGITLGMDELYK
Ypet MSKGEELFTGVVPILVELDGD
VNGHKFSVSGEGEGDATYGKLTLKLLCTTG
KLPVPWPTLVTTLGYGVQCFARYP
DHMKQHDFFKSAMPEGYVQERTIFFKD
DGNYKTRAEVKFEGDTLVNRIE
LKGIDFKEDGNILGHKLEYNYNSHNVYITA
DKQKNGIKANFKIRHNIEDGGVQL
ADHYQQNTPIGDGPVLLPDNHYLSYQS
ALFKDPNEKRDHMVLLEFLTAAGI
TEGMNELYK
154
Cy-plasmid
cgccccgccctgccactcatcgcagtactgttgtaattcattaagcattctgccgacatggaagccatcaca
aacggcatgatgaAcctgAatcgccagcggcatcagcaccttgtcgccttgcgtataatatttgcccatgg
tgaaaacgggggcgaagaagttgtccatattggccacgtttaaatcaaaactggtgaaactcacccaggga
ttggctgagacgaaaaacatattctcaataaaccctttaggGaaataggccaggttttcaccgtaacacgc
cacatcttgcgaatatatgtgtagaaactgccggaaatcgtcgtggtattcactccAgagcgatgaaaacg
tttcagtttgctcatggaaaacggtgtaacaagggtgaacactatcccatatcaccagctcaccgtctttcA
ttgccatacgaaattccggatgagcattcatcaggcgggcaagaatgtgaataaaggccggataaaacttg
tgcttatttttctttAcggtctttaaaaaggccgtaatatccagctgaacggtctggttataggtacattgag
caactgactgaaatgcctcaaaatgttctttacgatgccattgggatatatcaacggtggtatatccagtga
tttttttctccattttagcttccttagctcctgaaaatctcgataactcaaaaaatacgcccggtagtgatctt
atttcattatggtgaaagttggaacctcttacgtgcccgatcaactcgagtgccacctgacgtctaagaaac
cattattatcatgacattaacctataaaaataggcgtatcacgaggcagaatttcagataaaaaaaatcctt
agctttcgctaaggatgatttctggaattcgagtaagccgcttctagagcaccgattgagaagagaaaaga
aaaccgccgatcctgtccaccgcattactgcaaggtagtggacaagaccggcggtcttaagttttttggctg
aaagtagtaccattaacgacgaatgcgacgacccttaccgcgggtaccacgaggacgcggaccgctgctgc
cgccgccaccacgggtcttgtacagttcgtccatacccagcgtgatacccgccgcggtaacaaattccagca
ggaccatgtggtcacgtttttcgttcggatctttggacagtttggattgcgtgctcaagtagtgattatctgg
cagcaggaccggaccatcgccaatcggggtgttctgttgatagtgatcggccaattgcacgccgccatcttc
aatattgtgacggatcttgaagtttgctttaatgccgtttttctgtttatcagcggtgatgtacacattgtcgc
tgaagtaattatactccagtttgtgacccaggatgttaccgtcctctttaaagtcaatacctttcagctcaat
acgattcaccagcgtgtcaccctcgaacttgacttctgcgcgggtcttatagttaccgtcgtctttgaaaaag
atcgtacgttcctgaacgtagccttccggcacgcgctcttaaagaagtcatgctgtttcatgtgatccggata
gcgcgcgaaacattgcacgccccacgacagagtcgtcaccagggcaccacgggtaaattgccggttccgtg
gccgaccctggtcacgacgctgggttatggtgtacaatgttttgcacgctatccggaccacatgaaacagca
cgatttcttcaagagcgcgatgccggaaggctatgttcaggaacgtaccatctttttcaaagatgatggtaa
ttacaaaacccgcgcagaagtgaagttcgagggtgacaccctggtgaaccgtattgagctgaagggtattg
acttcaaggaagatggcaatattctgggtcacaaactggagtacaactataacagccataacgtctacatc
accgcggataagcaaaaaaatggtatcaaagcaaatttcaagattcgccacaacatcgaagatggcggcg
tgcaactggccgatcattatcagcagaataccccaatcggtgacggtccggtgctgttgccggataaccact
acctgagctatcaaagcgcgttgttcaaagacccgaatgaaaaacgtgaccacatggttctgctggaatttc
tgaccgctgcgggcatcactgaaggcatgaatgaactgtacaagacgcgtggtggcggcggttcgatgagc
aagactatcgttttgtccgtcggcgaggctacccgtaccttgaccgaaattcaatccaccgcggaccgtcaa
atttttgaggaaaaagtcggtcctctggtgggtcgtctgcgtctgaccgcgagcctgcgccagaacggtgcc
aaaacggcataccgtgttaatctgaaactggatcaggccgacgttgtggacagcggtctgccgaaagtccg
ctacacccaggtgtggagccacgatgtgacgatcgttgcgaatagcaccgaagcgagccgcaagagcctgt
acgacctgaccaagagcctggtggcaacgtcccaagttgaagatctggttgttaacctggtgccgctgggtc
gttaaagcatgccggaggaaacacagaaaaaagcccgcacctgacagtgcgggctttttttttcgaccaaa
ggggtgcatactagtagcggccgctgcagtccggcaaaaaagggcaaggtgtcaccaccctgccctttttct
ttaaaaccgaaaagattacttcgcgttatgcaggcttcctcgctcactgactcgctgcgctcggtcgttcggc
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tgcggcgagcggtatcagctcactcaaaggcggtaatacggttatccacagaatcaggggataacgcagg
aaagaacatgtgagcaaaaggccagcaaaaggccaggaaccgtaaaaaggccgcgttgctggcgtttttc
cacaggctccgcccccctgacgagcatcacaaaaatcgacgctcaagtcagaggtggcgaaacccgacag
gactataaagataccaggcgtttccccctggaagctccctcgtgcgctctcctgttccgaccctgccgcttac
cggatacctgtccgcctttctcccttcgggaagcgtggcgctttctcatagctcacgctgtaggtatctcagt
tcggtgtaggtcgttcgctccaagctgggctgtgtgcacgaaccccccgttcagcccgaccgctgcgcctta
tccggtaactatcgtcttgagtccaacccggtaagacacgacttatcgccactggcagcagccactggtaac
aggattagcagagcgaggtatgtaggcggtgctacagagttcttgaagtggtggcctaactacggctacac
tagaagaacagtatttggtatctgcgctctgctgaagccagttaccttcggaaaaagagttggtagctcttg
atccggcaaacaaaccaccgctggtagcggtggtttttttgtttgcaagcagcagattacgcgcagaaaaa
aaggatctcaagaagatcctttgatcttttctacggggtctgacgctcagtggaacgaaaactcacgttaag
ggattttggtcatgagattatcaaaaaggatcttcacctagatccttttaaattaaaaatgaagttttaaatc
aatctaaagtatatatgagtaaacttggtctgacagctcgaggcttggattctcaccaataaaaaacgcccg
gcggcaaccgagcgttctgaacaaatccagatggagttctgaggtcattactggatctatcaacaggagtc
caagcgagctcgatatcaaattagtcggccacggaaccggcagcttaccggtcgtgcagataaacttcagg
gtcaatttaccgtaggtggcgtcgccctcgccctcaccgctaacgctaaacttgtgaccgttgacatcaccat
ccagctcaaccagaatcggcacgacgccggtgaacagttcttcacccttgctaaccatgtctatttctcctct
ttactgactttaaacaaaattatttgtagaggtcataagtttcgtcgcatttcagcgactcatcagtgggctt
agcccagacttatgactgaagcttcgctagcactatacctaggactgagctagccgtaaagatcctgaatct
cgagattggtgccttgcttggattatgaaatgccagcctgatcatacaacgttggacgaagtagctttaccg
tccacacggtcggaacttggtgtgccgaatccaagtcgagataatcactagatgtcctgaggtgcatactag
aggaccacgcatcgtgatgcctatgcgcggtagtcccaccttgtccactagaatggaagattggcacgtatc
aagactttggagtagtaccataacgccgtttacggctagctcagtcctaggtatagtgctagctagcgcagc
gctcaacgggtgtgcttcccgttctgatgagtccgtgaggacgaaagcgcctctacaaataattttgtttaat
catgagaaagaggagaaaactagatgtctaaaggtgaagaactgtttacgggtgtcgtgccgattctggtc
gagttggacggcgacgtgaacggtcacaaattcagcgtgagcggcgagggcgagggtgacgcgacgtacg
gtaagctgactctgaagctgctgt
r-plasmid
ggtagttattttcaagcattaacatgaacttaaattcatcaaggctaatctctatatttgccttgtgagttttc
ttttgtgttagttcttttaataaccactcataaatcctcatagagtatttgttttcaaaagacttaacatgttc
cagattatattttatgaatttttttaactggaaaagataaggcaatatctcttcactaaaaactaattctaat
ttttcgcttgagaacttggcatagtttgtccactggaaaatctcaaagcctttaaccaaaggattcctgattt
ccacagttctcgtcatcagctctctggttgctttagctaatacaccataagcattttccctactgatgttcatc
atctgagcgtattggttataagtgaacgataccgtccgttctttccttgtagggttttcaatcgtggggttga
gtagtgccacacagcataaaattagcttggtttcatgctccgttaagtcatagcgactaatcgctagttcat
ttgctttgaaaacaactaattcagacatacatctcaattggtctaggtgattttaatcactataccaattgag
atgggctagtcaatgataattacatgtccttttcctttgagttgtgggtatctgtaaattctgctagacctttg
ctggaaaacttgtaaattctgctagaccctctgtaaattccgctagacctttgtgtgttttttttgtttatattc
aagtggttataatttatagaataaagaaagaataaaaaaagataaaaagaatagatcccagccctgtgta
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taactcactactttagtcagttccgcagtattacaaaaggatgtcgcaaacgctgtttgctcctctacaaaac
agaccttaaaaccctaaaggcttaagtagcaccctcgcaagctcgggcaaatcgctgaatattccttttgtc
tccgaccatcaggcacctgagtcgctgtctttttcgtgacattcagttcgctgcgctcacggctctggcagtg
aatgggggtaaatggcactacaggcgccttttatggattcatgcaaggaaactacccataatacaagaaaa
gcccgtcacgggcttctcagggcgttttatggcgggtctgctatgtggtgctatctgactttttgctgttcagc
agttcctgccctctgattttccagtctgaccacttcggattatcccgtgacaggtcattcagactggctaatg
cacccagtaaggcagcggtatcatcaacaggcttacccgtcttactgtccctagtgcttggattctcaccaat
aaaaaacgcccggcggcaaccgagcgttctgaacaaatccagatggagttctgaggtcattactggatcta
tcaacaggagtccaagcgagctcgtaaacttggtctgacagctctagctccggcaaaaaaacgggcaaggt
gtcaccaccctgccctttttctttaaaaccgaaaagattacttcgcgtttgccacctgacgtctaagaaaagg
aatattcagcaatttgcccgtgccgaagaaaggcccacccgtgaaggtgagccagtgagttgattgctacg
taattagttagttagcccttagtgactcgaattcgcggccgcttctagagcacaggccacagtaatacgact
cactatagggttgtcatgtgtatgttgggggatcccgactggcgagagccaggtaacgaatggatccccca
catactttgttgatcccgcaggattcggctcgtgtagctcattagctccgagccgagtcctcgaatacgagct
gggcacagaagatatggcttcgtgcccaggaggtgttcgcacttctctcgtgttcgattgtgggatcaatca
tggcaaatgcggccgccgaccagaatcatgcaagtgcgtaagatagtcgcgggtcggtggtcgcattactt
agcataaccccgcggggcctcttcgggggtctcgcggggttttttgctgaaacggctgctaacaaagcccga
aaggaagctgagttggctgctgccaccgctgagcaataactagcataaccccttggggcctctaaacgggt
cttgaggggttttttgctgaaaggaggaactacactgtctgcaggagtcactaagggttagttagttagatt
agcagaaagtcaaaagcctccgaccggaggcttttgactaaaacttcccttggggttatcattggggctcac
tcaaaggcggtaatcagataaaaaaaatccttagctttcgctaaggatgatttctgctagtattattagaaa
aactcatcgagcatcaaatgaaactgcaatttattcatatcaggattatcaataccatatttttgaaaaagc
cgtttctgtaatgaaggagaaaactcaccgaggcagttccaaagaatggcaaggtcctggtaacggtctgc
gattccgacccgtccaacatcaatacaacctattaatttcccctcgtcaaaaataaggttatcaagtgagaa
atcaccatgagtgacgactgaatccggtgagaatggcaagagcttgtgcatttctttccagacttgttcaac
aggccagccattacgctcgtcatcaaaatcactcgcatcaaccaaaccgttattcatgcgtgattgcgcctg
agcaagacgaaatacacgatcgctgttaaaaggacaattacaaacaggaatcgaatgtaaccggcgcagg
aacacggccagcgcatcaacaatattttcacctgaatcaggatattcttctaatacctggaaggctgttttcc
caggaatcgcggtggtgagtaaccacgcatcatcaggagtacggataaaatgcttgatggtcgggagagg
cataaactccgtcagccagttgagacggaccatctcatctgtaacatcattggcaacgctacctttgccatgt
ttcagaaacaactctggcgcatcgggcttcccatacaagcgatagattgtcgcacctgattgcccgacatta
tcgcgagcccatttatacccatataaatcagcgtccatgttggagtttaagcgcggacgggagcaagacgtt
tcccgttgaatatggctcataacaccccttgtattactgtttatgtaagcagacagttttattgttcatgatga
tatatttttatcttgtgcaatgtaacatcagagattttgagacacaacgtggctttgttgaataaatcgaact
tttgctgagttgaaggatcagctctagtagttacattgtcgatctgttcatggtgaacagctttgaatgcacc
aaaaactcgtaaaagctctgatgtatctatcttttttacaccgttttcatctgtgcatatggacagttttccct
ttgatatgtaacggtgaacagttgttctacttttgtttgttagtcttgatgcttcactgatagatacaagagcc
ataagaacctcagatccttccgtatttagccagtatgttctctagtgtggttcgttgtttttgcgtgagccatg
agaacgaaccattgagatcatacttactttgcatgtcactcaaaaattttgcctcaaaactggtgagctgaa
tttttgcagttaaagcatcgtgtagtgtttttcttagtccgttatgtaggtaggaatctgatgtaatggttgtt
ggtattttgtcaccattcatttttatctggttgttctcaagttcggttacgagatccatttgtctatctagttca
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acttggaaaatcaacgtatcagtcgggcggcctcgcttatcaaccaccaatttcatattgctgtaagtgttta
aatctttacttattggtttcaaaacccattggttaagccttttaaactcat
Sequences for Ch. 5
Plasmid maps
CRISPRi plasmid
attcgcaaacgccctctaatcgaaactaatggggaaactggagaaattgtctgggataaagggcgagattt
tgccacagtgcgcaaagtattgtccatgccccaagtcaatattgtcaagaaaacagaagtacagacaggcg
gattctccaaggagtcaattttaccaaaaagaaattcggacaagcttattgctcgtaaaaaagactgggat
ccaaaaaaatatggtggttttgatagtccaacggtagcttattcagtcctagtggttgctaaggtggaaaaa
gggaaatcgaagaagttaaaatccgttaaagagttactagggatcacaattatggaaagaagttcctttga
aaaaaatccgattgactttttagaagctaaaggatataaggaagttaaaaaagacttaatcattaaactac
ctaaatatagtctttttgagttagaaaacggtcgtaaacggatgctggctagtgccggagaattacaaaaa
ggaaatgagctggctctgccaagcaaatatgtgaattttttatatttagctagtcattatgaaaagttgaag
ggtagtccagaagataacgaacaaaaacaattgtttgtggagcagcataagcattatttagatgagattat
tgagcaaatcagtgaattttctaagcgtgttattttagcagatgccaatttagataaagttcttagtgcatat
aacaaacatagagacaaaccaatacgtgaacaagcagaaaatattattcatttatttacgttgacgaatct
tggagctcccgctgcttttaaatattttgatacaacaattgatcgtaaacgatatacgtctacaaaagaagt
tttagatgccactcttatccatcaatccatcactggtctttatgaaacacgcattgatttgagtcagctagga
ggtgactaactcgagtaaggatctccaggcatcaaataaaacgaaaggctcagtcgaaagactgggccttt
cgttttatctgttgtttgtcggtgaacgctctctactagagtcacactggctcaccttcgggtgggcctttctg
cgtttatacctagggatatattccgcttcctcgctcactgactcgctacgctcggtcgttcgactgcggcgag
cggaaatggcttacgaacggggcggagatttcctggaagatgccaggaagatacttaacagggaagtgag
agggccgcggcaaagccgtttttccataggctccgcccccctgacaagcatcacgaaatctgacgctcaaat
cagtggtggcgaaacccgacaggactataaagataccaggcgtttccccctggcggctccctcgtgcgctct
cctgttcctgcctttcggtttaccggtgtcattccgctgttatggccgcgtttgtctcattccacgcctgacact
cagttccgggtaggcagttcgctccaagctggactgtatgcacgaaccccccgttcagtccgaccgctgcgc
cttatccggtaactatcgtcttgagtccaacccggaaagacatgcaaaagcaccactggcagcagccactg
gtaattgatttagaggagttagtcttgaagtcatgcgccggttaaggctaaactgaaaggacaagttttggt
gactgcgctcctccaagccagttacctcggttcaaagagttggtagctcagagaaccttcgaaaaaccgccc
tgcaaggcggttttttcgttttcagagcaagagattacgcgcagaccaaaacgatctcaagaagatcatctt
attaatcagataaaatatttctagatttcagtgcaatttatctcttcaaatgtagcacctgaagtcagcccca
tacgatataagttgttactagttcttacccgcaaaaaaccccgcttcggcggggttttttcgcgcttttaattt
accaatgcttaatcagtgaggcacctatctcagcgatctgtctatttcgttcatccatagttgcctgactcccc
gtcgtgtagataactacgatacgggagggcttaccatctggccccagtgctgcaatgataccgcgagaccc
acgctcaccggctccagatttatcagcaataaaccagccagccggaagggccgagcgcagaagtggtcctg
caactttatccgcctccatccagtctattaattgttgccgggaagctagagtaagtagttcgccagttaatag
tttgcgcaacgttgttgccattgctacaggcatcgtggtgtcacgctcgtcgtttggtatggcttcattcagct
ccggttcccaacgatcaaggcgagttacatgatcccccatgttgtgcaaaaaagcggttagctccttcggtc
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ctccgatcgttgtcagaagtaagttggccgcagtgttatcactcatggttatggcagcactgcataattctct
tactgtcatgccatccgtaagatgcttttctgtgactggtgagtactcaaccaagtcattctgagaatagtgt
atgcggcgaccgagttgctcttgcccggcgtcaatacgggataataccgcgccacatagcagaactttaaa
agtgctcatcattggaaaacgttcttcggggcgaaaactctcaaggatcttaccgctgttgagatccagttc
gatgtaacccactcgtgcacccaactgatcttcagcatcttttactttcaccagcgtttctgggtgagcaaaa
acaggaaggcaaaatgccgcaaaaaagggaataagggcgacacggaaatgttgaatactcatactcttcc
tttttcaatcatgattgaagcatttatcagggttattgtctcatgagcggatacatatttgaatgtatttaga
aaaataaacaaattaattaataagccggcactaaggtaattccttatgctggatatatacgtgttccagttc
ttatcctatatcgaaagttcaattatacatgtctgcgtcgtcgatatcggtggcgtaccagtgtgttcgtgtc
atctaggaggggcgcgtaggataaataatttttcatacgcaagtgcgtatgccggcatacgcacttgcgtat
gaaaaattatttatatggtaatacgactcactatagggtttcatacgcaagtgcgtatgtttaagagctatg
ctggaaacagcatagcaagtttaaataaggctagtccgttatcaacttgaaaaagtggcaccgagtcggtg
ctttttttaagtctctagactcgcacatgagcaaaacggtagagcgtcactttcactagtgtcgcggccgcta
atacgactcactatagggactaaggtaattccttatgcgtttaagagctatgctggaaacagcatagcaagt
ttaaataaggctagtccgttatcaacttgaaaaagtggcaccgagtcggtgctttttttaagtctctagagtt
gatccggattgactctatgacggtacctgctgactagtgcgcctgcaggatggtaatacgactcactatagg
ggtctgcgtcgtcgatatcgggtttaagagctatgctggaaacagcatagcaagtttaaataaggctagtc
cgttatcaacttgaaaaagtggcaccgagtcggtgctttttttttgcgctgcagccaggcatcaaataaaac
gaaaggctcagtcgaaagactgggcctttcgttttatctgttgtttgtcggtgaacgctctctactagagtca
cactggctcaccttcgggtgggcctttctgcgtttatatttctagagtatggactagtgcttggattctcacca
ataaaaaacgcccggcggcaaccgagcgttctgaacaaatccagatggagttctgaggtcattactggatc
tatcaacaggagtccaagcgagctcgatatcaaaTCCCTATCAGTGATAGAGATTGA
CATCCCTATCAGTGATAGAGATACTGAGCACGGGTCTATACTAG
AGAAAGAGGAGAAATACTAGATGAGCAAAGGCGAAGAACTGTTC
ACGGGTGTGGTTCCGATCCTGGTTGAACTGGATGGCGATGTGAA
CGGTCATAAATTTAGCGTGTCTGGTGAAGGCGAAGGTGATGCGA
CCTACGGCAAACTGACGCTGAAACTGATTTGCACCACGGGTAAA
CTGCCGGTTCCGTGGCCGACCCTGGTGACCACGCTGGGTTATGG
TCTGATGTGTTTCGCACGTTACCCGGATCACATGAAACGCCATG
ATTTCTTTAAATCTGCGATGCCGGAAGGCTATGTGCAGGAACGT
ACCATCTTTTTCAAAGATGATGGTAACTACAAAACCCGCGCGGA
AGTTAAATTTGAAGGCGATACGCTGGTGAACCGTATTGAACTGA
AAGGTATCGATTTCAAAGAAGATGGCAATATTCTGGGTCACAAA
CTGGAATACAACTACAACAGTCATAACGTGTACATTACCGCCGA
TAAACAGAAAAACGGTATCAAAGCAAACTTCAAAATCCGTCACA
ACATCGAAGATGGCGGTGTTCAGCTGGCCGATCATTACCAGCAG
AACACCCCGATTGGCGATGGTCCGGTGCTGCTGCCGGATAATCA
TTATCTGAGTTACCAGAGCAAACTGTCTAAAGATCCGAATGAAA
AACGCGATCACATGGTTCTGCTGGAATTTGTGACCGCGGCCGGC
ATTACGCATGGTATGGATGAACTGTATAAAtaacgtctcattttcgccagatat
cgacgtcttaagacccactttcacatttaagttgtttttctaatccgcatatgatcaattcaaggccgaataa
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gaaggctggctctgcaccttggtgatcaaataattcgatagcttgtcgtaataatggcggcatactatcagt
agtaggtgtttccctttcttctttagcgacttgatgctcttgatcttccaatacgcaacctaaagtaaaatgcc
ccacagcgctgagtgcatataatgcattctctagtgaaaaaccttgttggcataaaaaggctaattgatttt
cgagagtttcatactgtttttctgtaggccgtgtacctaaatgtacttttgctccatcgcgatgacttagtaaa
gcacatctaaaacttttagcgttattacgtaaaaaatcttgccagctttccccttctaaagggcaaaagtga
gtatggtgcctatctaacatctcaatggctaaggcgtcgagcaaagcccgcttattttttacatgccaataca
atgtaggctgctctacacctagcttctgggcgagtttacgggttgttaaaccttcgattccgacctcattaag
cagctctaatgcgctgttaatcactttacttttatctaatctagacatcattaattcctaatttttgttgacact
ctatcgttgatagagttattttaccactccctatcagtgatagagaaaagaattcaaaagatctaaagagga
gaaaggatctatggataagaaatactcaataggcttagctatcggcacaaatagcgtcggatgggcggtg
atcactgatgaatataaggttccgtctaaaaagttcaaggttctgggaaatacagaccgccacagtatcaa
aaaaaatcttataggggctcttttatttgacagtggagagacagcggaagcgactcgtctcaaacggacag
ctcgtagaaggtatacacgtcggaagaatcgtatttgttatctacaggagattttttcaaatgagatggcga
aagtagatgatagtttctttcatcgacttgaagagtcttttttggtggaagaagacaagaagcatgaacgtc
atcctatttttggaaatatagtagatgaagttgcttatcatgagaaatatccaactatctatcatctgcgaaa
aaaattggtagattctactgataaagcggatttgcgcttaatctatttggccttagcgcatatgattaagttt
cgtggtcattttttgattgagggagatttaaatcctgataatagtgatgtggacaaactatttatccagttgg
tacaaacctacaatcaattatttgaagaaaaccctattaacgcaagtggagtagatgctaaagcgattcttt
ctgcacgattgagtaaatcaagacgattagaaaatctcattgctcagctccccggtgagaagaaaaatggc
ttatttgggaatctcattgctttgtcattgggtttgacccctaattttaaatcaaattttgatttggcagaaga
tgctaaattacagctttcaaaagatacttacgatgatgatttagataatttattggcgcaaattggagatca
atatgctgatttgtttttggcagctaagaatttatcagatgctattttactttcagatatcctaagagtaaata
ctgaaataactaaggctcccctatcagcttcaatgattaaacgctacgatgaacatcatcaagacttgactc
ttttaaaagctttagttcgacaacaacttccagaaaagtataaagaaatcttttttgatcaatcaaaaaacg
gatatgcaggttatattgatgggggagctagccaagaagaattttataaatttatcaaaccaattttagaaa
aaatggatggtactgaggaattattggtgaaactaaatcgtgaagatttgctgcgcaagcaacggaccttt
gacaacggctctattccccatcaaattcacttgggtgagctgcatgctattttgagaagacaagaagacttt
tatccatttttaaaagacaatcgtgagaagattgaaaaaatcttgacttttcgaattccttattatgttggtc
cattggcgcgtggcaatagtcgttttgcatggatgactcggaagtctgaagaaacaattaccccatggaatt
ttgaagaagttgtcgataaaggtgcttcagctcaatcatttattgaacgcatgacaaactttgataaaaatc
ttccaaatgaaaaagtactaccaaaacatagtttgctttatgagtattttacggtttataacgaattgacaa
aggtcaaatatgttactgaaggaatgcgaaaaccagcatttctttcaggtgaacagaagaaagccattgtt
gatttactcttcaaaacaaatcgaaaagtaaccgttaagcaattaaaagaagattatttcaaaaaaataga
atgttttgatagtgttgaaatttcaggagttgaagatagatttaatgcttcattaggtacctaccatgatttg
ctaaaaattattaaagataaagattttttggataatgaagaaaatgaagatatcttagaggatattgtttta
acattgaccttatttgaagatagggagatgattgaggaaagacttaaaacatatgctcacctctttgatgat
aaggtgatgaaacagcttaaacgtcgccgttatactggttggggacgtttgtctcgaaaattgattaatggt
attagggataagcaatctggcaaaacaatattagattttttgaaatcagatggttttgccaatcgcaatttt
atgcagctgatccatgatgatagtttgacatttaaagaagacattcaaaaagcacaagtgtctggacaagg
cgatagtttacatgaacatattgcaaatttagctggtagccctgctattaaaaaaggtattttacagactgt
aaaagttgttgatgaattggtcaaagtaatggggcggcataagccagaaaatatcgttattgaaatggcac
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gtgaaaatcagacaactcaaaagggccagaaaaattcgcgagagcgtatgaaacgaatcgaagaaggta
tcaaagaattaggaagtcagattcttaaagagcatcctgttgaaaatactcaattgcaaaatgaaaagctc
tatctctattatctccaaaatggaagagacatgtatgtggaccaagaattagatattaatcgtttaagtgat
tatgatgtcgatgccattgttccacaaagtttccttaaagacgattcaatagacaataaggtcttaacgcgt
tctgataaaaatcgtggtaaatcggataacgttccaagtgaagaagtagtcaaaaagatgaaaaactattg
gagacaacttctaaacgccaagttaatcactcaacgtaagtttgataatttaacgaaagctgaacgtggag
gtttgagtgaacttgataaagctggttttatcaaacgccaattggttgaaactcgccaaatcactaagcatg
tggcacaaattttggatagtcgcatgaatactaaatacgatgaaaatgataaacttattcgagaggttaaa
gtgattaccttaaaatctaaattagtttctgacttccgaaaagatttccaattctataaagtacgtgagatta
acaattaccatcatgcccatgatgcgtatctaaatgccgtcgttggaactgctttgattaagaaatatccaa
aacttgaatcggagtttgtctatggtgattataaagtttatgatgttcgtaaaatgattgctaagtctgagca
agaaataggcaaagcaaccgcaaaatatttcttttactctaatatcatgaacttcttcaaaacagaaattac
acttgcaaatggagag
anti-sgRNA
AGTTCTTATCCTATATCGAAAGTTCAATTATACATGTCTGCGTC
GTCGATATCGGTGGCGTACCAGTGTGTTCGTGTCATCTAGGAGG
GGCGCGTAGGATAAATAATTTTTCATACGCAAGTGCGTATCGGct
gcagtccggcaaaaaagggcaaggtgtcaccaccctgccctttttctttaaaaccgaaaagattacttcgcg
ttatgcaggcttcctcgctcactgactcgctgcgctcggtcgttcggctgcggcgagcggtatcagctcactc
aaaggcggtaatacggttatccacagaatcaggggataacgcaggaaagaacatgtgagcaaaaggcca
gcaaaaggccaggaaccgtaaaaaggccgcgttgctggcgtttttccacaggctccgcccccctgacgagc
atcacaaaaatcgacgctcaagtcagaggtggcgaaacccgacaggactataaagataccaggcgtttcc
ccctggaagctccctcgtgcgctctcctgttccgaccctgccgcttaccggatacctgtccgcctttctccctt
cgggaagcgtggcgctttctcatagctcacgctgtaggtatctcagttcggtgtaggtcgttcgctccaagct
gggctgtgtgcacgaaccccccgttcagcccgaccgctgcgccttatccggtaactatcgtcttgagtccaa
cccggtaagacacgacttatcgccactggcagcagccactggtaacaggattagcagagcgaggtatgtag
gcggtgctacagagttcttgaagtggtggcctaactacggctacactagaagaacagtatttggtatctgcg
ctctgctgaagccagttaccttcggaaaaagagttggtagctcttgatccggcaaacaaaccaccgctggta
gcggtggtttttttgtttgcaagcagcagattacgcgcagaaaaaaaggatctcaagaagatcctttgatct
tttctacggggtctgacgctcagtggaacgaaaactcacgttaagggattttggtcatgagattatcaaaaa
ggatcttcacctagatccttttaaattaaaaatgaagttttaaatcaatctaaagtatatatgagtaaacttg
gtctgacagctcgagtcccgtcaagtcagcgtaatgctctgccagtgttacaaccaattaaccaattctgatt
agaaaaactcatcgagcatcaaatgaaactgcaatttattcatatcaggattatcaataccatatttttgaa
aaagccgtttctgtaatgaaggagaaaactcaccgaggcagttccataggatggcaagatcctggtatcgg
tctgcgattccgactcgtccaacatcaatacaacctattaatttcccctcgtcaaaaataaggttatcaagtg
agaaatcaccatgagtgacgactgaatccggtgagaatggcaaaagcttatgcatttctttccagacttgtt
caacaggccagccattacgctcgtcatcaaaatcactcgcatcaaccaaaccgttattcattcgtgattgcg
cctgagcgagacgaaatacgcgatcgctgttaaaaggacaattacaaacaggaatcgaatgcaaccggcg
caggaacactgccagcgcatcaacaatattttcacctgaatcaggatattcttctaatacctggaatgctgt
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tttcccggggatcgcagtggtgagtaaccatgcatcatcaggagtacggataaaatgcttgatggtcggaa
gaggcataaattccgtcagccagtttagtctgaccatctcatctgtaacatcattggcaacgctacctttgcc
atgtttcagaaacaactctggcgcatcgggcttcccatacaatcgatagattgtcgcacctgattgcccgac
attatcgcgagcccatttatacccatataaatcagcatccatgttggaatttaatcgcggcctggagcaaga
cgtttcccgttgaatatggctcataacaccccttgtattactgtttatgtaagcagacagttttattgttcatg
atgatatatttttatcttgtgcaatgtaacatcagagattttgagacacaacgtggctttgttgaataaatcg
aacttttgctgagttgaaggatcagctcgagtgccacctgacgtctaagaaaccattattatcatgacatta
acctataaaaataggcgtatcacgaggcagaatttcagataaaaaaaatccttagctttcgctaaggatga
tttctgGAATTCATAAAAAACGCCCGGCGGCAACCGAGCGTTACCTG
TAGGATCGTACAGGTTTACGCAAGAAAATGGTTTGTTATAGTCG
AATAAACACTTTTTCAAGTTGATAACGGACTAGCCTTATTTAAA
CTTGCTATGCTGTTTCCAGCATAGCTCTTAAACGCATAAGGAAT
TACCTTAGTCCGCAAAAAACCCCGCTTCGGCGGGGTTTTTTCGC
CGACGGTGTAGGCACGTAAGAGGTTCCAACTTTCACCATAATGA
AACAGGGTCTATACTAGAGAAAGAGGAGAAATACTAGATGAAGA
ACATCAACGCGGATGATACGTACCGTATTATCAACAAGATTAAA
GCCTGCAGTTCGAACAACGATATCAACCAGTGCTTATCCGACAT
GACCAAAATGGTACATTGTGAGTACTACCTGCTGGCGATCATTT
ATCCGCATAGCATGGTAAAATCAGATATTAGCATTCTCGACAAC
TATCCCAAGAAATGGCGTCAGTATTATGATGACGCAAATCTCAT
CAAGTACGATCCGATCGTAGATTATTCTAACTCCAATCATTCAC
CCATTAACTGGAATATCTTTGAAAACAACGCTGTTAACAAAAAA
AGTCCCAATGTCATTAAAGAGGCCAAAACCTCGGGCCTGATTAC
CGGATTTTCCTTTCCAATCCATACGGCGAATAACGGCTTTGGCA
TGCTCTCTTTCGCACACAGTGAGAAGGACAACTATATTGATTCC
CTTTTTCTTCATGCGTGCATGAATATTCCCCTGATCGTCCCGTCT
CTGGTGGACAATTACCGCAAGATCAATATTGCTAATAACAAAAG
TAATAACGACCTTACGAAACGCGAGAAAGAGTGCCTGGCGTGGG
CGTGCGAAGGGAAAAGTTCGTGGGATATCTCTAAGATTCTTGGC
TGTTCGGAGCGCACTGTGACCTTCCATCTGACGAACGCCCAAAT
GAAATTAAACACGACGAATCGTTGCCAGTCCATCTCCAAAGCCA
TTCTGACGGGCGCAATCGACTGTCCGTATTTTAAAAATTAACCA
GGCATCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCCTTT
CGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCTACTAGAGTCA
CACTGGCTCACCTTCGGGTGGGCCTTTCTGCGTTTATATAAGTA
GGGTCGACCAAGAACCGCAAGATGACCTGTAGGATCGTACAGGT
TTACGCAAGAAAATGGTTTGTTATAGTCGAATAAACAAGTAATT
GTCAACAAACTCCAGCATAGCTCTTAAACCCGATATCGACGACG
CAGACTTTTTTTTTTCCAGCATAGCTCTTAAACATACGCACTTGC
GTATGAAACAGAGAATATAAAAAGCCAGATTATTAATCCGGCTT
TTTTATTATTTTCCAGATGGAGTTCTGAGGTCATTACTGGATCT
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AGAgcaatacgcaaaccgcctctccccgcgcgttggccgattcattaatgcagctggcacgacaggtttc
ccgactggaaagcgggcagtgagcgcaacgcaattaatgtgagttagctcactcattaggcaccccaggct
ttacactttatgcttccggctcgtatgttgtgtggaattgtgagcggataacaatttcacacatactagagaa
agaggagaaatactagatggcttcctccgaagacgttatcaaagagttcatgcgtttcaaagttcgtatgg
aaggttccgttaacggtcacgagttcgaaatcgaaggtgaaggtgaaggtcgtccgtacgaaggtacccag
accgctaaactgaaagttaccaaaggtggtccgctgccgttcgcttgggacatcctgtccccgcagttccag
tacggttccaaagcttacgttaaacacccggctgacatcccggactacctgaaactgtccttcccggaaggt
ttcaaatgggaacgtgttatgaacttcgaagacggtggtgttgttaccgttacccaggactcctccctgcaa
gacggtgagttcatctacaaagttaaactgcgtggtaccaacttcccgtccgacggtccggttatgcagaaa
aaaaccatgggttgggaagcttccaccgaacgtatgtacccggaagacggtgctctgaaaggtgaaatca
aaatgcgtctgaaactgaaagacggtggtcactacgacgctgaagttaaaaccacctacatggctaaaaa
accggttcagctgccgggtgcttacaaaaccgacatcaaactggacatcacctcccacaacgaagactaca
ccatcgttgaacagtacgaacgtgctgaaggtcgtcactccaccggtgcttaataacgctgatagtgctagt
gtagatcgctactagagccaggcatcaaataaaacgaaaggctcagtcgaaagactgggcctttcgtttta
tctgttgtttgtcggtgaacgctctctactagagtcacactggctcaccttcgggtgggcctttctgcgtttat
atactagtACTAAGGTAATTCCTTATGCTGGATATATACGTGTTCC
mVenus plasmid
ggggaattgtgagcggataacaattcccctgtagaaataattttgtttaactttaataaggagatataccat
gggcagcagccatcaccatcatcaccacagccaggatccgAATTGGCGTCCCTATCAGT
GATAGAGATTGACATCCCTATCAGTGATAGAGATACTGAGCACG
GGTCTATACTAGAGAAAGAGGAGAAATACTAGATGAGCAAAGGC
GAAGAACTGTTCACGGGTGTGGTTCCGATCCTGGTTGAACTGGA
TGGCGATGTGAACGGTCATAAATTTAGCGTGTCTGGTGAAGGCG
AAGGTGATGCGACCTACGGCAAACTGACGCTGAAACTGATTTGC
ACCACGGGTAAACTGCCGGTTCCGTGGCCGACCCTGGTGACCAC
GCTGGGTTATGGTCTGATGTGTTTCGCACGTTACCCGGATCACA
TGAAACGCCATGATTTCTTTAAATCTGCGATGCCGGAAGGCTAT
GTGCAGGAACGTACCATCTTTTTCAAAGATGATGGTAACTACAA
AACCCGCGCGGAAGTTAAATTTGAAGGCGATACGCTGGTGAACC
GTATTGAACTGAAAGGTATCGATTTCAAAGAAGATGGCAATATT
CTGGGTCACAAACTGGAATACAACTACAACAGTCATAACGTGTA
CATTACCGCCGATAAACAGAAAAACGGTATCAAAGCAAACTTCA
AAATCCGTCACAACATCGAAGATGGCGGTGTTCAGCTGGCCGAT
CATTACCAGCAGAACACCCCGATTGGCGATGGTCCGGTGCTGCT
GCCGGATAATCATTATCTGAGTTACCAGAGCAAACTGTCTAAAG
ATCCGAATGAAAAACGCGATCACATGGTTCTGCTGGAATTTGTG
ACCGCGGCCGGCATTACGCATGGTATGGATGAACTGTATAAAAG
GCCTGCAGCAAACGACGAAAACTACGCTTTAGTAGCTTTAACCA
GGCATCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCCTTT
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CGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCTACTAGAGTCA
CACTGGCTCACCTTCGGGTGGGCCTTTCTGCGTTTATAACTAGT
GCGaagcttgcggccgcataatgcttaagtcgaacagaaagtaatcgtattgtacacggccgcataatc
gaaattaatacgactcactataggggaattgtgagcggataacaattccccatcttagtatattagttaagt
ataagaaggagatatacatatggcagatctcaattggatatcggccggccacgcgatcgctgacgtcggta
ccctcgagtctggtaaagaaaccgctgctgcgaaatttgaacgccagcacatggactcgtctactagcgca
gcttaattaacctaggctgctgccaccgctgagcaataactagcataaccccttggggcctctaaacgggtc
ttgaggggttttttgctgaaacctcaggcatttgagaagcacacggtcacactgcttccggtagtcaataaa
ccggtaaaccagcaatagacataagcggctatttaacgaccctgccctgaaccgacgacaagctgacgacc
gggtctccgcaagtggcacttttcggggaaatgtgcgcggaacccctatttgtttatttttctaaatacattc
aaatatgtatccgctcatgaattaattcttagaaaaactcatcgagcatcaaatgaaactgcaatttattca
tatcaggattatcaataccatatttttgaaaaagccgtttctgtaatgaaggagaaaactcaccgaggcagt
tccataggatggcaagatcctggtatcggtctgcgattccgactcgtccaacatcaatacaacctattaattt
cccctcgtcaaaaataaggttatcaagtgagaaatcaccatgagtgacgactgaatccggtgagaatggca
aaagtttatgcatttctttccagacttgttcaacaggccagccattacgctcgtcatcaaaatcactcgcatc
aaccaaaccgttattcattcgtgattgcgcctgagcgagacgaaatacgcggtcgctgttaaaaggacaat
tacaaacaggaatcgaatgcaaccggcgcaggaacactgccagcgcatcaacaatattttcacctgaatca
ggatattcttctaatacctggaatgctgttttcccggggatcgcagtggtgagtaaccatgcatcatcagga
gtacggataaaatgcttgatggtcggaagaggcataaattccgtcagccagtttagtctgaccatctcatct
gtaacatcattggcaacgctacctttgccatgtttcagaaacaactctggcgcatcgggcttcccatacaatc
gatagattgtcgcacctgattgcccgacattatcgcgagcccatttatacccatataaatcagcatccatgtt
ggaatttaatcgcggcctagagcaagacgtttcccgttgaatatggctcatactcttcctttttcaatattatt
gaagcatttatcagggttattgtctcatgagcggatacatatttgaatgtatttagaaaaataaacaaatag
gcatgctagcgcagaaacgtcctagaagatgccaggaggatacttagcagagagacaataaggccggagc
gaagccgtttttccataggctccgcccccctgacgaacatcacgaaatctgacgctcaaatcagtggtggcg
aaacccgacaggactataaagataccaggcgtttccccctgatggctccctcttgcgctctcctgttcccgtc
ctgcggcgtccgtgttgtggtggaggctttacccaaatcaccacgtcccgttccgtgtagacagttcgctcca
agctgggctgtgtgcaagaaccccccgttcagcccgactgctgcgccttatccggtaactatcatcttgagtc
caacccggaaagacacgacaaaacgccactggcagcagccattggtaactgagaattagtggatttagat
atcgagagtcttgaagtggtggcctaacagaggctacactgaaaggacagtatttggtatctgcgctccact
aaagccagttaccaggttaagcagttccccaactgacttaaccttcgatcaaaccgcctccccaggcggttt
tttcgtttacagagcaggagattacgacgatcgtaaaaggatctcaagaagatcctttacggattcccgaca
ccatcactctagatttcagtgcaatttatctcttcaaatgtagcacctgaagtcagccccatacgatataagt
tgtaattctcatgttagtcatgccccgcgcccaccggaaggagctgactgggttgaaggctctcaagggcat
cggtcgagatcccggtgcctaatgagtgagctaacttacattaattgcgttgcgctcactgcccgctttccag
tcgggaaacctgtcgtgccagctgcattaatgaatcggccaacgcgcggggagaggcggtttgcgtattgg
gcgccagggtggtttttcttttcaccagtgagacgggcaacagctgattgcccttcaccgcctggccctgag
agagttgcagcaagcggtccacgctggtttgccccagcaggcgaaaatcctgtttgatggtggttaacggc
gggatataacatgagctgtcttcggtatcgtcgtatcccactaccgagatgtccgcaccaacgcgcagcccg
gactcggtaatggcgcgcattgcgcccagcgccatctgatcgttggcaaccagcatcgcagtgggaacgat
gccctcattcagcatttgcatggtttgttgaaaaccggacatggcactccagtcgccttcccgttccgctatc
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ggctgaatttgattgcgagtgagatatttatgccagccagccagacgcagacgcgccgagacagaacttaa
tgggcccgctaacagcgcgatttgctggtgacccaatgcgaccagatgctccacgcccagtcgcgtaccgtc
ttcatgggagaaaataatactgttgatgggtgtctggtcagagacatcaagaaataacgccggaacattag
tgcaggcagcttccacagcaatggcatcctggtcatccagcggatagttaatgatcagcccactgacgcgtt
gcgcgagaagattgtgcaccgccgctttacaggcttcgacgccgcttcgttctaccatcgacaccaccacgc
tggcacccagttgatcggcgcgagatttaatcgccgcgacaatttgcgacggcgcgtgcagggccagactg
gaggtggcaacgccaatcagcaacgactgtttgcccgccagttgttgtgccacgcggttgggaatgtaattc
agctccgccatcgccgcttccactttttcccgcgttttcgcagaaacgtggctggcctggttcaccacgcggg
aaacggtctgataagagacaccggcatactctgcgacatcgtataacgttactggtttcacattcaccaccc
tgaattgactctcttccgggcgctatcatgccataccgcgaaaggttttgcgccattcgatggtgtccgggat
ctcgacgctctcccttatgcgactcctgcattaggaaattaatacgactcactata
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target sites and sgRNA/anti-sgRNA for ftsZ
pZ2 target site tttcatacgcaagtgcgtatcgg
pZ3 target site actaaggtaattccttatgctgg
pZ4 target site gtctgcgtcgtcgatatcggtgg
pZ2 sgRNA gggtttcatacgcaagtgcg
tatgtttaagagctatgctg
gaaacagcatagcaagttta
aataaggctagtccgttatc
aacttgaaaaagtggcaccg
agtcggtgcttttttt
pZ3 sgRNA gggactaaggtaattcc
ttatgcgtttaagagct
atgctggaaacagcata
gcaagtttaaataaggct
agtccgttatcaacttgaa
aaagtggcaccgagtcggt
gcttttttt
pZ4 sgRNA ggggtctgcgtcgtcgatat
cgggtttaagagctatg
ctggaaacagcatagca
agtttaaataaggctag
tccgttatcaacttgaaa
aagtggcaccgagtcggtg
cttttttt
pZ3 anti-sgRNA cactttttcaagttgataa
cggactagccttatttaaa
cttgctatgctgtttccag
catagctcttaaacgcata
aggaattaccttagtccgca
aaaaaccccgcttcggcggg
gttttttcgc
pZ4-pZ2 anti-sgRNA caagtaattgtcaacaaact
ccagcatagctcttaaacccg
atatcgacgacgcagactttt
ttttttccagcatagctctta
aacatacgcacttgcgtatga
aacagagaatataaaaagcca
gattattaatccggctttttt
attattt
166
sgRNA/anti-sgRNA for mVenus
mVenus-sgRNA GGGCCAUCCAGUUCAACCAGG
AUGUUUAAGAGCUAUGCUGGAAA
CAGCAUAGCAAGUUUAAAUAAG
GCUAGUCCGUUAUCAACUUGAA
AAAGUGGCACCGAGUCGGUCG
UUUUUUUACACUGUCUGCAGUCC
mVenus anti-sgRNA(42) GGGAUUUCCAGCAUAGCUCUU
AAACAUCCUGGUUGAACUGGAUGG
CCACACUGUCUGCAGUCCGGACA
CGCACCAG
mVenus anti-sgRNA(56) GGGCACUUUUUCAAGUUGAU
AACGACUUGCUAUGCUGUUUCCAGC
AUAGCUCUUAAACAUCCUGGUUG
AACUGGAUGGCCACACUGUCUG
CAGUCCGGACACGCACC
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